<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Virol J</journal-id><journal-title>Virology Journal</journal-title><issn pub-type="epub">1743-422X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19134204</article-id><article-id pub-id-type="pmc">2636769</article-id><article-id pub-id-type="publisher-id">1743-422X-6-4</article-id><article-id pub-id-type="doi">10.1186/1743-422X-6-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Feeling manipulated: cytomegalovirus immune manipulation</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Miller-Kittrell</surname><given-names>Mindy</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mmille14@utk.edu</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Sparer</surname><given-names>Tim E</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>tsparer@utk.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Microbiology, University of Tennessee, 1414 Cumberland Ave., Knoxville, TN, USA</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>9</day><month>1</month><year>2009</year></pub-date><volume>6</volume><fpage>4</fpage><lpage>4</lpage><ext-link ext-link-type="uri" xlink:href="http://www.virologyj.com/content/6/1/4"/><history><date date-type="received"><day>18</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>9</day><month>1</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Miller-Kittrell and Sparer; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Miller-Kittrell and Sparer; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>               Miller-Kittrell               Mindy                              mmille14@utk.edu            </dc:author><dc:title>            Feeling manipulated: cytomegalovirus immune manipulation         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Virology Journal 6(1): 4-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1743-422X(2009)6:1&#x0003c;4&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1743-422X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>No one likes to feel like they have been manipulated, but in the case of cytomegalovirus (CMV) immune manipulation, we do not really have much choice. Whether you call it CMV immune modulation, manipulation, or evasion, the bottom line is that CMV alters the immune response in such a way to allow the establishment of latency with lifelong shedding. With millions of years of coevolution within their hosts, CMVs, like other herpesviruses, encode numerous proteins that can broadly influence the magnitude and quality of both innate and adaptive immune responses. These viral proteins include both homologues of host proteins, such as MHC class I or chemokine homologues, and proteins with little similarity to any other known proteins, such as the chemokine binding protein. Although a strong immune response is launched against CMV, these virally encoded proteins can interfere with the host's ability to efficiently recognize and clear virus, while others induce or alter specific immune responses to benefit viral replication or spread within the host. Modulation of host immunity allows survival of both the virus and the host. One way of describing it would be a kind of "mutually assured survival" (as opposed to MAD, Mutually Assured Destruction). Evaluation of this relationship provides important insights into the life cycle of CMV as well as a greater understanding of the complexity of the immune response to pathogens in general.</p></abstract></article-meta></front><body><sec><title>Introduction</title><p>After an initial primary infection herpesviruses establish latency for the life of the host with periodic and spontaneous reactivation. The coevolution of herpesviruses along with their host allowed these viruses to evolve mechanisms to modulate the host immune response. While some virally encoded proteins facilitate immune evasion, interfering with the host's ability to efficiently recognize and clear virus, others induce or alter specific immune responses to benefit the viral life cycle. Among the herpesviruses, cytomegaloviruses (CMVs) encode the greatest number of genes committed to altering both innate and adaptive immune responses (Additional files <xref ref-type="supplementary-material" rid="S1">1</xref> and <xref ref-type="supplementary-material" rid="S2">2</xref>).</p><sec><title>Innate Immune Responses</title><sec><title>Complement Cascade</title><p>The complement system is composed of a number of plasma proteins that induce inflammatory mediators, opsonization of pathogens, and direct lysis of pathogens and infected cells. The binding of complement proteins to antibody-antigen complexes activates the classical complement pathway, bridging innate and humoral immune responses. The binding of complement proteins directly to the surface of pathogens or infected cells initiates the alternative pathway. Both pathways lead to a common activation of the C3 convertase and subsequent elicitation of chemoattractants (e.g. C5a), opsonizing factors (e.g. C3b) and the membrane attack complex. Antibody-mediated complement lysis is an important mechanism for elimination of virus-infected cells. Therefore, a number of herpesviruses encode complement regulatory proteins. Herpes simplex virus 1 (HSV-1) and Epstein Barr virus (EBV) both have homologues of regulators of complement activation (RCA) proteins, such as CD46 and CD55 [<xref ref-type="bibr" rid="B1">1</xref>]. Complement control proteins including CD46, CD55, and CD59 regulate and also inhibit various stages within the complement cascade [<xref ref-type="bibr" rid="B2">2</xref>]. While no CMV encoded RCA homologues have been identified, CMVs have evolved mechanisms for limiting complement activity. HCMV infected fibroblasts are resistant to complement lysis when treated with CMV-specific antibodies, which would be expected to induce the classical complement pathway [<xref ref-type="bibr" rid="B3">3</xref>]. Human CMV (HCMV) incorporates cellular CD55 and CD59 into its virion. The importance of these complement inhibitory proteins was demonstrated when antibodies against CD55 decreased HCMV replication in fibroblasts following incubation with complement components [<xref ref-type="bibr" rid="B4">4</xref>]. The decrease in viral titers in the presence of these antibodies showed that inhibition of complement activation (i.e. interfering with inhibitory CD55) is important for HCMV replication. HCMV also upregulates the expression of CD46 and CD55 on the surface of infected cells, which decreases the accumulation of C3 convertases. This in turn, protects the cells from complement mediated lysis [<xref ref-type="bibr" rid="B5">5</xref>]. Although the mechanisms differ from other herpesviruses, HCMV is able to inactivate the complement cascade, increasing virus replication/survival.</p><p>Mouse CMV (MCMV) also induces CD46 expression on infected fibroblasts. This upregulation was mapped to a CMV responsive element within the CD46 promoter [<xref ref-type="bibr" rid="B6">6</xref>]. Mice typically express the complement regulator CRRY instead of CD46 [<xref ref-type="bibr" rid="B7">7</xref>]. However, MCMV infected cells resist complement lysis and CD46 expression is associated with this decrease [<xref ref-type="bibr" rid="B6">6</xref>]. The viral proteins that interfere with this specific, antibody-mediated complement activity during MCMV infection have not been identified.</p></sec><sec><title>Fc Receptor Homologues</title><p>Clinical evidence supports a role for antibodies in limiting cytomegalovirus infection [<xref ref-type="bibr" rid="B8">8</xref>] and modulation of antibody-mediated immunity would be beneficial for CMV survival. CMV infected cells can bind immunoglobulins in serum of seronegative individuals [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. This phenomenon was linked to the expression of Fc binding proteins (FcBPs) on the surface of infected cells that are specific for IgG but not other isotypes [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. Both MCMV and HCMV encode FcBPs. MCMV encodes one FcBP, fcr-1 or m138. Although, m138 has no homology to the HCMV Fc&#x003b3; BP it has conserved structural features with cellular Fc&#x003b3; receptors (Fc&#x003b3;Rs) and the viral Fc&#x003b3;R of HSV (gE-gI) [<xref ref-type="bibr" rid="B16">16</xref>]. Normally the FcRs from the host interact with the Fc region of Igs and mediate a number of effector functions including phagocytosis, release of inflammatory cytokines, and natural killer (NK) cell-mediated antibody dependent cellular cytotoxicity (ADCC)[<xref ref-type="bibr" rid="B17">17</xref>]. It has been speculated that the Fc region of anti-CMV antibodies bind the viral Fc&#x003b3;R instead of host Fc&#x003b3;Rs and block antiviral activities. m138 is important for MCMV replication <italic>in vivo</italic>. However, both wild-type and B cell deficient mice infected with a &#x00394;m138 MCMV mutant had lower viral titers in several organs compared to mice infected with wild-type MCMV. Thus impaired growth of MCMV is not due to an enhanced humoral immune response in the absence of m138 (i.e. similar titers were found in the presence or absence of humoral responses) [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Interestingly, m138 downregulates expression of H60 and MULT-1, two ligands of the activating NK receptor, NKG2D. The importance of this downregulation <italic>in vivo </italic>was demonstrated when the &#x00394;m138 MCMV was found at two logs reduced titer compared to wt MCMV. Both replicated equivalently in NK cell depleted mice. The downregulation of MULT-1, but not H60, is due to defective cellular trafficking that results in degradation of the protein [<xref ref-type="bibr" rid="B20">20</xref>]. m138 also decreases cell surface trafficking of the costimulatory molecule B7-1 on dendritic cells (DCs), interfering with the ability of these cells to activate antigen specific T cells [<xref ref-type="bibr" rid="B21">21</xref>]. Thus the MCMV Fc&#x003b3;R should broadly affect both NK cell recognition and perhaps presentation to the adaptive immune response, although in a manner different from HSV-1 gE-gI.</p><p>Two HCMV Fc&#x003b3;Rs have been identified, gp34 and gp68, which are encoded by the genes <italic>TRL11/IRL11 </italic>and <italic>UL119-UL118</italic>, respectively [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Although the function of the HCMV-encoded Fc&#x003b3;Rs has not been determined, initially it was assumed they would function like the viral Fc&#x003b3;R from HSV-1 (gE-gI), which protects infected cells from ADCC and complement activation [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Recently it was shown that gp68 binds the same IgG domain and with the same stoichiometry as HSV-1 gE-gI. However, the two proteins have different pH requirements for binding which may relate to different mechanisms following IgG engagement, although this possibility requires additional study [<xref ref-type="bibr" rid="B26">26</xref>].</p></sec><sec><title>Interferon-Mediated Immunity</title><p>While interferons (IFNs) are induced early during CMV infection [<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B32">32</xref>], CMVs encode a number of proteins that mitigate the effects of IFN activation [<xref ref-type="bibr" rid="B33">33</xref>-<xref ref-type="bibr" rid="B35">35</xref>]. The type I interferons IFN&#x003b1; and IFN&#x003b2; are part of the innate immune response to viral infections [<xref ref-type="bibr" rid="B36">36</xref>]. The binding of IFN&#x003b1; and IFN&#x003b2; to the IFN receptor induces Jak/Stat signalling leading to the rapid upregulation of interferon-stimulated genes (ISGs), such as MHC class I molecules and various cytokines [<xref ref-type="bibr" rid="B37">37</xref>]. Two HCMV immediate early gene products, 72 kDa immediate early 1 (IE1) protein (IE1-p72) and IE2 protein (IE86), interfere with IFN signalling. IE1-p72 binds STAT2 inhibiting the ISG transcriptional activator, ISGF3, from binding to the ISG promoter [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. IE86 blocks binding of the transcription factor NF&#x003ba;B to the IFN&#x003b2; promoter and leads to the downregulation of IFN&#x003b2; expression in HCMV infected fibroblasts [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B41">41</xref>].</p><p>The HCMV tegument protein pp65 (<italic>UL83</italic>) has been implicated in blocking interferon activity early during infection prior to transcription of the immediate early gene products [<xref ref-type="bibr" rid="B30">30</xref>]. Microarray analysis using wt HCMV and a <italic>UL83 </italic>deletion mutant revealed pp65 downregulates numerous ISGs although the mechanism for this is unclear [<xref ref-type="bibr" rid="B42">42</xref>]. Conflicting reports have attributed this decrease to interference with either NF&#x003ba;B activity or another transcriptional regulator, IRF-3, although both authors suggest a pp65-mediated defect in nuclear localization of the transcription factors likely contributes to the decreased activity [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. However, a <italic>UL83 </italic>mutant virus like that used in these previous studies was also shown to have decreased IE86 expression. In contrast, cells infected with an HCMV mutant in which stop codons were used to disrupt pp65 expression, preserving IE86 expression, showed no difference in IFN expression compared to wt HCMV [<xref ref-type="bibr" rid="B44">44</xref>]. This suggests IE86 activity is crucial in mitigating IFN-mediated events following infection. Nevertheless, the conservation of <italic>UL83 </italic>within CMV genomes and the attenuation of an MCMV lacking expression of the murine pp65 homolog [<xref ref-type="bibr" rid="B45">45</xref>] points to the importance of pp65 for CMV survival <italic>in vivo</italic>.</p><p>The MCMV encoded protein, M27, interferes with both type I and type II (IFN&#x003b3;) interferon activity by downregulating the signalling molecule, STAT2 [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>]. M27 decreases transcription of constituents of the immunoproteasome [<xref ref-type="bibr" rid="B48">48</xref>]. This IFN&#x003b3; inducible proteasome enhances MHC class I processing of peptides for presentation. Therefore, M27 may not only protect MCMV from the direct antiviral effects of interferon induction but also interfere with the presentation of viral peptides to CD8<sup>+ </sup>T cells, a common theme to be discussed below.</p><p>MCMV and HCMV also encode proteins that interact with interferon induced gene products. The MCMV gene products m142 and m143 decrease activation of protein kinase R (PKR) [<xref ref-type="bibr" rid="B49">49</xref>], an enzyme that blocks protein synthesis in infected cells leading to impaired viral replication. PKR is activated via dsRNA, which is produced during transcription of complementary strands of the CMV genome. Both m142 and m143 have dsRNA binding domains and may interfere with the binding of PKR with dsRNA, preventing its activation [<xref ref-type="bibr" rid="B50">50</xref>]. The HCMV encoded proteins TRS1 and IRS1 are capable of binding dsRNA and can substitute for the vaccinia virus (VV) RNA binding protein [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. However, the role of these proteins in the context of HMCV infection has not been evaluated [<xref ref-type="bibr" rid="B53">53</xref>].</p></sec><sec><title>Natural Killer Cells</title><p>Natural killer (NK) cells are cytotoxic cells of the innate immune response that play an important role in eliminating virus-infected cells early during infection. Signalling induced via activating receptors in absence of inhibitory receptor signalling regulates the cytotoxic activity of NK cells. Inhibitory receptors recognize specific MHC class I alleles whereas a number of ligands can bind activating receptors to trigger NK cell mediated killing. NK cells are important for controlling CMV infections both in mice and humans [<xref ref-type="bibr" rid="B54">54</xref>]. Therefore, it is not surprising the CMVs encode numerous proteins that interfere with NK cell activity [<xref ref-type="bibr" rid="B55">55</xref>].</p><p>Some HCMV encoded proteins alter expression of NK cell receptor ligands. The <italic>UL16 </italic>encoded glycoprotein, gpUL16, binds a number of ligands of the NK cell activating receptor, NKG2D. gpUL16 binds members of the UL16-binding protein (ULBP) and MIC family of proteins, which are stress induced NK ligands [<xref ref-type="bibr" rid="B56">56</xref>]. In particular, gpUL16 binds to ULBPs 1 and 2 [<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B58">58</xref>] and MICB [<xref ref-type="bibr" rid="B59">59</xref>]. gpUL16 downregulates these proteins, retaining them intracellularly in the ER or Golgi network [<xref ref-type="bibr" rid="B60">60</xref>-<xref ref-type="bibr" rid="B62">62</xref>]. The interaction of gpUL16 with these ligands blocks NK cell activation <italic>in vitro </italic>[<xref ref-type="bibr" rid="B56">56</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B64">64</xref>] and may represent a way for HCMV to inhibit NK cell activation due to replication-induced cell stress.</p><p>Like gpUL16, the recently identified HCMV microRNA (miRNA), miR-UL112, also decreases expression of the NK ligand, MICB. miRNAs bind to 3' UTRs and prevent their translation. The miR-UL112 mediated decrease in MICB helps protect HCMV-infected cells from NK cell recognition and killing [<xref ref-type="bibr" rid="B65">65</xref>] and suggests that control of MICB expression and avoidance of NK recognition is important to the HCMV life cycle. As the field of CMV miRNA's begins to expand, an understanding of the role that miRNAs play in immune manipulation will also expand.</p><p>MCMV also encodes three proteins that downregulate ligands of the NK cell activating receptor, NKG2D. The <italic>m145 </italic>encoded protein decreases expression of MULT-1 [<xref ref-type="bibr" rid="B66">66</xref>], the <italic>m155 </italic>encoded glycoprotein (m155) downregulates H60 [<xref ref-type="bibr" rid="B67">67</xref>], and the <italic>m152 </italic>encoded glycoprotein (gp40) downregulates proteins of the RAE-1 family [<xref ref-type="bibr" rid="B68">68</xref>-<xref ref-type="bibr" rid="B70">70</xref>]. MCMV mutants lacking any one of these genes are attenuated <italic>in vivo </italic>and NK cell depletion restores MCMV growth. These results support a role for these proteins in inhibiting NK cell mediated clearance [<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B69">69</xref>,<xref ref-type="bibr" rid="B71">71</xref>,<xref ref-type="bibr" rid="B72">72</xref>]. Although the exact mechanism of action is not known for these proteins, both m155 and gp40 act at a post-transcriptional step and likely interfere with trafficking of NK ligands to the cell membrane [<xref ref-type="bibr" rid="B67">67</xref>,<xref ref-type="bibr" rid="B69">69</xref>,<xref ref-type="bibr" rid="B72">72</xref>].</p><p>MCMV encodes two homologues of MHC class I molecules, although neither has similarity to the HCMV homolog, <italic>UL18 </italic>[<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B74">74</xref>]. The MCMV gene <italic>m157 </italic>has low sequence homology to MHC class I molecules but structural analysis shows it has MHC-like folds [<xref ref-type="bibr" rid="B75">75</xref>]. m157 is expressed on infected cells and is tethered to the membrane with a glycosylphosphatidylinositol (GPI) anchor [<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>]. m157 binds to Ly49H, an activating receptor of the Ly49 family of NK receptors [<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B78">78</xref>]. Interestingly, the m157-Ly49H interaction activates NK cells <italic>in vitro </italic>inducing NK cell cytotoxicity and cytokine and chemokine expression [<xref ref-type="bibr" rid="B79">79</xref>,<xref ref-type="bibr" rid="B80">80</xref>]. In the structural paper exploring m157/Ly49H interactions, Adams et al showed that m157 activation of Ly49H is sufficient to override MHC I/NK cell inhibition [<xref ref-type="bibr" rid="B81">81</xref>]. <italic>In vivo</italic>, MCMV mutants lacking m157 are more virulent in mice due to decreased NK cell activity [<xref ref-type="bibr" rid="B82">82</xref>]. Furthermore, MCMV replicates to higher titers in mouse strains that lack expression of Ly49H receptors [<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B84">84</xref>], demonstrating that Ly49H activation is important for immune protection against MCMV. Although Ly49H protects against MCMV in laboratory mice, MCMV isolates from wild mice have m157 variants that fail to activate NK cells, thus providing evidence of evasion of NK recognition [<xref ref-type="bibr" rid="B85">85</xref>]. Mutations in m157 were also shown to accumulate following multiple passages of MCMV in mice indicating selection pressure for m157 variants that fail to activate NK cells. Furthermore, m157 also binds the inhibitory NK receptor, Ly49I, of some susceptible mice strains such as 129/J [<xref ref-type="bibr" rid="B75">75</xref>]. This has led to the speculation that CMVs evolved m157 to interact with NK inhibitory receptors but in some strains of mice this immune manipulation "backfires" and causes NK cell activation. These data suggest that m157 activation of NK may occur less frequently in natural infection of mice in the wild.</p><p><italic>m144 </italic>is another MCMV encoded MHC class I homolog [<xref ref-type="bibr" rid="B74">74</xref>,<xref ref-type="bibr" rid="B86">86</xref>]. m144 is expressed on the cell surface despite its inability to bind endogenous peptides like other MHC homologues [<xref ref-type="bibr" rid="B87">87</xref>]. m144 can inhibit NK cell cytolysis <italic>in vitro </italic>[<xref ref-type="bibr" rid="B88">88</xref>], suggesting it serves as a decoy receptor to inhibit NK cell activation. Consistent with this idea, MCMV mutants without m144 expression grow poorly in mice due to enhanced NK cell activation [<xref ref-type="bibr" rid="B89">89</xref>]. While a flexible region within m144 that could potentially interact with host receptors has been identified [<xref ref-type="bibr" rid="B90">90</xref>], m144 has not been shown to bind any cellular receptors and its mechanism of function remains unknown [<xref ref-type="bibr" rid="B88">88</xref>]. A rat CMV (RCMV) homolog of m144, r144, has also been identified [<xref ref-type="bibr" rid="B91">91</xref>]. Wild type RCMV shows enhanced replication in the salivary gland and spleen of neonatal rats when compared to an r144 deletion mutant [<xref ref-type="bibr" rid="B92">92</xref>]. However, what affect this protein has on NK cell activity is not currently known.</p><p>HCMV encodes several proteins that interact with and alter NK cell responses. One of the earliest identified proteins, gpUL18, is encoded by the gene <italic>UL18 </italic>and is a MHC class I homologue [<xref ref-type="bibr" rid="B93">93</xref>,<xref ref-type="bibr" rid="B94">94</xref>]. gpUL18 binds the &#x003b2;<sub>2</sub>-microglobulin (&#x003b2;<sub>2</sub>m) and unlike the MHC homologue of MCMV, m144, gpUL18 also binds endogenous peptide [<xref ref-type="bibr" rid="B95">95</xref>,<xref ref-type="bibr" rid="B96">96</xref>]. gpUL18 binds the NK cell inhibitory receptor LIR-1 with higher affinity than host MHC class I molecules [<xref ref-type="bibr" rid="B97">97</xref>-<xref ref-type="bibr" rid="B100">100</xref>]. However, the function of gpUL18 has not been clearly defined. gpUL18 expression both inhibits and activates NK cells <italic>in vitro </italic>[<xref ref-type="bibr" rid="B101">101</xref>-<xref ref-type="bibr" rid="B106">106</xref>]. For instance, gpUL18 activates NK cells from LIR-1<sup>- </sup>mice implicating a complex mechanism for NK cell modulation. Furthermore, clinical isolates of HCMV express gpUL18 variants with different LIR-1 binding affinities [<xref ref-type="bibr" rid="B107">107</xref>,<xref ref-type="bibr" rid="B108">108</xref>] that may have differential functions. HCMV gpUL18-deletion mutants have shown both gpUL18 dependent and independent effects on NK cell activity in different cellular systems [<xref ref-type="bibr" rid="B101">101</xref>,<xref ref-type="bibr" rid="B109">109</xref>]. In addition to its effect on NK cells, gpUL18 was recently shown to inhibit dendritic cell maturation and migration. While dendritic cells express LIR-1, whether this receptor mediates the effect of gpUL18 on dendritic cell activity was not determined [<xref ref-type="bibr" rid="B110">110</xref>]. Importantly, the HCMV encoded proteins that downregulate host MHC class I molecules do not interfere with the expression of gpUL18, which provides "protection" from NK cell lysis that occurs when MHC class I is downregulated [<xref ref-type="bibr" rid="B111">111</xref>,<xref ref-type="bibr" rid="B112">112</xref>]. Collectively, current data suggests gpUL18 may impact the function of several cell types <italic>in vivo </italic>that may partially relate to its ability to bind and activate LIR-1 [<xref ref-type="bibr" rid="B113">113</xref>].</p><p>Recently, it was found that the <italic>UL142 </italic>gene encodes a second HCMV MHC class I homologue [<xref ref-type="bibr" rid="B114">114</xref>]. Cells expressing gpUL142 are protected from NK cell lysis. However, this effect was not evaluated in the context of HCMV infection [<xref ref-type="bibr" rid="B115">115</xref>]. While the mechanism of this effect has yet to be determined, gpUL142 was shown to downregulate MICA, a ligand for the activating NK cell receptor, NKG2D [<xref ref-type="bibr" rid="B116">116</xref>].</p><p>Interestingly, HCMV increases expression of the non-classical MHC class I molecule, HLA-E, while downregulating expression of many other MHC class I alleles [<xref ref-type="bibr" rid="B117">117</xref>]. This upregulation is due to the expression of UL40, a HCMV encoded protein that contains a peptide sequence identical to the HLA-E leader peptide [<xref ref-type="bibr" rid="B118">118</xref>-<xref ref-type="bibr" rid="B120">120</xref>]. Therefore, UL40 increases expression of HLA-E independent of TAP mediated peptide processing, which the HCMV encoded protein, gpUS6, inhibits during infection [<xref ref-type="bibr" rid="B121">121</xref>]. HLA-E is a ligand for the inhibitory receptor CD94/NKG2A and the UL40 induced upregulation of HLA-E would be expected to protect HCMV infected cells from NK cell lysis. However, conflicting reports have found UL40 inhibited or had no effect on NK cell lysis of HCMV infected cells [<xref ref-type="bibr" rid="B117">117</xref>,<xref ref-type="bibr" rid="B122">122</xref>]. Additionally, the HLA-E restricted NK-CTLs recognize the UL40 peptide and kill virally infected cells [<xref ref-type="bibr" rid="B123">123</xref>,<xref ref-type="bibr" rid="B124">124</xref>]. Thus, whether UL40 protects HCMV infected cells or targets them for destruction requires further evaluation.</p><p>The tegument protein, pp65, also interferes with NK cell function by binding the activating receptor NKp30. pp65 mediates the dissociation of CD3&#x003be;, a signal transducing polypeptide, from NK cells impairing their activation [<xref ref-type="bibr" rid="B125">125</xref>]. Since pp65 is not secreted or expressed on infected cells, it is currently unclear how this protein mediates its effects.</p><p>Finally, the protein product of <italic>UL141</italic>, gp141, decreases the expression of CD155, a ligand for NK cell activating receptors by inhibiting CD155 transport to the cell surface [<xref ref-type="bibr" rid="B126">126</xref>]. This downregulation inhibits NK cell activity <italic>in vitro </italic>but further information regarding its function and impact <italic>in vivo </italic>remain to be answered.</p></sec><sec><title>Cytokine Homologues</title><p>Interleukin-10 (IL-10) is an immunosuppressive cytokine that downregulates inflammatory cytokine synthesis and interferes with antigen presentation by decreasing expression of MHC class II on antigen presenting cells [<xref ref-type="bibr" rid="B127">127</xref>]. Members of the poxvirus and herpesvirus families, including HCMV, encode IL-10 homologues [<xref ref-type="bibr" rid="B128">128</xref>]. In contrast to other viral IL-10 homologues, such as those encoded by EBV and orf virus, a poxvirus, both of which have high amino acid similarity (80%) to their host IL-10. The HCMV IL-10 protein, cmvIL-10, has only limited homology (27%) to human IL-10 (hIL-10) [<xref ref-type="bibr" rid="B129">129</xref>]. cmvIL-10 binds the IL-10 receptor, hIL-10R, albeit with lower affinity than hIL-10 [<xref ref-type="bibr" rid="B129">129</xref>,<xref ref-type="bibr" rid="B130">130</xref>]. Nevertheless, it retains the capacity to induce a strong anti-inflammatory response. cmvIL-10 downregulates expression of IFN&#x003b3; and TNF&#x003b1; in peripheral blood mononuclear cells (PBMCs) and decreases expression of both MHC class I and II on PBMCs and DCs [<xref ref-type="bibr" rid="B130">130</xref>-<xref ref-type="bibr" rid="B133">133</xref>]. DCs exposed to cmvIL-10 inefficiently stimulated T cell proliferation [<xref ref-type="bibr" rid="B132">132</xref>] supporting its role in immune suppression. Furthermore, cmvIL-10 inhibits cytokine production due to the activation of the phosphotidylinositol 3-kinase pathway [<xref ref-type="bibr" rid="B134">134</xref>]. Interestingly, cmvIL-10 was recently shown to stimulate B cell proliferation but the impact of this on the immune response to CMV is unclear [<xref ref-type="bibr" rid="B135">135</xref>]. cmvIL-10 alters the function of non-leukocyte populations as well. By interfering with placental cytotrophoblast invasion, cmvIL-10 could affect placental development, which contributes to the sequelae observed following congenital CMV infections [<xref ref-type="bibr" rid="B136">136</xref>].</p><p>An alternatively spliced version of cmvIL-10 was originally identified during latent HCMV infection and termed latency associated cmvIL-10 (LacmvIL-10) [<xref ref-type="bibr" rid="B137">137</xref>]. However, this transcript is also expressed during productive infection [<xref ref-type="bibr" rid="B138">138</xref>]. LacmvIL-10 fails to induce signalling pathways associated with IL-10R activation, which implies LacmvIL-10 may not bind to IL-10R or, at least, differentially activates this receptor. LacmvIL-10 also decreases MHC class II expression on granulocyte-macrophage progenitors (GM-Ps) and monocytes, both sites of CMV latency, possibly limiting clearance of latently infected cells [<xref ref-type="bibr" rid="B139">139</xref>].</p><p>A number of primate CMVs encode proteins similar to IL-10 [<xref ref-type="bibr" rid="B140">140</xref>] but only the function of the rhesus CMV (RhCMV) homologue has been evaluated to date. RhcmvIL-10 downregulates cytokine expression in PBMCs and MHC class II molecule expression in monocytes [<xref ref-type="bibr" rid="B130">130</xref>]. Therefore, the function of human cmvIL-10 is conserved in RhCMV. Interestingly, chimpanzee cytomegalovirus (CCMV) and MCMV do not encode IL-10 homologues [<xref ref-type="bibr" rid="B140">140</xref>]. MCMV infection induces cellular IL-10 expression providing a mechanism for immune interference in the absence of a virally encoded IL-10 protein [<xref ref-type="bibr" rid="B141">141</xref>,<xref ref-type="bibr" rid="B142">142</xref>]. Therefore, IL-10 immune suppression, whether cellular or viral in origin, likely creates an environment that supports efficient viral replication in the host.</p></sec><sec><title>Cytokine Receptor Homologues</title><p>The HCMV gene, <italic>UL144</italic>, encodes a protein with limited homology to the herpes simplex virus entry mediator (HVEM), a member of the tumour necrosis factor receptor (TNFR) superfamily [<xref ref-type="bibr" rid="B143">143</xref>]. UL144 is the only TNFR homolog identified in herpesviruses. The UL144 protein does not bind any known TNF ligands [<xref ref-type="bibr" rid="B143">143</xref>-<xref ref-type="bibr" rid="B145">145</xref>]. UL144 binds to a member of the Ig superfamily, B and T lymphocyte attenuator (BTLA) [<xref ref-type="bibr" rid="B146">146</xref>], also a ligand of HVEM [<xref ref-type="bibr" rid="B147">147</xref>]. Binding of UL144 to BTLA blocks T cell proliferation and could impair lymphocyte responses to HCMV [<xref ref-type="bibr" rid="B146">146</xref>]. UL144 activates TNFR-activated factor (TRAF6) leading to NF&#x003ba;B activation and upregulation of the chemokine CCL22 [<xref ref-type="bibr" rid="B145">145</xref>,<xref ref-type="bibr" rid="B148">148</xref>]. CCL22 is a chemoattractant of Th2 and regulatory T cells. Activation and attraction of these cells may help HMCV evade T cell-mediated antiviral activity. UL144 is located in the UL/b' region of HCMV, a portion of the genome thought to encode potential virulence factors. Different UL144 genotypes have been identified in clinical isolates. However, all but one report has found no association between the different genotypes and CMV disease [<xref ref-type="bibr" rid="B144">144</xref>,<xref ref-type="bibr" rid="B149">149</xref>-<xref ref-type="bibr" rid="B155">155</xref>]. Although there is much speculation on the role that UL144 plays in immune modulation, its role in CMV pathogenesis and survival is still unclear.</p></sec><sec><title>Viral Chemokine Homologues</title><p>Many CMVs also encode chemokine homologues. Chemokines are small, chemotactic cytokines that are important for leukocyte trafficking and activation. The best characterized of the CMV chemokines is the CC chemokine homolog of MCMV. Originally identified as the <italic>m131 </italic>gene product, MCK1, transcriptional analysis during MCMV infection determined that a spliced product of <italic>m131 </italic>and <italic>m129</italic>, referred to as MCK2 was the only transcript encoded from this locus. The CC chemokine domain is confined to the MCK1 coding region and is connected to a long carboxyl-terminal domain (199 amino acids) with no known homology to other proteins. This makes MCK2 considerably longer than other chemokines [<xref ref-type="bibr" rid="B156">156</xref>,<xref ref-type="bibr" rid="B157">157</xref>]. In contrast to <italic>UL146 </italic>(see below), the DNA sequence of MCK2 is highly conserved in isolates from wild mice [<xref ref-type="bibr" rid="B158">158</xref>].</p><p>Initial studies <italic>in vitro </italic>showed MCK1 induced higher levels of Ca<sup>2+ </sup>mobilization in peritoneal exudates cells from MCMV infected mice than cells from uninfected mice. This demonstrated that MCK1 could activate cells recruited to the site of MCMV infection [<xref ref-type="bibr" rid="B159">159</xref>]. The spliced product, MCK2, is important for viral spread within the host. When a recombinant MCMV with mutations in the <italic>m131 </italic>gene (generated either via point mutations or insertions) was inoculated into mice, these recombinants showed a defect in dissemination to the salivary gland. Mice infected with these mutants developed less inflammation at the site of inoculation, reduced secondary viremia, as well as lower viral titers in the salivary glands, a site of dissemination following secondary viremia [<xref ref-type="bibr" rid="B160">160</xref>,<xref ref-type="bibr" rid="B161">161</xref>]. This was the first direct evidence that a CMV encoded chemokine is important for the dissemination of the virus in its host. Additional work identified the MCK2-recruited cell type as a late myeloid progenitor, consistent with reports that CMV infects and can remain latent in cells of the myelomonocytic lineage [<xref ref-type="bibr" rid="B162">162</xref>].</p><p>Rat CMV (RCMV) encodes a CC chemokine with similarity to both <italic>m131 </italic>and <italic>m129</italic>, having N-terminal chemokine homology and a long carboxyl-terminus like MCK2 [<xref ref-type="bibr" rid="B163">163</xref>]. Rats infected with RCMV deletion mutants lacking pr131 expression, the product of the r131 locus, had reduced viral loads in the spleen and salivary glands. Additionally these mice had reduced swelling and macrophage infiltration at the site of virus inoculation [<xref ref-type="bibr" rid="B164">164</xref>]. Therefore, pr131 appears to be a functional homolog of MCK2.</p><p>Guinea pig CMV (GPCMV) contains a gene with homology to CC chemokines, though it lacks positional or sequence similarity to the <italic>m131</italic>/<italic>m129 </italic>genes of MCMV. GPCMV-MIP is most similar to the cellular chemokines, CCL3/CCL4 (MIP-1&#x003b1;/&#x003b2;) and CCL14 (HCC-1). GPCMV-MIP induced Ca<sup>2+ </sup>flux and migration of cells expressing hCCR-1 but did not elicit a response from cells expressing other CC receptors [<xref ref-type="bibr" rid="B165">165</xref>]. CCL14 is known to increase the proliferation of monocyte progenitors, therefore GPCMV-MIP may enhance the proliferation and/or recruitment of permissive cells consistent with the role of MCK2 [<xref ref-type="bibr" rid="B166">166</xref>].</p><p>HCMV encodes two ORFs with homology to CXC chemokines, <italic>UL146 </italic>and <italic>UL147 </italic>[<xref ref-type="bibr" rid="B167">167</xref>]. While no functional data is available for the protein product of UL147, vCXCL-2 (also called pUL147 and vCXC-2), analysis of the protein product of <italic>UL146</italic>, vCXCL-1 (also denoted pUL146 and vCXC-1), demonstrated its capacity as a functional chemokine. vCXCL-1 was shown to bind exclusively to hCXCR2 with an affinity similar to that of the host chemokine, CXCL8. Additionally, vCXCL-1 was able to induce chemotaxis and intracellular calcium release in human neutrophils, again to levels comparable to host chemokines [<xref ref-type="bibr" rid="B168">168</xref>]. A mutant HCMV virus with a deletion of <italic>UL146-UL147 </italic>was unable to infect neutrophils but retained its ability to infect other cells providing additional evidence these proteins facilitate an interaction of HCMV with neutrophils [<xref ref-type="bibr" rid="B169">169</xref>].</p><p>Chimpanzee CMV (CCMV) encodes homologues of <italic>UL146 </italic>and <italic>UL147 </italic>as well as the related gene <italic>UL146a</italic>. However, only the product of <italic>UL146 </italic>(vCXCL-1<sub>CCMV</sub>) has been evaluated thus far. vCXCL-1<sub>CCMV </sub>induces chemotaxis and calcium release in human neutrophils. Additionally, it was shown to increase expression of adhesion molecules on the surface of neutrophils and reduce apoptosis in these cells [<xref ref-type="bibr" rid="B170">170</xref>]. Taken together, the function of the HCMV and CCMV vCXCL-1s <italic>in vitro </italic>suggest the potential for these viral chemokines to alter the response of neutrophils in the course of CMV infection.</p><p>Due to the strict species specificity of CMVs, <italic>in vivo </italic>characterization of <italic>UL146 </italic>and <italic>UL147 </italic>has been limited to sequence analysis of clinical HCMV isolates. <italic>UL146 </italic>is highly variable, differing as much as 60% among isolates at the amino acid level [<xref ref-type="bibr" rid="B152">152</xref>]. It was postulated that this variability might correlate with the severity of CMV disease however no clear relationship has been identified [<xref ref-type="bibr" rid="B151">151</xref>,<xref ref-type="bibr" rid="B171">171</xref>-<xref ref-type="bibr" rid="B173">173</xref>]. It was recently suggested the variability of <italic>UL146 </italic>may have arisen in early human populations and likely does not contribute to the pathogenesis of congenital infection [<xref ref-type="bibr" rid="B173">173</xref>]. Our lab is currently working to identify whether the vCXCL-1 isolates from different clinical strains induce functional differences in neutrophils.</p><p>HCMV also encodes genes with limited homology to CC chemokines. <italic>UL128 </italic>and <italic>UL130 </italic>both have signal sequences and conserved cysteine motifs similar to CC chemokines [<xref ref-type="bibr" rid="B174">174</xref>], but it is yet to be determined whether these proteins actually function as chemokines. Interestingly, the <italic>UL128-131 </italic>locus was found to be necessary for endothelial cell and leukocyte tropism based on the inability of HCMV <italic>UL128-131 </italic>deletion mutants to infect these cell types [<xref ref-type="bibr" rid="B169">169</xref>]. This likely explains the loss of endothelial cell tropism in lab-adapted strains of HCMV, a number of which were shown to have deletions or mutations in at least one gene from this region [<xref ref-type="bibr" rid="B174">174</xref>]. The UL128-131 proteins have recently been shown to interact with gH/gL complexes that mediate entry of CMV into endothelial and epithelial cells, in contrast to the gH/gL complexes that mediate virus entry into fibroblasts [<xref ref-type="bibr" rid="B175">175</xref>,<xref ref-type="bibr" rid="B176">176</xref>].</p></sec><sec><title>Chemokine Receptor Homologues</title><p>In addition to viral chemokine homologues, CMVs encode proteins with homology to chemokine receptors [<xref ref-type="bibr" rid="B177">177</xref>,<xref ref-type="bibr" rid="B178">178</xref>]. Chemokine receptors are members of the G-protein coupled receptor (GPCR) family [<xref ref-type="bibr" rid="B179">179</xref>]. The four chemokine receptor homologues encoded by the cytomegaloviruses have homology to the CC chemokine receptor family. Two genes, <italic>UL33 </italic>and <italic>UL78</italic>, are conserved among all sequenced CMVs, while primate CMVs encode two additional GPCRs, <italic>US27 </italic>and <italic>US28 </italic>[<xref ref-type="bibr" rid="B180">180</xref>].</p><p>The HCMV <italic>US28 </italic>encoded protein (pUS28) is the best characterized of the GPCR homologues. <italic>US28 </italic>has the highest sequence homology to the cellular receptor, CCR1, and binds a number of CC chemokines including CCL5 (RANTES), CCL2 (MCP-1), CCL3 (MIP-1&#x003b1;), and CCL4 (MIP-1&#x003b2;) [<xref ref-type="bibr" rid="B181">181</xref>,<xref ref-type="bibr" rid="B182">182</xref>]. Interestingly, pUS28 binds with highest affinity to the CX<sub>3</sub>C chemokine, CX<sub>3</sub>CL1 (fractalkine) [<xref ref-type="bibr" rid="B183">183</xref>]. Upon binding, pUS28 induces chemokine internalization, removing chemokines from the extracellular environment [<xref ref-type="bibr" rid="B184">184</xref>-<xref ref-type="bibr" rid="B186">186</xref>]. Consistent with this role, pUS28 inhibits monocyte migration <italic>in vitro </italic>and media from US28 expressing, CMV-infected monolayers deplete CCL5 and CCL2 from the media [<xref ref-type="bibr" rid="B187">187</xref>]. Constitutive endocytosis and recycling of pUS28 contributes to chemokine internalization however chemokine binding is not sufficient to induce constitutive endocytosis of pUS28 [<xref ref-type="bibr" rid="B188">188</xref>]. By acting as a "chemokine sink", pUS28 could alter or inhibit chemokine-dependent immune responses. The related chemokine homolog, pUS27, also shows some ability to internalize chemokines [<xref ref-type="bibr" rid="B185">185</xref>,<xref ref-type="bibr" rid="B189">189</xref>], perhaps illustrating a conservation of function between the viral GPCRs.</p><p>pUS28 elicits ligand-dependent signalling, triggering calcium mobilization upon CCL5, CCL2, CCL3 and CCL7 binding. pUS28 utilizes the G proteins G&#x003b1;<sub>i </sub>and G&#x003b1;<sub>16 </sub>to mediate calcium mobilization upon binding of CCL5 or CCL7 [<xref ref-type="bibr" rid="B181">181</xref>,<xref ref-type="bibr" rid="B190">190</xref>,<xref ref-type="bibr" rid="B191">191</xref>]. Interestingly, G&#x003b1;<sub>16 </sub>expression is restricted to hematopoietic cells [<xref ref-type="bibr" rid="B192">192</xref>]. HCMV has a tropism for this cell lineage where pUS28 may alter G&#x003b1;<sub>16 </sub>signalling to benefit CMV's life cycle. pUS28 also induces agonist-dependent migration of smooth muscle cells (SMCs). Migration of SMCs in response to pUS28 requires the protein tyrosine kinase (PTK) pathway, indicating pUS28 activates a number of cellular pathways <italic>in vitro </italic>[<xref ref-type="bibr" rid="B193">193</xref>,<xref ref-type="bibr" rid="B194">194</xref>]. As with many CMV proteins, the effects of pUS28 vary depending on the system and cell types analyzed.</p><p>Like the Kaposi's sarcoma-associated herpesvirus (KSHV) GPCR homolog, ORF74 [<xref ref-type="bibr" rid="B195">195</xref>], pUS28 can constitutively activate several signalling pathways, including phospholipase C (PLC), NF&#x003ba;B, NFAT, and cAMP-responsive element (CRE)-dependent pathways [<xref ref-type="bibr" rid="B188">188</xref>,<xref ref-type="bibr" rid="B191">191</xref>,<xref ref-type="bibr" rid="B195">195</xref>-<xref ref-type="bibr" rid="B198">198</xref>]. CC chemokines do not enhance signalling, although CX<sub>3</sub>CL1 acts as a partial inverse agonist, decreasing the levels of pUS28 constitutive activity [<xref ref-type="bibr" rid="B191">191</xref>,<xref ref-type="bibr" rid="B196">196</xref>]. The constitutive endocytosis of pUS28 occurs independently of its constitutive signalling and different domains of pUS28 control these two phenomena [<xref ref-type="bibr" rid="B188">188</xref>]. pUS28, like KSHV ORF74, can induce transformation of NIH3T3 cells and promote tumour formation in nude mice. Mice inoculated with cells expressing a mutated pUS28 that lacks constitutive activity show attenuated tumour formation demonstrating the importance of constitutive signalling in pUS28-mediated tumour formation [<xref ref-type="bibr" rid="B199">199</xref>].</p><p>Despite extensive research on the function of pUS28, its role in CMV pathogenesis <italic>in vivo </italic>is still unknown. pUS28 sequesters host chemokines in order to alter the immune response or activates signalling pathways that contribute to viral replication or spread. pUS28-induced SMC migration may play a role in the accelerated vascular disease associated with HCMV [<xref ref-type="bibr" rid="B200">200</xref>,<xref ref-type="bibr" rid="B201">201</xref>]. Although HCMV nucleic acids have been isolated from certain cancers [<xref ref-type="bibr" rid="B202">202</xref>,<xref ref-type="bibr" rid="B203">203</xref>], whether HCMV is causal in these cancers remains to be established. Perhaps pUS28 may contribute to tumour formation in these individuals.</p><p>The <italic>UL33 </italic>gene is conserved in all &#x003b2; herpesviruses, including HCMV (<italic>UL33</italic>), RCMV (<italic>R33</italic>), and MCMV (<italic>M33</italic>). While no ligands have been identified for either pUL33 or pR33, pM33 is activated by CCL5 [<xref ref-type="bibr" rid="B204">204</xref>]. All three viral proteins show constitutive activity, although they differentially activate specific signalling pathways [<xref ref-type="bibr" rid="B196">196</xref>,<xref ref-type="bibr" rid="B205">205</xref>-<xref ref-type="bibr" rid="B207">207</xref>]. While not essential for viral replication <italic>in vitro</italic>, both pR33 and pM33 are important for replication of CMV in the salivary gland [<xref ref-type="bibr" rid="B208">208</xref>-<xref ref-type="bibr" rid="B210">210</xref>]. In MCMV, this defect was linked to the constitutive activity of pM33 [<xref ref-type="bibr" rid="B211">211</xref>] and illustrates the importance of constitutive signalling <italic>in vivo</italic>. Like pUS28, pM33 and pR33 induce SMC migration [<xref ref-type="bibr" rid="B204">204</xref>,<xref ref-type="bibr" rid="B212">212</xref>]. Taken together, this suggests GPCRs of the <italic>UL33 </italic>family alter cellular trafficking during CMV infection, which may contribute to viral pathogenesis.</p><p>The <italic>UL78 </italic>gene family encoded proteins have only limited homology to known chemokine receptors [<xref ref-type="bibr" rid="B180">180</xref>]. Nevertheless, this gene is conserved in all &#x003b2; herpesviruses suggesting they have some role in the herpesviruses life cycle. The <italic>UL78 </italic>proteins of MCMV and RCMV, pM78 and pR78, respectively, are important for viral replication <italic>in vitro </italic>and <italic>in vivo </italic>[<xref ref-type="bibr" rid="B213">213</xref>-<xref ref-type="bibr" rid="B215">215</xref>]. The HCMV homolog, pUL78, is not required for replication of HCMV <italic>in vitro </italic>[<xref ref-type="bibr" rid="B216">216</xref>] thus MCMV and RCMV may be more dependent on its function for viral replication. Although, members of the <italic>UL78 </italic>family are clearly important for viral replication for some CMVs, data regarding their specific function as GPCRs is not currently available.</p></sec><sec><title>Viral Chemokine Binding Proteins</title><p>Chemokine binding proteins (CBPs) are virally encoded secreted proteins that competitively bind chemokines and interfere with their interactions with cellular receptors. Unlike viral chemokine and chemokine receptor homologues, which were likely acquired from the host, CBPs generally show no homology to known proteins and homology of these proteins across viruses is not conserved [<xref ref-type="bibr" rid="B217">217</xref>]. Until recently, no CMV species was known to encode a CBP. However, a HCMV encoded protein, p21.5, has been identified with chemokine binding properties. mRNA transcripts of the gene <italic>UL21.5 </italic>are packaged in the HCMV virion and thus may function soon after viral entry into the cell. Although many CBPs interact with multiple chemokines [<xref ref-type="bibr" rid="B218">218</xref>], p21.5 is unusual in that it selectively binds CCL5 (RANTES) <italic>in vitro </italic>blocking the interaction of the chemokine with its cellular receptors [<xref ref-type="bibr" rid="B219">219</xref>]. No data is available which evaluates the ability of p21.5 to interfere with CCL5 function <italic>in vivo </italic>and its effect on viral survival.</p></sec><sec><title>Apoptosis</title><p>Apoptosis is a mechanism for programmed cell death that plays an important role in the elimination of cells during development and virally infected cells as part of the host's innate immunity [<xref ref-type="bibr" rid="B220">220</xref>,<xref ref-type="bibr" rid="B221">221</xref>]. Many viruses including CMVs have strategies to prevent apoptosis [<xref ref-type="bibr" rid="B222">222</xref>,<xref ref-type="bibr" rid="B223">223</xref>]. HCMV encodes two proteins in particular that directly interfere with the apoptosis pathway. The HCMV <italic>UL36 </italic>gene encodes a viral inhibitor of caspase-8 induced apoptosis (vICA) and exon 1 of <italic>UL37 </italic>encodes the viral mitochondrial inhibitor of apoptosis (vMIA) [<xref ref-type="bibr" rid="B224">224</xref>].</p><p>vMIA protects cells from intrinsic apoptosis induced following damage to the mitochondrial membrane [<xref ref-type="bibr" rid="B225">225</xref>-<xref ref-type="bibr" rid="B227">227</xref>]. vMIA only blocks apoptosis mediated through the death receptor, Fas, in cells in which apoptosis proceeds through a mitochondrial-dependent step [<xref ref-type="bibr" rid="B228">228</xref>]. vMIA has not been identified in virion particles and inhibits apoptosis at later times compared to vICA [<xref ref-type="bibr" rid="B225">225</xref>,<xref ref-type="bibr" rid="B229">229</xref>]. vMIA localizes to the mitochondria [<xref ref-type="bibr" rid="B230">230</xref>-<xref ref-type="bibr" rid="B232">232</xref>] and this localization is needed for vMIA to induce structural changes and inhibit mitochondrial release of cytochrome c, blocking downstream events in the apoptosis pathway [<xref ref-type="bibr" rid="B227">227</xref>,<xref ref-type="bibr" rid="B233">233</xref>]. vMIA also induces the release of calcium from the ER which may play a role in the inhibition of apoptosis [<xref ref-type="bibr" rid="B234">234</xref>].</p><p>vMIA was initially shown to interact with adenine nucleotide translocator (ANT), a regulator of mitochondrial membrane permeability [<xref ref-type="bibr" rid="B227">227</xref>,<xref ref-type="bibr" rid="B235">235</xref>]. However, this interaction does not correlate with vMIA function and is likely non-specific [<xref ref-type="bibr" rid="B235">235</xref>]. vMIA also binds the proapoptotic protein, Bax, inducing aggregation of Bax molecules at the mitochondrial membrane preventing membrane permeabilization [<xref ref-type="bibr" rid="B236">236</xref>,<xref ref-type="bibr" rid="B237">237</xref>]. The screening of proteins that interact with the antiapoptotic domain of vMIA identified the protein, Growth Arrest and DNA Damage 45 (GADD45&#x003b1;). GADD45&#x003b1; enhances vMIA-induced apoptosis possibly protecting it from proteasomal degradation [<xref ref-type="bibr" rid="B238">238</xref>]. Interestingly, vMIA was also recently shown to interfere with caspase-independent cell death by blocking the activity of the serine protease, HtrA2/Omi [<xref ref-type="bibr" rid="B239">239</xref>]. Sequence homologues of vMIA have only been found in primate CMVs [<xref ref-type="bibr" rid="B240">240</xref>]. However, a recently identified positional homologue of vMIA in MCMV, m38.5, was shown to interact with Bax and inhibit apoptosis [<xref ref-type="bibr" rid="B226">226</xref>,<xref ref-type="bibr" rid="B241">241</xref>,<xref ref-type="bibr" rid="B242">242</xref>]. Therefore, vMIA functional homologues may exist in other cytomegaloviruses.</p><p>In contrast to vMIA, vICA protects cells <italic>in vitro </italic>from extrinsic apoptosis mediated through ligation of the death receptors, Fas and TNFR-1 [<xref ref-type="bibr" rid="B228">228</xref>]. vICA is a virion constituent [<xref ref-type="bibr" rid="B243">243</xref>] that inhibits caspase-8 activation [<xref ref-type="bibr" rid="B228">228</xref>]. Procaspase-8 is prevented from interacting with the adapter protein, Fas-associated death domain (FADD) and inhibits the processing of procaspase-8 to its active form [<xref ref-type="bibr" rid="B244">244</xref>]. Therefore, vICA is functionally similar, although mechanistically distinct from, cellular and viral FLICE inhibitory proteins (FLIPS), which also interfere with caspase-8 activation [<xref ref-type="bibr" rid="B245">245</xref>].</p><p>vICA is dispensable for replication and some HCMV lab strains have inactivating mutations in the <italic>UL36 </italic>gene [<xref ref-type="bibr" rid="B228">228</xref>,<xref ref-type="bibr" rid="B243">243</xref>,<xref ref-type="bibr" rid="B246">246</xref>]. Nevertheless, vICA homologues are conserved in the genomes of all sequenced &#x003b2;-herpesviruses except for guinea pig CMV (GPCMV) where no positional homologues has been identified [<xref ref-type="bibr" rid="B247">247</xref>]. The vICA homologues of RhCMV and MCMV, Rh36 and M36, respectively, also have antiapoptotic activities when transiently expressed <italic>in vitro </italic>[<xref ref-type="bibr" rid="B240">240</xref>,<xref ref-type="bibr" rid="B248">248</xref>]. Recently, it was shown that a M36 deletion mutant was attenuated in the lungs and salivary glands of mice but could be rescued by expression of a dominant-negative variant of FADD [<xref ref-type="bibr" rid="B249">249</xref>]. This provides important evidence for the functional significance of this protein <italic>in vivo</italic>.</p><p>The MCMV <italic>M45 </italic>encoded protein has sequence, although not functional, homology to a cellular ribonucleotide reductase [<xref ref-type="bibr" rid="B250">250</xref>,<xref ref-type="bibr" rid="B251">251</xref>]. Nevertheless, a M45 mutant virus is attenuated in SCID mice [<xref ref-type="bibr" rid="B251">251</xref>]. Recently M45 was shown to suppress the cell death pathway in a manner unique to viral proteins [<xref ref-type="bibr" rid="B252">252</xref>]. M45 interacts with the receptor-interacting protein kinase I (RIPI) via a RIP homotypic interaction motif (RHIM). By binding to RIPI, M45 protects certain cell types from caspase-independent cell death following death receptor signalling [<xref ref-type="bibr" rid="B253">253</xref>,<xref ref-type="bibr" rid="B254">254</xref>]. This "alternative apoptosis" would likely be activated in HCMV infected cells in which vICA inhibits caspase-8 activity [<xref ref-type="bibr" rid="B255">255</xref>].</p></sec></sec><sec><title>Adaptive Immune Response</title><sec><title>T Cell Mediated Immunity</title><p>T cell mediated immune responses, particularly CD8<sup>+ </sup>T cell dependent responses, are integral to the clearance of cytomegalovirus infections [<xref ref-type="bibr" rid="B54">54</xref>]. Cytomegaloviruses, as do many herpesviruses, impair T cell activation by interfering with both MHC class I and II antigen processing and presentation [<xref ref-type="bibr" rid="B256">256</xref>]. Although this has been shown <italic>in vitro</italic>, Th or CTL responses are still generated during CMV infection <italic>in vivo </italic>[<xref ref-type="bibr" rid="B257">257</xref>-<xref ref-type="bibr" rid="B260">260</xref>].</p><p>The U<sub>S </sub>region of the HCMV genome encodes a number of endoplasmic reticulum (ER) resident glycoproteins that alter MHC class I expression [<xref ref-type="bibr" rid="B261">261</xref>]. The first of these proteins to be expressed following HCMV infection is the <italic>US3 </italic>encoded immediate early protein, gpUS3, which likely interferes with T cell recognition early during viral replication [<xref ref-type="bibr" rid="B262">262</xref>-<xref ref-type="bibr" rid="B264">264</xref>]. gpUS3 binds MHC class I molecules and retains them in the ER, inhibiting antigen presentation to CD8<sup>+ </sup>T cells [<xref ref-type="bibr" rid="B265">265</xref>-<xref ref-type="bibr" rid="B269">269</xref>]. The transmembrane domains of gpUS3 are responsible for binding MHC class I [<xref ref-type="bibr" rid="B270">270</xref>,<xref ref-type="bibr" rid="B271">271</xref>]. However, luminal regions of gpUS3 are needed for retention of MHC class I in the ER [<xref ref-type="bibr" rid="B270">270</xref>-<xref ref-type="bibr" rid="B273">273</xref>]. Interestingly, gpUS3 also binds tapasin and this interaction prevents tapasin-mediated protein loading of MHC class I molecules. Therefore, gpUS3 only retains MHC class I alleles that are tapasin dependent [<xref ref-type="bibr" rid="B274">274</xref>]. An alternatively spiced form of gpUS3 competitively binds tapasin and may represent a regulatory mechanism for gpUS3 activity [<xref ref-type="bibr" rid="B275">275</xref>].</p><p>In contrast to gpUS3, the binding of MHC class I molecules to the <italic>US2 </italic>and <italic>US11 </italic>encoded HCMV proteins, gpUS2 and gpUS11, leads to the rapid degradation of MHC class I molecules [<xref ref-type="bibr" rid="B276">276</xref>-<xref ref-type="bibr" rid="B279">279</xref>]. Both proteins bind MHC class I molecules resulting in their removal from the ER to the cytosol where they undergo proteasome-dependent degradation [<xref ref-type="bibr" rid="B266">266</xref>,<xref ref-type="bibr" rid="B276">276</xref>,<xref ref-type="bibr" rid="B277">277</xref>]. This process requires a functional ubiquitination system although only gpUS2 specifically depends on MHC class I ubiquitination for protein degradation [<xref ref-type="bibr" rid="B280">280</xref>-<xref ref-type="bibr" rid="B283">283</xref>]. In addition to the ubiquitin system, gpUS2 and gpUS11 associate with other cellular proteins that facilitate recognition and removal of proteins via the endoplasmic reticulum associated protein degradation (ERAD) pathway [<xref ref-type="bibr" rid="B284">284</xref>-<xref ref-type="bibr" rid="B287">287</xref>]. gpUS2 forms a complex with the chaperones, calnexin, BiP, and calreticulin to mediate MHC class I degradation [<xref ref-type="bibr" rid="B288">288</xref>]. In contrast, gpUS11-dependent protein degradation requires Derlin-1, a protein that plays a role in the removal of misfolded proteins [<xref ref-type="bibr" rid="B289">289</xref>].</p><p>Why HCMV encodes two different proteins that target MHC class I for degradation is unclear. gpUS2 and gpUS11 differ in their specificities for MHC class I alleles [<xref ref-type="bibr" rid="B290">290</xref>,<xref ref-type="bibr" rid="B291">291</xref>]. While they may overlap in function, they likely mediate distinct effects on MHC class I expression [<xref ref-type="bibr" rid="B292">292</xref>,<xref ref-type="bibr" rid="B293">293</xref>]. This difference in specificity is likely the result of different binding requirements for gpUS2 and gpUS11. The luminal portion of gpUS2 interacts with residues in the &#x003b1;<sub>2</sub>/&#x003b1;<sub>3 </sub>region of the luminal domain of MHC class I molecules [<xref ref-type="bibr" rid="B294">294</xref>-<xref ref-type="bibr" rid="B296">296</xref>]. Specifically, gpUS2-mediated degradation requires the presence of an arginine at residue 181 of MHC class I molecules. However, this residue is not sufficient for degradation of some MHC class I alleles and other residues must be important for these molecules [<xref ref-type="bibr" rid="B297">297</xref>]. The luminal region of gpUS11 is also important for MHC class I binding, however, gpUS11 interacts with residues in the &#x003b1;<sub>1</sub>/&#x003b1;<sub>2 </sub>domain of MHC class I molecules [<xref ref-type="bibr" rid="B298">298</xref>,<xref ref-type="bibr" rid="B299">299</xref>].</p><p>The HCMV <italic>US6 </italic>gene, encodes another glycoprotein, gpUS6, that downregulates MHC class I expression [<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B300">300</xref>,<xref ref-type="bibr" rid="B301">301</xref>]. Like the other U<sub>S </sub>proteins that interfere with MHC class I expression, gpUS6 mediates retention of MHC class I via its luminal domain [<xref ref-type="bibr" rid="B302">302</xref>]. However, the gpUS6 mechanism is unique in that it binds to TAP-1 and TAP-2 heterodimers [<xref ref-type="bibr" rid="B303">303</xref>] in the transporter associated with antigen processing (TAP) complex [<xref ref-type="bibr" rid="B121">121</xref>,<xref ref-type="bibr" rid="B300">300</xref>,<xref ref-type="bibr" rid="B304">304</xref>,<xref ref-type="bibr" rid="B305">305</xref>]. Through its association with TAP, gpUS6 prevents the binding of ATP to TAP [<xref ref-type="bibr" rid="B306">306</xref>] and subsequent TAP peptide translocation [<xref ref-type="bibr" rid="B300">300</xref>,<xref ref-type="bibr" rid="B301">301</xref>]. gpUS6 expression is solely responsible for the inhibition of TAP in HCMV infected cells [<xref ref-type="bibr" rid="B307">307</xref>] and downregulates all MHC class I alleles tested [<xref ref-type="bibr" rid="B308">308</xref>]. In addition to impairing CD8<sup>+ </sup>T cell responses, this decrease in MHC class I expression also makes infected cells susceptible to NK cell cytotoxicity [<xref ref-type="bibr" rid="B308">308</xref>], which may explain why CMVs have evolved mechanisms for preventing NK lysis (NK cell section).</p><p>Two additional HCMV encoded proteins, gpUS8 and gpUS10, bind MHC class I molecules. However, neither protein downregulates cell surface MHC class I expression, although gpUS10 slows MHC class I maturation and egress from the ER. The function of these proteins in HCMV infection is currently unknown [<xref ref-type="bibr" rid="B309">309</xref>,<xref ref-type="bibr" rid="B310">310</xref>].</p><p>Other cytomegaloviruses have homologues of some of the HCMV U<sub>S </sub>family members. CCMV encodes a gpUS6 homologue that binds TAP. However, this interaction does not downregulate MHC class I expression in chimpanzee cells <italic>in vitro</italic>, making the function of this homologue unclear [<xref ref-type="bibr" rid="B305">305</xref>]. In contrast, RhCMV encodes homologues of gpUS2, gpUS3, gpUS6, and gpUS11 [<xref ref-type="bibr" rid="B311">311</xref>], each of which functions similarly to its HCMV counterpart [<xref ref-type="bibr" rid="B312">312</xref>]. A newly identified RhCMV protein, viral inhibitor of heavy chain expression (VIHCE), is encoded by the <italic>rh178 </italic>gene, a gene unrelated to the US6 gene family. VIHCE inhibits signal-peptide dependent MHC class I heavy chain translation, a mechanism distinct from other modulators of MHC class I expression [<xref ref-type="bibr" rid="B313">313</xref>]. Therefore, RhCMV may be a valuable model system for analyzing the function of these proteins during CMV infection <italic>in vivo</italic>.</p><p>MCMV encodes three proteins unrelated to those of HCMV that interfere with MHC class I expression in infected cells. <italic>m6</italic>, <italic>m152</italic>, and <italic>m4</italic>, encode gp48, gp40, and gp34 respectively. Both gp40 and gp48 inhibit antigen presentation to CD8<sup>+ </sup>T cells <italic>in vitro </italic>[<xref ref-type="bibr" rid="B314">314</xref>,<xref ref-type="bibr" rid="B315">315</xref>]. gp40 and gp48 bind MHC class I molecules and retain them intracellularly [<xref ref-type="bibr" rid="B314">314</xref>-<xref ref-type="bibr" rid="B316">316</xref>], although each protein does so via different mechanisms. gp40 retains MHC class I molecules in the ER-Golgi intermediate compartment (ERGIC)-cis golgi network [<xref ref-type="bibr" rid="B314">314</xref>] whereas gp48 binds to MHC class I molecules and targets them to lysosomes for degradation [<xref ref-type="bibr" rid="B315">315</xref>]. Deletion of <italic>m152 </italic>restores MHC class I expression in MCMV infected cells suggesting gp40 is the main regulator of MHC class I downregulation [<xref ref-type="bibr" rid="B317">317</xref>,<xref ref-type="bibr" rid="B318">318</xref>]. However, gp48 cooperates with gp40 to enhance MHC class I retention <italic>in vitro </italic>[<xref ref-type="bibr" rid="B319">319</xref>]. gp48 and gp40 also show different specificities for MHC class I alleles and thus are both required for efficient MHC class I downregulation in certain cell types [<xref ref-type="bibr" rid="B320">320</xref>,<xref ref-type="bibr" rid="B321">321</xref>]. Surprisingly, the presence of <italic>m152 </italic>does not impact the CTL response in mice based on studies using recombinant MCMVs. Therefore, the <italic>in vivo </italic>role of <italic>m152 </italic>as well as <italic>m4 </italic>and <italic>m6 </italic>is not clear [<xref ref-type="bibr" rid="B322">322</xref>-<xref ref-type="bibr" rid="B324">324</xref>]. One possible explanation for this lack of CTL alteration <italic>in vivo </italic>is uninfected antigen presenting cells (APCs) cross-priming CD8<sup>+ </sup>T cells, which could circumvent function of gp40 in mice [<xref ref-type="bibr" rid="B324">324</xref>]. If these proteins cannot prevent priming of CD8<sup>+ </sup>T cells, what is their function? There are a couple of possibilities. One is that the delay in CD8<sup>+ </sup>T cell recognition is enough to allow the virus to establish a foothold within the host and eventually establish latency. Also without this initial CD8<sup>+ </sup>T cell recognition, immunopathology could be diminished allowing the host to survive and viral spread. Recently the Reddehase group has shown that the presence of these immune modulating proteins (gp40, and gp48) actually enhance priming of CD8+ T cells [<xref ref-type="bibr" rid="B325">325</xref>]. How this benefits CMV survival <italic>in vivo </italic>is hard to reconcile, but may represent the evolution of mouse immune responses to counter these "immunevasions." The Reddehase and Hill labs are both actively persuing answers to these questions and why CMVs would have evolved mechanisms to enhance CTL priming.</p><p>The MCMV protein gp34 also associates with MHC class I molecules [<xref ref-type="bibr" rid="B326">326</xref>,<xref ref-type="bibr" rid="B327">327</xref>]. In contrast to gp40 and gp48, gp34 decreases the intracellular retention of MHC class I molecules [<xref ref-type="bibr" rid="B319">319</xref>,<xref ref-type="bibr" rid="B326">326</xref>]. However, this phenomenon is seen only in the absence of m6 (gp48) suggesting gp48 expression may antagonize the function of gp34 and provide a mechanism to regulate the extent of MHC class I expression in infected cells [<xref ref-type="bibr" rid="B317">317</xref>,<xref ref-type="bibr" rid="B319">319</xref>].</p><p>HCMV can also interfere with the presentation of MHC class II on antigen presenting cells such as macrophages [<xref ref-type="bibr" rid="B328">328</xref>]. gpUS3, gpUS2, and pp65 mediate this effect. gpUS3 binds and downregulates MHC class II, which subsequently decreases antigen presentation to CD4<sup>+ </sup>T cells. gpUS3 interferes with the sorting of MHC class II to lysosomes inhibiting peptide loading in these compartments and subsequent MHC class II expression at the cell surface [<xref ref-type="bibr" rid="B269">269</xref>]. gpUS2 also interferes with CD4<sup>+ </sup>T cell recognition by downregulating MHC class II molecules. Similar to its effect on MHC class I, gpUS2 binds the &#x003b1; chain of MHC class II resulting in the proteasome-dependent degradation of MHC class II molecules in a number of different cell types <italic>in vitro </italic>[<xref ref-type="bibr" rid="B269">269</xref>,<xref ref-type="bibr" rid="B329">329</xref>-<xref ref-type="bibr" rid="B331">331</xref>]. Lastly, the tegument protein, pp65, also downregulates MHC class II expression. Yet another mechanism for MHC class II down regulation, pp65 mediates MHC class II trafficking to lysosomes causing their destruction [<xref ref-type="bibr" rid="B332">332</xref>]. MCMV infection also downregulates MHC class II expression although the viral proteins responsible for this are not currently identified [<xref ref-type="bibr" rid="B141">141</xref>,<xref ref-type="bibr" rid="B333">333</xref>]. As observed with MHC class I downregulation, CMVs have evolved multiple modes for achieving manipulation of MHC class II host responses in order to achieve evolutionary success.</p></sec></sec></sec><sec><title>Conclusion</title><p>Whether it is the destruction of important immune molecules, a redirection of these proteins intracellularly, transcriptional or translational control, alteration of signal transduction cascades, or the production of novel interfering proteins, CMVs "push" and "pull" at the immune response in such a way as to ensure their evolutionary success. Based on the numerous viral proteins that respond to the host's defence mechanisms, the relationship of CMVs with their hosts is complex. In spite of the manipulation of both the magnitude and quality of the innate and adaptive immune responses, the host still launches a robust anti-CMV immune response but not before the virus establishes latency within the host. Therefore CMV infection does not eliminate host immunity but modulates it to allow survival of both the virus and the host, as both are important to the life cycle of the virus. With its millions of years of co evolution within us, we can use CMVs acquired "knowledge" of the immune system to uncover novel immune pathways. We can potentially exploit CMVs potential vulnerabilities for developing CMV vaccines (i.e. ones that can not establish latency) or novel therapeutics that could minimize CMV-induced damage in immune compromised hosts.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>MMK carried out the literature review and wrote this manuscript. TES conceived of the review and edited the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Authors' Information</title><p>MMK recently received her PhD with a dissertation exploring CMV viral chemokines from the University of Tennessee. TES is an assistant professor at the University of Tennessee whose lab focuses on CMV immune modulation.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Cytomegalovirus modulation of the innate immune response.</bold> A listing of the cytomegalovirus encoded proteins that interfere with the innate immune response.</p></caption><media xlink:href="1743-422X-6-4-S1.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>CMV Modulation of the adaptive immune response</bold>. A listing of the cytomegalovirus encoded proteins that interfere with the adaptive immune response.</p></caption><media xlink:href="1743-422X-6-4-S2.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tortorella</surname><given-names>D</given-names></name><name><surname>Gewurz</surname><given-names>BE</given-names></name><name><surname>Furman</surname><given-names>MH</given-names></name><name><surname>Schust</surname><given-names>DJ</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Viral subversion of the immune system</article-title><source>Annu Rev Immunol</source><year>2000</year><volume>18</volume><fpage>861</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">10837078</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>RL</given-names></name></person-group><article-title>The complement system: its importance in the host response to viral infection</article-title><source>Microbiol Rev</source><year>1982</year><volume>46</volume><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">7045625</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spiller</surname><given-names>OB</given-names></name><name><surname>Hanna</surname><given-names>SM</given-names></name><name><surname>Devine</surname><given-names>DV</given-names></name><name><surname>Tufaro</surname><given-names>F</given-names></name></person-group><article-title>Neutralization of cytomegalovirus virions: the role of complement</article-title><source>J Infect Dis</source><year>1997</year><volume>176</volume><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">9237698</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spear</surname><given-names>GT</given-names></name><name><surname>Lurain</surname><given-names>NS</given-names></name><name><surname>Parker</surname><given-names>CJ</given-names></name><name><surname>Ghassemi</surname><given-names>M</given-names></name><name><surname>Payne</surname><given-names>GH</given-names></name><name><surname>Saifuddin</surname><given-names>M</given-names></name></person-group><article-title>Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV)</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>4376</fpage><lpage>4381</lpage><pub-id pub-id-type="pmid">7594597</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spiller</surname><given-names>OB</given-names></name><name><surname>Morgan</surname><given-names>BP</given-names></name><name><surname>Tufaro</surname><given-names>F</given-names></name><name><surname>Devine</surname><given-names>DV</given-names></name></person-group><article-title>Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells</article-title><source>Eur J Immunol</source><year>1996</year><volume>26</volume><fpage>1532</fpage><lpage>1538</lpage><pub-id pub-id-type="pmid">8766557</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Kurita-Taniguchi</surname><given-names>M</given-names></name><name><surname>Kondo</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Yamanishi</surname><given-names>K</given-names></name><name><surname>Okabe</surname><given-names>M</given-names></name><name><surname>Seya</surname><given-names>T</given-names></name></person-group><article-title>Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region</article-title><source>Eur J Immunol</source><year>2002</year><volume>32</volume><fpage>2954</fpage><lpage>2964</lpage><pub-id pub-id-type="pmid">12355449</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holers</surname><given-names>VM</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Molina</surname><given-names>H</given-names></name></person-group><article-title>The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function</article-title><source>Immunol Today</source><year>1992</year><volume>13</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">1378280</pub-id></citation></ref><ref id="B8"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Pass</surname><given-names>RF</given-names></name></person-group><person-group person-group-type="editor"><name><surname>David MK, Peter M Howley</surname></name></person-group><article-title>Cytomegaloviruses</article-title><source>Fields Virology</source><year>2001</year><edition>4</edition><publisher-name>Philadelphia: Lippincott Williams and Williams</publisher-name><fpage>2675</fpage><lpage>2703</lpage></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westmoreland</surname><given-names>D</given-names></name><name><surname>St Jeor</surname><given-names>S</given-names></name><name><surname>Rapp</surname><given-names>F</given-names></name></person-group><article-title>The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin</article-title><source>J Immunol</source><year>1976</year><volume>116</volume><fpage>1566</fpage><lpage>1570</lpage><pub-id pub-id-type="pmid">178801</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>R</given-names></name><name><surname>Peitchel</surname><given-names>R</given-names></name><name><surname>Goldman</surname><given-names>JN</given-names></name><name><surname>Goldman</surname><given-names>M</given-names></name></person-group><article-title>An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts</article-title><source>J Immunol</source><year>1976</year><volume>116</volume><fpage>772</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">176272</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>AA</given-names></name><name><surname>Teschner</surname><given-names>M</given-names></name><name><surname>Sethi</surname><given-names>KK</given-names></name><name><surname>Brandis</surname><given-names>H</given-names></name></person-group><article-title>Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus</article-title><source>J Immunol</source><year>1976</year><volume>117</volume><fpage>253</fpage><lpage>258</lpage><pub-id pub-id-type="pmid">180179</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>J</given-names></name><name><surname>Einsfelder</surname><given-names>B</given-names></name></person-group><article-title>Induction of surface IgG receptors in cytomegalovirus-infected human fibroblasts</article-title><source>Eur J Biochem</source><year>1984</year><volume>138</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">6319131</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>T</given-names></name><name><surname>Hornberger</surname><given-names>E</given-names></name><name><surname>Sakuma</surname><given-names>S</given-names></name><name><surname>Plotkin</surname><given-names>SA</given-names></name></person-group><article-title>Demonstration of immunoglobulin G receptors induced by human cytomegalovirus</article-title><source>J Clin Microbiol</source><year>1975</year><volume>2</volume><fpage>332</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">171279</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Murayama</surname><given-names>T</given-names></name><name><surname>Ishida</surname><given-names>K</given-names></name><name><surname>Furukawa</surname><given-names>T</given-names></name></person-group><article-title>Characterization of IgG Fc receptors induced by human cytomegalovirus</article-title><source>J Gen Virol</source><year>1989</year><volume>70</volume><fpage>893</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">2543765</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murayama</surname><given-names>T</given-names></name><name><surname>Natsuume-Sakai</surname><given-names>S</given-names></name><name><surname>Shimokawa</surname><given-names>K</given-names></name><name><surname>Furukawa</surname><given-names>T</given-names></name></person-group><article-title>Fc receptor(s) induced by human cytomegalovirus bind differentially with human immunoglobulin G subclasses</article-title><source>J Gen Virol</source><year>1986</year><volume>67</volume><fpage>1475</fpage><lpage>1478</lpage><pub-id pub-id-type="pmid">3014057</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thale</surname><given-names>R</given-names></name><name><surname>Lucin</surname><given-names>P</given-names></name><name><surname>Schneider</surname><given-names>K</given-names></name><name><surname>Eggers</surname><given-names>M</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor</article-title><source>J Virol</source><year>1994</year><volume>68</volume><fpage>7757</fpage><lpage>7765</lpage><pub-id pub-id-type="pmid">7966565</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ravetch</surname><given-names>JV</given-names></name><name><surname>Bolland</surname><given-names>S</given-names></name></person-group><article-title>IgG Fc receptors</article-title><source>Annu Rev Immunol</source><year>2001</year><volume>19</volume><fpage>275</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">11244038</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crnkovic-Mertens</surname><given-names>I</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Milotic</surname><given-names>I</given-names></name><name><surname>Szepan</surname><given-names>U</given-names></name><name><surname>Kucic</surname><given-names>N</given-names></name><name><surname>Krmpotic</surname><given-names>A</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>1377</fpage><lpage>1382</lpage><pub-id pub-id-type="pmid">9445038</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Pavic</surname><given-names>I</given-names></name><name><surname>Polic</surname><given-names>B</given-names></name><name><surname>Crnkovic</surname><given-names>I</given-names></name><name><surname>Lucin</surname><given-names>P</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus</article-title><source>J Exp Med</source><year>1994</year><volume>179</volume><fpage>1713</fpage><lpage>1717</lpage><pub-id pub-id-type="pmid">8163949</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lenac</surname><given-names>T</given-names></name><name><surname>Budt</surname><given-names>M</given-names></name><name><surname>Arapovic</surname><given-names>J</given-names></name><name><surname>Hasan</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Simic</surname><given-names>H</given-names></name><name><surname>Krmpotic</surname><given-names>A</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Ruzsics</surname><given-names>Z</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name></person-group><article-title>The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60</article-title><source>J Exp Med</source><year>2006</year><volume>203</volume><fpage>1843</fpage><lpage>1850</lpage><pub-id pub-id-type="pmid">16831899</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mintern</surname><given-names>JD</given-names></name><name><surname>Klemm</surname><given-names>EJ</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Paquet</surname><given-names>ME</given-names></name><name><surname>Napier</surname><given-names>MD</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><fpage>8422</fpage><lpage>8431</lpage><pub-id pub-id-type="pmid">17142739</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atalay</surname><given-names>R</given-names></name><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Borst</surname><given-names>E</given-names></name><name><surname>Benz</surname><given-names>C</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name></person-group><article-title>Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>8596</fpage><lpage>8608</lpage><pub-id pub-id-type="pmid">12163579</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lilley</surname><given-names>BN</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Tirabassi</surname><given-names>RS</given-names></name></person-group><article-title>Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>11218</fpage><lpage>11221</lpage><pub-id pub-id-type="pmid">11602761</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubin</surname><given-names>G</given-names></name><name><surname>Basu</surname><given-names>S</given-names></name><name><surname>Mallory</surname><given-names>DL</given-names></name><name><surname>Basu</surname><given-names>M</given-names></name><name><surname>Tal-Singer</surname><given-names>R</given-names></name><name><surname>Friedman</surname><given-names>HM</given-names></name></person-group><article-title>Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates</article-title><source>J Virol</source><year>1994</year><volume>68</volume><fpage>2478</fpage><lpage>2485</lpage><pub-id pub-id-type="pmid">7511171</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dowler</surname><given-names>KW</given-names></name><name><surname>Veltri</surname><given-names>RW</given-names></name></person-group><article-title>In vitro neutralization of HSV-2: inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR)</article-title><source>J Med Virol</source><year>1984</year><volume>13</volume><fpage>251</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">6327900</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sprague</surname><given-names>ER</given-names></name><name><surname>Reinhard</surname><given-names>H</given-names></name><name><surname>Cheung</surname><given-names>EJ</given-names></name><name><surname>Farley</surname><given-names>AH</given-names></name><name><surname>Trujillo</surname><given-names>RD</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Bjorkman</surname><given-names>PJ</given-names></name></person-group><article-title>The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>3490</fpage><lpage>3499</lpage><pub-id pub-id-type="pmid">18216124</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>KA</given-names></name><name><surname>Pietropaolo</surname><given-names>RL</given-names></name><name><surname>Compton</surname><given-names>T</given-names></name></person-group><article-title>Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway</article-title><source>Mol Cell Biol</source><year>1999</year><volume>19</volume><fpage>3607</fpage><lpage>3613</lpage><pub-id pub-id-type="pmid">10207084</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Cong</surname><given-names>JP</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>13985</fpage><lpage>13990</lpage><pub-id pub-id-type="pmid">9391139</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simmen</surname><given-names>KA</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name><name><surname>Luukkonen</surname><given-names>BG</given-names></name><name><surname>Lopper</surname><given-names>M</given-names></name><name><surname>Bittner</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>NE</given-names></name><name><surname>Jackson</surname><given-names>MR</given-names></name><name><surname>Compton</surname><given-names>T</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>7140</fpage><lpage>7145</lpage><pub-id pub-id-type="pmid">11390970</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>EP</given-names></name><name><surname>Wing</surname><given-names>B</given-names></name><name><surname>Coleman</surname><given-names>D</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>12319</fpage><lpage>12330</lpage><pub-id pub-id-type="pmid">11711622</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Cong</surname><given-names>JP</given-names></name><name><surname>Mamtora</surname><given-names>G</given-names></name><name><surname>Gingeras</surname><given-names>T</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>14470</fpage><lpage>14475</lpage><pub-id pub-id-type="pmid">9826724</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>L</given-names></name><name><surname>Mowen</surname><given-names>K</given-names></name><name><surname>Rodems</surname><given-names>S</given-names></name><name><surname>Weaver</surname><given-names>B</given-names></name><name><surname>Reich</surname><given-names>N</given-names></name><name><surname>Spector</surname><given-names>D</given-names></name><name><surname>David</surname><given-names>M</given-names></name></person-group><article-title>Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex</article-title><source>Mol Cell Biol</source><year>1998</year><volume>18</volume><fpage>3796</fpage><lpage>3802</lpage><pub-id pub-id-type="pmid">9632763</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Rahill</surname><given-names>BM</given-names></name><name><surname>Waldman</surname><given-names>WJ</given-names></name><name><surname>Sedmak</surname><given-names>DD</given-names></name></person-group><article-title>Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>6107</fpage><lpage>6113</lpage><pub-id pub-id-type="pmid">10229853</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>C</given-names></name><name><surname>DeFilippis</surname><given-names>V</given-names></name><name><surname>Malouli</surname><given-names>D</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>Cytomegalovirus immune evasion</article-title><source>Curr Top Microbiol Immunol</source><year>2008</year><volume>325</volume><fpage>333</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">18637515</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeFilippis</surname><given-names>V</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>6419</fpage><lpage>6431</lpage><pub-id pub-id-type="pmid">15858025</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>CR</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Pathogen subversion of cell-intrinsic innate immunity</article-title><source>Nat Immunol</source><year>2007</year><volume>8</volume><fpage>1179</fpage><lpage>1187</lpage><pub-id pub-id-type="pmid">17952043</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>U</given-names></name><name><surname>Steinhoff</surname><given-names>U</given-names></name><name><surname>Reis</surname><given-names>LF</given-names></name><name><surname>Hemmi</surname><given-names>S</given-names></name><name><surname>Pavlovic</surname><given-names>J</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name><name><surname>Aguet</surname><given-names>M</given-names></name></person-group><article-title>Functional role of type I and type II interferons in antiviral defense</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>1918</fpage><lpage>1921</lpage><pub-id pub-id-type="pmid">8009221</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paulus</surname><given-names>C</given-names></name><name><surname>Krauss</surname><given-names>S</given-names></name><name><surname>Nevels</surname><given-names>M</given-names></name></person-group><article-title>A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>3840</fpage><lpage>3845</lpage><pub-id pub-id-type="pmid">16497831</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>YE</given-names></name><name><surname>Kim</surname><given-names>ET</given-names></name><name><surname>Park</surname><given-names>JJ</given-names></name><name><surname>Song</surname><given-names>MJ</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Hayward</surname><given-names>GS</given-names></name><name><surname>Ahn</surname><given-names>JH</given-names></name></person-group><article-title>Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>10444</fpage><lpage>10454</lpage><pub-id pub-id-type="pmid">18701593</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RT</given-names></name><name><surname>Bresnahan</surname><given-names>WA</given-names></name></person-group><article-title>Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>3873</fpage><lpage>3877</lpage><pub-id pub-id-type="pmid">15731283</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RT</given-names></name><name><surname>Bresnahan</surname><given-names>WA</given-names></name></person-group><article-title>Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>10763</fpage><lpage>10771</lpage><pub-id pub-id-type="pmid">17041226</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abate</surname><given-names>DA</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>10995</fpage><lpage>11006</lpage><pub-id pub-id-type="pmid">15452220</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>EP</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>11439</fpage><lpage>11444</lpage><pub-id pub-id-type="pmid">12972646</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RT</given-names></name><name><surname>Bresnahan</surname><given-names>WA</given-names></name></person-group><article-title>Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>920</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">16378994</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morello</surname><given-names>CS</given-names></name><name><surname>Cranmer</surname><given-names>LD</given-names></name><name><surname>Spector</surname><given-names>DH</given-names></name></person-group><article-title>In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83)</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>7678</fpage><lpage>7693</lpage><pub-id pub-id-type="pmid">10438858</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abenes</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Haghjoo</surname><given-names>E</given-names></name><name><surname>Tong</surname><given-names>T</given-names></name><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name></person-group><article-title>Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>1697</fpage><lpage>1707</lpage><pub-id pub-id-type="pmid">11160668</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Trilling</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Wilborn</surname><given-names>M</given-names></name><name><surname>Bubic</surname><given-names>I</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Koszinowski</surname><given-names>U</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name></person-group><article-title>A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses</article-title><source>J Exp Med</source><year>2005</year><volume>201</volume><fpage>1543</fpage><lpage>1553</lpage><pub-id pub-id-type="pmid">15883169</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Basler</surname><given-names>M</given-names></name><name><surname>Groettrup</surname><given-names>M</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name></person-group><article-title>A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>1831</fpage><lpage>1842</lpage><pub-id pub-id-type="pmid">14747547</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valchanova</surname><given-names>RS</given-names></name><name><surname>Picard-Maureau</surname><given-names>M</given-names></name><name><surname>Budt</surname><given-names>M</given-names></name><name><surname>Brune</surname><given-names>W</given-names></name></person-group><article-title>Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>10181</fpage><lpage>10190</lpage><pub-id pub-id-type="pmid">17005695</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Child</surname><given-names>SJ</given-names></name><name><surname>Hanson</surname><given-names>LK</given-names></name><name><surname>Brown</surname><given-names>CE</given-names></name><name><surname>Janzen</surname><given-names>DM</given-names></name><name><surname>Geballe</surname><given-names>AP</given-names></name></person-group><article-title>Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>10173</fpage><lpage>10180</lpage><pub-id pub-id-type="pmid">17005694</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hakki</surname><given-names>M</given-names></name><name><surname>Geballe</surname><given-names>AP</given-names></name></person-group><article-title>Double-stranded RNA binding by human cytomegalovirus pTRS1</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>7311</fpage><lpage>7318</lpage><pub-id pub-id-type="pmid">15919885</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hakki</surname><given-names>M</given-names></name><name><surname>Marshall</surname><given-names>EE</given-names></name><name><surname>De Niro</surname><given-names>KL</given-names></name><name><surname>Geballe</surname><given-names>AP</given-names></name></person-group><article-title>Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>11817</fpage><lpage>11826</lpage><pub-id pub-id-type="pmid">16987971</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Child</surname><given-names>SJ</given-names></name><name><surname>Hakki</surname><given-names>M</given-names></name><name><surname>De Niro</surname><given-names>KL</given-names></name><name><surname>Geballe</surname><given-names>AP</given-names></name></person-group><article-title>Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">14671101</pub-id></citation></ref><ref id="B54"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Edward</surname><given-names>S</given-names></name><name><surname>Mocarski</surname><given-names>TS</given-names></name><name><surname>Pass</surname><given-names>RobertF</given-names></name></person-group><person-group person-group-type="editor"><name><surname>David MK, Peter M Howley</surname></name></person-group><article-title>Cytomegaloviruses</article-title><source>Fields Virology</source><year>2007</year><volume>2</volume><edition>5</edition><publisher-name>Philadelphia: Lippincott Williams and Williams</publisher-name><fpage>2701</fpage><lpage>2772</lpage></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Armstrong</surname><given-names>M</given-names></name><name><surname>Prod'homme</surname><given-names>V</given-names></name><name><surname>Aicheler</surname><given-names>R</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Rickards</surname><given-names>CR</given-names></name><name><surname>Cochrane</surname><given-names>D</given-names></name><name><surname>Llewellyn-Lacey</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>Griffin</surname><given-names>CA</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name></person-group><article-title>Modulation of natural killer cells by human cytomegalovirus</article-title><source>J Clin Virol</source><year>2008</year><volume>41</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">18069056</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>CL</given-names></name><name><surname>Chalupny</surname><given-names>NJ</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name></person-group><article-title>The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions</article-title><source>Immunol Rev</source><year>2001</year><volume>181</volume><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">11513139</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubin</surname><given-names>M</given-names></name><name><surname>Cassiano</surname><given-names>L</given-names></name><name><surname>Chalupny</surname><given-names>J</given-names></name><name><surname>Chin</surname><given-names>W</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Fanslow</surname><given-names>W</given-names></name><name><surname>Mullberg</surname><given-names>J</given-names></name><name><surname>Rousseau</surname><given-names>AM</given-names></name><name><surname>Ulrich</surname><given-names>D</given-names></name><name><surname>Armitage</surname><given-names>R</given-names></name></person-group><article-title>ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells</article-title><source>Eur J Immunol</source><year>2001</year><volume>31</volume><fpage>1428</fpage><lpage>1437</lpage><pub-id pub-id-type="pmid">11465099</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Mullberg</surname><given-names>J</given-names></name><name><surname>Sutherland</surname><given-names>CL</given-names></name><name><surname>Chin</surname><given-names>W</given-names></name><name><surname>Armitage</surname><given-names>R</given-names></name><name><surname>Fanslow</surname><given-names>W</given-names></name><name><surname>Kubin</surname><given-names>M</given-names></name><name><surname>Chalupny</surname><given-names>NJ</given-names></name></person-group><article-title>ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor</article-title><source>Immunity</source><year>2001</year><volume>14</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">11239445</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Chalupny</surname><given-names>NJ</given-names></name><name><surname>Manley</surname><given-names>TJ</given-names></name><name><surname>Riddell</surname><given-names>SR</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Spies</surname><given-names>T</given-names></name></person-group><article-title>Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein</article-title><source>J Immunol</source><year>2003</year><volume>170</volume><fpage>4196</fpage><lpage>4200</lpage><pub-id pub-id-type="pmid">12682252</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>C</given-names></name><name><surname>Chalupny</surname><given-names>NJ</given-names></name><name><surname>Sutherland</surname><given-names>CL</given-names></name><name><surname>Dosch</surname><given-names>S</given-names></name><name><surname>Sivakumar</surname><given-names>PV</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name></person-group><article-title>Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity</article-title><source>J Exp Med</source><year>2003</year><volume>197</volume><fpage>1427</fpage><lpage>1439</lpage><pub-id pub-id-type="pmid">12782710</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rolle</surname><given-names>A</given-names></name><name><surname>Mousavi-Jazi</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Odeberg</surname><given-names>J</given-names></name><name><surname>Soderberg-Naucler</surname><given-names>C</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Karre</surname><given-names>K</given-names></name><name><surname>Cerboni</surname><given-names>C</given-names></name></person-group><article-title>Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein</article-title><source>J Immunol</source><year>2003</year><volume>171</volume><fpage>902</fpage><lpage>908</lpage><pub-id pub-id-type="pmid">12847260</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vales-Gomez</surname><given-names>M</given-names></name><name><surname>Winterhalter</surname><given-names>A</given-names></name><name><surname>Roda-Navarro</surname><given-names>P</given-names></name><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Boyle</surname><given-names>L</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Brooks</surname><given-names>A</given-names></name><name><surname>Reyburn</surname><given-names>HT</given-names></name></person-group><article-title>The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope</article-title><source>Cell Microbiol</source><year>2006</year><volume>8</volume><fpage>581</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">16548884</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Welte</surname><given-names>SA</given-names></name><name><surname>Sinzger</surname><given-names>C</given-names></name><name><surname>Lutz</surname><given-names>SZ</given-names></name><name><surname>Singh-Jasuja</surname><given-names>H</given-names></name><name><surname>Sampaio</surname><given-names>KL</given-names></name><name><surname>Eknigk</surname><given-names>U</given-names></name><name><surname>Rammensee</surname><given-names>HG</given-names></name><name><surname>Steinle</surname><given-names>A</given-names></name></person-group><article-title>Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein</article-title><source>Eur J Immunol</source><year>2003</year><volume>33</volume><fpage>194</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">12594848</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odeberg</surname><given-names>J</given-names></name><name><surname>Browne</surname><given-names>H</given-names></name><name><surname>Metkar</surname><given-names>S</given-names></name><name><surname>Froelich</surname><given-names>CJ</given-names></name><name><surname>Branden</surname><given-names>L</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Soderberg-Naucler</surname><given-names>C</given-names></name></person-group><article-title>The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>4539</fpage><lpage>4545</lpage><pub-id pub-id-type="pmid">12663760</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stern-Ginossar</surname><given-names>N</given-names></name><name><surname>Elefant</surname><given-names>N</given-names></name><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Wolf</surname><given-names>DG</given-names></name><name><surname>Saleh</surname><given-names>N</given-names></name><name><surname>Biton</surname><given-names>M</given-names></name><name><surname>Horwitz</surname><given-names>E</given-names></name><name><surname>Prokocimer</surname><given-names>Z</given-names></name><name><surname>Prichard</surname><given-names>M</given-names></name><name><surname>Hahn</surname><given-names>G</given-names></name><name><surname>Goldman-Wohl</surname><given-names>D</given-names></name><name><surname>Greenfield</surname><given-names>C</given-names></name><name><surname>Yagel</surname><given-names>S</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Altuvia</surname><given-names>Y</given-names></name><name><surname>Margalit</surname><given-names>H</given-names></name><name><surname>Mandelboim</surname><given-names>O</given-names></name></person-group><article-title>Host immune system gene targeting by a viral miRNA</article-title><source>Science</source><year>2007</year><volume>317</volume><fpage>376</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">17641203</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krmpotic</surname><given-names>A</given-names></name><name><surname>Hasan</surname><given-names>M</given-names></name><name><surname>Loewendorf</surname><given-names>A</given-names></name><name><surname>Saulig</surname><given-names>T</given-names></name><name><surname>Halenius</surname><given-names>A</given-names></name><name><surname>Lenac</surname><given-names>T</given-names></name><name><surname>Polic</surname><given-names>B</given-names></name><name><surname>Bubic</surname><given-names>I</given-names></name><name><surname>Kriegeskorte</surname><given-names>A</given-names></name><name><surname>Pernjak-Pugel</surname><given-names>E</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Busch</surname><given-names>DH</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name></person-group><article-title>NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145</article-title><source>J Exp Med</source><year>2005</year><volume>201</volume><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">15642742</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lodoen</surname><given-names>MB</given-names></name><name><surname>Abenes</surname><given-names>G</given-names></name><name><surname>Umamoto</surname><given-names>S</given-names></name><name><surname>Houchins</surname><given-names>JP</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>1075</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">15477345</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lodoen</surname><given-names>M</given-names></name><name><surname>Ogasawara</surname><given-names>K</given-names></name><name><surname>Hamerman</surname><given-names>JA</given-names></name><name><surname>Arase</surname><given-names>H</given-names></name><name><surname>Houchins</surname><given-names>JP</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules</article-title><source>J Exp Med</source><year>2003</year><volume>197</volume><fpage>1245</fpage><lpage>1253</lpage><pub-id pub-id-type="pmid">12756263</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krmpotic</surname><given-names>A</given-names></name><name><surname>Busch</surname><given-names>DH</given-names></name><name><surname>Bubic</surname><given-names>I</given-names></name><name><surname>Gebhardt</surname><given-names>F</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Hasan</surname><given-names>M</given-names></name><name><surname>Scalzo</surname><given-names>AA</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name></person-group><article-title>MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo</article-title><source>Nat Immunol</source><year>2002</year><volume>3</volume><fpage>529</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">12021778</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>AK</given-names></name><name><surname>Jamieson</surname><given-names>AM</given-names></name><name><surname>Raulet</surname><given-names>DH</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name></person-group><article-title>The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>12564</fpage><lpage>12571</lpage><pub-id pub-id-type="pmid">17855532</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abenes</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Haghjoo</surname><given-names>E</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name></person-group><article-title>Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>6891</fpage><lpage>6899</lpage><pub-id pub-id-type="pmid">15194765</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>M</given-names></name><name><surname>Krmpotic</surname><given-names>A</given-names></name><name><surname>Ruzsics</surname><given-names>Z</given-names></name><name><surname>Bubic</surname><given-names>I</given-names></name><name><surname>Lenac</surname><given-names>T</given-names></name><name><surname>Halenius</surname><given-names>A</given-names></name><name><surname>Loewendorf</surname><given-names>A</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>2920</fpage><lpage>2930</lpage><pub-id pub-id-type="pmid">15709011</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cavanaugh</surname><given-names>VJ</given-names></name><name><surname>Stenberg</surname><given-names>RM</given-names></name><name><surname>Staley</surname><given-names>TL</given-names></name><name><surname>Virgin</surname><given-names>HWt</given-names></name><name><surname>MacDonald</surname><given-names>MR</given-names></name><name><surname>Paetzold</surname><given-names>S</given-names></name><name><surname>Farrell</surname><given-names>HE</given-names></name><name><surname>Rawlinson</surname><given-names>WD</given-names></name><name><surname>Campbell</surname><given-names>AE</given-names></name></person-group><article-title>Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism</article-title><source>J Virol</source><year>1996</year><volume>70</volume><fpage>1365</fpage><lpage>1374</lpage><pub-id pub-id-type="pmid">8627652</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawlinson</surname><given-names>WD</given-names></name><name><surname>Farrell</surname><given-names>HE</given-names></name><name><surname>Barrell</surname><given-names>BG</given-names></name></person-group><article-title>Analysis of the complete DNA sequence of murine cytomegalovirus</article-title><source>J Virol</source><year>1996</year><volume>70</volume><fpage>8833</fpage><lpage>8849</lpage><pub-id pub-id-type="pmid">8971012</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arase</surname><given-names>H</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Campbell</surname><given-names>AE</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>1323</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">11950999</pub-id></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>AH</given-names></name><name><surname>Guseva</surname><given-names>NV</given-names></name><name><surname>Ball</surname><given-names>BL</given-names></name><name><surname>Heusel</surname><given-names>JW</given-names></name></person-group><article-title>Characterization of Murine Cytomegalovirus m157 from Infected Cells and Identification of Critical Residues Mediating Recognition by the NK Cell Receptor Ly49H</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">18566392</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tripathy</surname><given-names>SK</given-names></name><name><surname>Smith</surname><given-names>HR</given-names></name><name><surname>Holroyd</surname><given-names>EA</given-names></name><name><surname>Pingel</surname><given-names>JT</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>545</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">16352579</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kielczewska</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><name><surname>Dimasi</surname><given-names>N</given-names></name><name><surname>Vidal</surname><given-names>SM</given-names></name></person-group><article-title>Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">17182575</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>HR</given-names></name><name><surname>Heusel</surname><given-names>JW</given-names></name><name><surname>Mehta</surname><given-names>IK</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Dorner</surname><given-names>BG</given-names></name><name><surname>Naidenko</surname><given-names>OV</given-names></name><name><surname>Iizuka</surname><given-names>K</given-names></name><name><surname>Furukawa</surname><given-names>H</given-names></name><name><surname>Beckman</surname><given-names>DL</given-names></name><name><surname>Pingel</surname><given-names>JT</given-names></name><name><surname>Scalzo</surname><given-names>AA</given-names></name><name><surname>Fremont</surname><given-names>DH</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>Recognition of a virus-encoded ligand by a natural killer cell activation receptor</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>8826</fpage><lpage>8831</lpage><pub-id pub-id-type="pmid">12060703</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorner</surname><given-names>BG</given-names></name><name><surname>Smith</surname><given-names>HR</given-names></name><name><surname>French</surname><given-names>AR</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Poursine-Laurent</surname><given-names>J</given-names></name><name><surname>Beckman</surname><given-names>DL</given-names></name><name><surname>Pingel</surname><given-names>JT</given-names></name><name><surname>Kroczek</surname><given-names>RA</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>3119</fpage><lpage>3131</lpage><pub-id pub-id-type="pmid">14978118</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>EJ</given-names></name><name><surname>Juo</surname><given-names>ZS</given-names></name><name><surname>Venook</surname><given-names>RT</given-names></name><name><surname>Boulanger</surname><given-names>MJ</given-names></name><name><surname>Arase</surname><given-names>H</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name><name><surname>Garcia</surname><given-names>KC</given-names></name></person-group><article-title>Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>10128</fpage><lpage>10133</lpage><pub-id pub-id-type="pmid">17537914</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bubic</surname><given-names>I</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Krmpotic</surname><given-names>A</given-names></name><name><surname>Saulig</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Gain of virulence caused by loss of a gene in murine cytomegalovirus</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>7536</fpage><lpage>7544</lpage><pub-id pub-id-type="pmid">15220428</pub-id></citation></ref><ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>KA</given-names></name><name><surname>Devora</surname><given-names>G</given-names></name><name><surname>Lai</surname><given-names>WC</given-names></name><name><surname>O'Donnell</surname><given-names>CL</given-names></name><name><surname>Bennett</surname><given-names>M</given-names></name><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group><article-title>Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H</article-title><source>J Exp Med</source><year>2001</year><volume>194</volume><fpage>29</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">11435470</pub-id></citation></ref><ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fodil-Cornu</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Belanger</surname><given-names>S</given-names></name><name><surname>Makrigiannis</surname><given-names>AP</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name><name><surname>Buller</surname><given-names>RM</given-names></name><name><surname>Vidal</surname><given-names>SM</given-names></name></person-group><article-title>Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>6394</fpage><lpage>6405</lpage><pub-id pub-id-type="pmid">18941230</pub-id></citation></ref><ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voigt</surname><given-names>V</given-names></name><name><surname>Forbes</surname><given-names>CA</given-names></name><name><surname>Tonkin</surname><given-names>JN</given-names></name><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name><name><surname>Smith</surname><given-names>HR</given-names></name><name><surname>Yokoyama</surname><given-names>WM</given-names></name><name><surname>Scalzo</surname><given-names>AA</given-names></name></person-group><article-title>Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>13483</fpage><lpage>13488</lpage><pub-id pub-id-type="pmid">14597723</pub-id></citation></ref><ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>LK</given-names></name><name><surname>Dalton</surname><given-names>BL</given-names></name><name><surname>Karabekian</surname><given-names>Z</given-names></name><name><surname>Farrell</surname><given-names>HE</given-names></name><name><surname>Rawlinson</surname><given-names>WD</given-names></name><name><surname>Stenberg</surname><given-names>RM</given-names></name><name><surname>Campbell</surname><given-names>AE</given-names></name></person-group><article-title>Transcriptional analysis of the murine cytomegalovirus HindIII-I region: identification of a novel immediate-early gene region</article-title><source>Virology</source><year>1999</year><volume>260</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">10405367</pub-id></citation></ref><ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>TL</given-names></name><name><surname>Bjorkman</surname><given-names>PJ</given-names></name></person-group><article-title>Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>460</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">9420246</pub-id></citation></ref><ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cretney</surname><given-names>E</given-names></name><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name><name><surname>Densley</surname><given-names>EH</given-names></name><name><surname>Farrell</surname><given-names>HE</given-names></name><name><surname>Davis-Poynter</surname><given-names>NJ</given-names></name><name><surname>Smyth</surname><given-names>MJ</given-names></name></person-group><article-title>m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection</article-title><source>J Exp Med</source><year>1999</year><volume>190</volume><fpage>435</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">10430631</pub-id></citation></ref><ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>HE</given-names></name><name><surname>Vally</surname><given-names>H</given-names></name><name><surname>Lynch</surname><given-names>DM</given-names></name><name><surname>Fleming</surname><given-names>P</given-names></name><name><surname>Shellam</surname><given-names>GR</given-names></name><name><surname>Scalzo</surname><given-names>AA</given-names></name><name><surname>Davis-Poynter</surname><given-names>NJ</given-names></name></person-group><article-title>Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo</article-title><source>Nature</source><year>1997</year><volume>386</volume><fpage>510</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">9087412</pub-id></citation></ref><ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Natarajan</surname><given-names>K</given-names></name><name><surname>Hicks</surname><given-names>A</given-names></name><name><surname>Mans</surname><given-names>J</given-names></name><name><surname>Robinson</surname><given-names>H</given-names></name><name><surname>Guan</surname><given-names>R</given-names></name><name><surname>Mariuzza</surname><given-names>RA</given-names></name><name><surname>Margulies</surname><given-names>DH</given-names></name></person-group><article-title>Crystal structure of the murine cytomegalovirus MHC-I homolog m144</article-title><source>J Mol Biol</source><year>2006</year><volume>358</volume><fpage>157</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">16500675</pub-id></citation></ref><ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beisser</surname><given-names>PS</given-names></name><name><surname>Kloover</surname><given-names>JS</given-names></name><name><surname>Grauls</surname><given-names>GE</given-names></name><name><surname>Blok</surname><given-names>MJ</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name></person-group><article-title>The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host</article-title><source>J Virol</source><year>2000</year><volume>74</volume><fpage>1045</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">10623772</pub-id></citation></ref><ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kloover</surname><given-names>JS</given-names></name><name><surname>Grauls</surname><given-names>GE</given-names></name><name><surname>Blok</surname><given-names>MJ</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name></person-group><article-title>A rat cytomegalovirus strain with a disruption of the r144 MHC class I-like gene is attenuated in the acute phase of infection in neonatal rats</article-title><source>Arch Virol</source><year>2002</year><volume>147</volume><fpage>813</fpage><lpage>824</lpage><pub-id pub-id-type="pmid">12038690</pub-id></citation></ref><ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Barrell</surname><given-names>BG</given-names></name></person-group><article-title>Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens</article-title><source>Nature</source><year>1988</year><volume>331</volume><fpage>269</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">2827039</pub-id></citation></ref><ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>CS</given-names></name><name><surname>Ljunggren</surname><given-names>HG</given-names></name><name><surname>Achour</surname><given-names>A</given-names></name></person-group><article-title>Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">18096997</pub-id></citation></ref><ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Minson</surname><given-names>T</given-names></name></person-group><article-title>A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin</article-title><source>Nature</source><year>1990</year><volume>347</volume><fpage>770</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">2172831</pub-id></citation></ref><ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fahnestock</surname><given-names>ML</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Feldman</surname><given-names>RM</given-names></name><name><surname>Neveu</surname><given-names>JM</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Bjorkman</surname><given-names>PJ</given-names></name></person-group><article-title>The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides</article-title><source>Immunity</source><year>1995</year><volume>3</volume><fpage>583</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">7584148</pub-id></citation></ref><ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Fanger</surname><given-names>N</given-names></name><name><surname>Borges</surname><given-names>L</given-names></name><name><surname>Kubin</surname><given-names>M</given-names></name><name><surname>Chin</surname><given-names>W</given-names></name><name><surname>Peterson</surname><given-names>L</given-names></name><name><surname>Hsu</surname><given-names>ML</given-names></name></person-group><article-title>A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules</article-title><source>Immunity</source><year>1997</year><volume>7</volume><fpage>273</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">9285411</pub-id></citation></ref><ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Bjorkman</surname><given-names>PJ</given-names></name></person-group><article-title>Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>10095</fpage><lpage>10100</lpage><pub-id pub-id-type="pmid">18632577</pub-id></citation></ref><ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Occhino</surname><given-names>M</given-names></name><name><surname>Ghiotto</surname><given-names>F</given-names></name><name><surname>Soro</surname><given-names>S</given-names></name><name><surname>Mortarino</surname><given-names>M</given-names></name><name><surname>Bosi</surname><given-names>S</given-names></name><name><surname>Maffei</surname><given-names>M</given-names></name><name><surname>Bruno</surname><given-names>S</given-names></name><name><surname>Nardini</surname><given-names>M</given-names></name><name><surname>Figini</surname><given-names>M</given-names></name><name><surname>Tramontano</surname><given-names>A</given-names></name><name><surname>Ciccone</surname><given-names>E</given-names></name></person-group><article-title>Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>957</fpage><lpage>968</lpage><pub-id pub-id-type="pmid">18178836</pub-id></citation></ref><ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>TL</given-names></name><name><surname>Heikeman</surname><given-names>AP</given-names></name><name><surname>Bjorkman</surname><given-names>PJ</given-names></name></person-group><article-title>The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18</article-title><source>Immunity</source><year>1999</year><volume>11</volume><fpage>603</fpage><lpage>613</lpage><pub-id pub-id-type="pmid">10591185</pub-id></citation></ref><ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname><given-names>CC</given-names></name><name><surname>Chapman</surname><given-names>TL</given-names></name><name><surname>Bjorkman</surname><given-names>PJ</given-names></name><name><surname>Formankova</surname><given-names>D</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Phillips</surname><given-names>JH</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group><article-title>Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog</article-title><source>J Exp Med</source><year>1998</year><volume>187</volume><fpage>1681</fpage><lpage>1687</lpage><pub-id pub-id-type="pmid">9584146</pub-id></citation></ref><ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reyburn</surname><given-names>HT</given-names></name><name><surname>Mandelboim</surname><given-names>O</given-names></name><name><surname>Vales-Gomez</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>DM</given-names></name><name><surname>Pazmany</surname><given-names>L</given-names></name><name><surname>Strominger</surname><given-names>JL</given-names></name></person-group><article-title>The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells</article-title><source>Nature</source><year>1997</year><volume>386</volume><fpage>514</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">9087413</pub-id></citation></ref><ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prod'homme</surname><given-names>V</given-names></name><name><surname>Griffin</surname><given-names>C</given-names></name><name><surname>Aicheler</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Rickards</surname><given-names>CR</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Borysiewicz</surname><given-names>LK</given-names></name><name><surname>Lopez-Botet</surname><given-names>M</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name></person-group><article-title>The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>4473</fpage><lpage>4481</lpage><pub-id pub-id-type="pmid">17372005</pub-id></citation></ref><ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>CS</given-names></name><name><surname>Riise</surname><given-names>GC</given-names></name><name><surname>Bergstrom</surname><given-names>T</given-names></name><name><surname>Karre</surname><given-names>K</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name><name><surname>Berg</surname><given-names>L</given-names></name></person-group><article-title>Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>3536</fpage><lpage>3543</lpage><pub-id pub-id-type="pmid">17339449</pub-id></citation></ref><ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Choi</surname><given-names>SE</given-names></name><name><surname>Yun</surname><given-names>IH</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Ahn</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Ha</surname><given-names>J</given-names></name><name><surname>Hwang</surname><given-names>ES</given-names></name><name><surname>Cha</surname><given-names>CY</given-names></name><name><surname>Miyagawa</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>CG</given-names></name></person-group><article-title>Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis</article-title><source>Biochem Biophys Res Commun</source><year>2004</year><volume>315</volume><fpage>144</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">15013438</pub-id></citation></ref><ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saverino</surname><given-names>D</given-names></name><name><surname>Ghiotto</surname><given-names>F</given-names></name><name><surname>Merlo</surname><given-names>A</given-names></name><name><surname>Bruno</surname><given-names>S</given-names></name><name><surname>Battini</surname><given-names>L</given-names></name><name><surname>Occhino</surname><given-names>M</given-names></name><name><surname>Maffei</surname><given-names>M</given-names></name><name><surname>Tenca</surname><given-names>C</given-names></name><name><surname>Pileri</surname><given-names>S</given-names></name><name><surname>Baldi</surname><given-names>L</given-names></name><name><surname>Fabbi</surname><given-names>M</given-names></name><name><surname>Bachi</surname><given-names>A</given-names></name><name><surname>De Santanna</surname><given-names>A</given-names></name><name><surname>Grossi</surname><given-names>CE</given-names></name><name><surname>Ciccone</surname><given-names>E</given-names></name></person-group><article-title>Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>5629</fpage><lpage>5637</lpage><pub-id pub-id-type="pmid">15100307</pub-id></citation></ref><ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garrigue</surname><given-names>I</given-names></name><name><surname>Corte</surname><given-names>MF</given-names></name><name><surname>Magnin</surname><given-names>N</given-names></name><name><surname>Couzi</surname><given-names>L</given-names></name><name><surname>Capdepont</surname><given-names>S</given-names></name><name><surname>Rio</surname><given-names>C</given-names></name><name><surname>Merville</surname><given-names>P</given-names></name><name><surname>Dechanet-Merville</surname><given-names>J</given-names></name><name><surname>Fleury</surname><given-names>H</given-names></name><name><surname>Lafon</surname><given-names>ME</given-names></name></person-group><article-title>Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients</article-title><source>J Clin Virol</source><year>2007</year><volume>40</volume><fpage>120</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">17827058</pub-id></citation></ref><ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerboni</surname><given-names>C</given-names></name><name><surname>Achour</surname><given-names>A</given-names></name><name><surname>Warnmark</surname><given-names>A</given-names></name><name><surname>Mousavi-Jazi</surname><given-names>M</given-names></name><name><surname>Sandalova</surname><given-names>T</given-names></name><name><surname>Hsu</surname><given-names>ML</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Karre</surname><given-names>K</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name></person-group><article-title>Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j</article-title><source>Eur J Immunol</source><year>2006</year><volume>36</volume><fpage>732</fpage><lpage>741</lpage><pub-id pub-id-type="pmid">16479538</pub-id></citation></ref><ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odeberg</surname><given-names>J</given-names></name><name><surname>Cerboni</surname><given-names>C</given-names></name><name><surname>Browne</surname><given-names>H</given-names></name><name><surname>Karre</surname><given-names>K</given-names></name><name><surname>Moller</surname><given-names>E</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name><name><surname>Soderberg-Naucler</surname><given-names>C</given-names></name></person-group><article-title>Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18</article-title><source>Scand J Immunol</source><year>2002</year><volume>55</volume><fpage>149</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">11896931</pub-id></citation></ref><ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>CS</given-names></name><name><surname>Walther-Jallow</surname><given-names>L</given-names></name><name><surname>Buentke</surname><given-names>E</given-names></name><name><surname>Ljunggren</surname><given-names>HG</given-names></name><name><surname>Achour</surname><given-names>A</given-names></name><name><surname>Chambers</surname><given-names>BJ</given-names></name></person-group><article-title>Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells</article-title><source>J Leukoc Biol</source><year>2008</year><volume>83</volume><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">17898320</pub-id></citation></ref><ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Oh</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Sung</surname><given-names>YC</given-names></name><name><surname>Hwang</surname><given-names>SY</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>3464</fpage><lpage>3469</lpage><pub-id pub-id-type="pmid">11907106</pub-id></citation></ref><ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Jun</surname><given-names>Y</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000123</fpage><pub-id pub-id-type="pmid">18688275</pub-id></citation></ref><ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassan-Walker</surname><given-names>AF</given-names></name><name><surname>Cope</surname><given-names>AV</given-names></name><name><surname>Griffiths</surname><given-names>PD</given-names></name><name><surname>Emery</surname><given-names>VC</given-names></name></person-group><article-title>Transcription of the human cytomegalovirus natural killer decoy gene, UL18, in vitro and in vivo</article-title><source>J Gen Virol</source><year>1998</year><volume>79</volume><fpage>2113</fpage><lpage>2116</lpage><pub-id pub-id-type="pmid">9747719</pub-id></citation></ref><ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Dolan</surname><given-names>A</given-names></name><name><surname>Akter</surname><given-names>P</given-names></name><name><surname>Addison</surname><given-names>C</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>Alcendor</surname><given-names>DJ</given-names></name><name><surname>McGeoch</surname><given-names>DJ</given-names></name><name><surname>Hayward</surname><given-names>GS</given-names></name></person-group><article-title>The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome</article-title><source>J Gen Virol</source><year>2003</year><volume>84</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">12533697</pub-id></citation></ref><ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wills</surname><given-names>MR</given-names></name><name><surname>Ashiru</surname><given-names>O</given-names></name><name><surname>Reeves</surname><given-names>MB</given-names></name><name><surname>Okecha</surname><given-names>G</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Sinclair</surname><given-names>J</given-names></name><name><surname>Sissons</surname><given-names>JG</given-names></name></person-group><article-title>Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>7457</fpage><lpage>7465</lpage><pub-id pub-id-type="pmid">16301653</pub-id></citation></ref><ref id="B116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chalupny</surname><given-names>NJ</given-names></name><name><surname>Rein-Weston</surname><given-names>A</given-names></name><name><surname>Dosch</surname><given-names>S</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name></person-group><article-title>Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><volume>346</volume><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">16750166</pub-id></citation></ref><ref id="B117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>McSharry</surname><given-names>B</given-names></name><name><surname>Retiere</surname><given-names>C</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>S</given-names></name><name><surname>Borysiewicz</surname><given-names>LK</given-names></name><name><surname>Braud</surname><given-names>VM</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name></person-group><article-title>UL40-mediated NK evasion during productive infection with human cytomegalovirus</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>7570</fpage><lpage>7575</lpage><pub-id pub-id-type="pmid">12032324</pub-id></citation></ref><ref id="B118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Braud</surname><given-names>VM</given-names></name><name><surname>Rickards</surname><given-names>C</given-names></name><name><surname>Powell</surname><given-names>MB</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Gadola</surname><given-names>S</given-names></name><name><surname>Cerundolo</surname><given-names>V</given-names></name><name><surname>Borysiewicz</surname><given-names>LK</given-names></name><name><surname>McMichael</surname><given-names>AJ</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name></person-group><article-title>Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>1031</fpage><pub-id pub-id-type="pmid">10669413</pub-id></citation></ref><ref id="B119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ulbrecht</surname><given-names>M</given-names></name><name><surname>Martinozzi</surname><given-names>S</given-names></name><name><surname>Grzeschik</surname><given-names>M</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Ellwart</surname><given-names>JW</given-names></name><name><surname>Pla</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>EH</given-names></name></person-group><article-title>Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>5019</fpage><lpage>5022</lpage><pub-id pub-id-type="pmid">10799855</pub-id></citation></ref><ref id="B120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerboni</surname><given-names>C</given-names></name><name><surname>Mousavi-Jazi</surname><given-names>M</given-names></name><name><surname>Wakiguchi</surname><given-names>H</given-names></name><name><surname>Carbone</surname><given-names>E</given-names></name><name><surname>Karre</surname><given-names>K</given-names></name><name><surname>Soderstrom</surname><given-names>K</given-names></name></person-group><article-title>Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity</article-title><source>Eur J Immunol</source><year>2001</year><volume>31</volume><fpage>2926</fpage><lpage>2935</lpage><pub-id pub-id-type="pmid">11592068</pub-id></citation></ref><ref id="B121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lehner</surname><given-names>PJ</given-names></name><name><surname>Karttunen</surname><given-names>JT</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Cresswell</surname><given-names>P</given-names></name></person-group><article-title>The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>6904</fpage><lpage>6909</lpage><pub-id pub-id-type="pmid">9192664</pub-id></citation></ref><ref id="B122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>CS</given-names></name><name><surname>Mach</surname><given-names>M</given-names></name><name><surname>Schendel</surname><given-names>DJ</given-names></name><name><surname>Weiss</surname><given-names>EH</given-names></name><name><surname>Hilgert</surname><given-names>I</given-names></name><name><surname>Hahn</surname><given-names>G</given-names></name></person-group><article-title>NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>3257</fpage><lpage>3266</lpage><pub-id pub-id-type="pmid">12218145</pub-id></citation></ref><ref id="B123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pietra</surname><given-names>G</given-names></name><name><surname>Romagnani</surname><given-names>C</given-names></name><name><surname>Mazzarino</surname><given-names>P</given-names></name><name><surname>Falco</surname><given-names>M</given-names></name><name><surname>Millo</surname><given-names>E</given-names></name><name><surname>Moretta</surname><given-names>A</given-names></name><name><surname>Moretta</surname><given-names>L</given-names></name><name><surname>Mingari</surname><given-names>MC</given-names></name></person-group><article-title>HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>10896</fpage><lpage>10901</lpage><pub-id pub-id-type="pmid">12960383</pub-id></citation></ref><ref id="B124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzarino</surname><given-names>P</given-names></name><name><surname>Pietra</surname><given-names>G</given-names></name><name><surname>Vacca</surname><given-names>P</given-names></name><name><surname>Falco</surname><given-names>M</given-names></name><name><surname>Colau</surname><given-names>D</given-names></name><name><surname>Coulie</surname><given-names>P</given-names></name><name><surname>Moretta</surname><given-names>L</given-names></name><name><surname>Mingari</surname><given-names>MC</given-names></name></person-group><article-title>Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion</article-title><source>Eur J Immunol</source><year>2005</year><volume>35</volume><fpage>3240</fpage><lpage>3247</lpage><pub-id pub-id-type="pmid">16224817</pub-id></citation></ref><ref id="B125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnon</surname><given-names>TI</given-names></name><name><surname>Achdout</surname><given-names>H</given-names></name><name><surname>Levi</surname><given-names>O</given-names></name><name><surname>Markel</surname><given-names>G</given-names></name><name><surname>Saleh</surname><given-names>N</given-names></name><name><surname>Katz</surname><given-names>G</given-names></name><name><surname>Gazit</surname><given-names>R</given-names></name><name><surname>Gonen-Gross</surname><given-names>T</given-names></name><name><surname>Hanna</surname><given-names>J</given-names></name><name><surname>Nahari</surname><given-names>E</given-names></name><name><surname>Porgador</surname><given-names>A</given-names></name><name><surname>Honigman</surname><given-names>A</given-names></name><name><surname>Plachter</surname><given-names>B</given-names></name><name><surname>Mevorach</surname><given-names>D</given-names></name><name><surname>Wolf</surname><given-names>DG</given-names></name><name><surname>Mandelboim</surname><given-names>O</given-names></name></person-group><article-title>Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">15821739</pub-id></citation></ref><ref id="B126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Vojtesek</surname><given-names>B</given-names></name><name><surname>Armstrong</surname><given-names>M</given-names></name><name><surname>Griffin</surname><given-names>C</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Morris</surname><given-names>RJ</given-names></name><name><surname>Llewellyn-Lacey</surname><given-names>S</given-names></name><name><surname>Rickards</surname><given-names>C</given-names></name><name><surname>Nomoto</surname><given-names>A</given-names></name><name><surname>Sinzger</surname><given-names>C</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name></person-group><article-title>Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">15640804</pub-id></citation></ref><ref id="B127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>KW</given-names></name><name><surname>de Waal Malefyt</surname><given-names>R</given-names></name><name><surname>Coffman</surname><given-names>RL</given-names></name><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group><article-title>Interleukin-10 and the interleukin-10 receptor</article-title><source>Annu Rev Immunol</source><year>2001</year><volume>19</volume><fpage>683</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">11244051</pub-id></citation></ref><ref id="B128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redpath</surname><given-names>S</given-names></name><name><surname>Ghazal</surname><given-names>P</given-names></name><name><surname>Gascoigne</surname><given-names>NR</given-names></name></person-group><article-title>Hijacking and exploitation of IL-10 by intracellular pathogens</article-title><source>Trends Microbiol</source><year>2001</year><volume>9</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11173248</pub-id></citation></ref><ref id="B129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kotenko</surname><given-names>SV</given-names></name><name><surname>Saccani</surname><given-names>S</given-names></name><name><surname>Izotova</surname><given-names>LS</given-names></name><name><surname>Mirochnitchenko</surname><given-names>OV</given-names></name><name><surname>Pestka</surname><given-names>S</given-names></name></person-group><article-title>Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>1695</fpage><lpage>1700</lpage><pub-id pub-id-type="pmid">10677520</pub-id></citation></ref><ref id="B130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>JV</given-names></name><name><surname>Lockridge</surname><given-names>KM</given-names></name><name><surname>Barry</surname><given-names>PA</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Tsang</surname><given-names>M</given-names></name><name><surname>Penfold</surname><given-names>ME</given-names></name><name><surname>Schall</surname><given-names>TJ</given-names></name></person-group><article-title>Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>1285</fpage><lpage>1292</lpage><pub-id pub-id-type="pmid">11773404</pub-id></citation></ref><ref id="B131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raftery</surname><given-names>MJ</given-names></name><name><surname>Wieland</surname><given-names>D</given-names></name><name><surname>Gronewald</surname><given-names>S</given-names></name><name><surname>Kraus</surname><given-names>AA</given-names></name><name><surname>Giese</surname><given-names>T</given-names></name><name><surname>Schonrich</surname><given-names>G</given-names></name></person-group><article-title>Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><fpage>3383</fpage><lpage>3391</lpage><pub-id pub-id-type="pmid">15322202</pub-id></citation></ref><ref id="B132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>WL</given-names></name><name><surname>Baumgarth</surname><given-names>N</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Barry</surname><given-names>PA</given-names></name></person-group><article-title>Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>8720</fpage><lpage>8731</lpage><pub-id pub-id-type="pmid">15280480</pub-id></citation></ref><ref id="B133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>BC</given-names></name><name><surname>Logsdon</surname><given-names>NJ</given-names></name><name><surname>Josephson</surname><given-names>K</given-names></name><name><surname>Cook</surname><given-names>J</given-names></name><name><surname>Barry</surname><given-names>PA</given-names></name><name><surname>Walter</surname><given-names>MR</given-names></name></person-group><article-title>Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>9404</fpage><lpage>9409</lpage><pub-id pub-id-type="pmid">12093920</pub-id></citation></ref><ref id="B134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>JV</given-names></name></person-group><article-title>The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>2083</fpage><lpage>2086</lpage><pub-id pub-id-type="pmid">17121792</pub-id></citation></ref><ref id="B135"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>JV</given-names></name><name><surname>Cadaoas</surname><given-names>J</given-names></name><name><surname>Castillo</surname><given-names>PR</given-names></name><name><surname>Saini</surname><given-names>V</given-names></name><name><surname>Slobedman</surname><given-names>B</given-names></name></person-group><article-title>Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10</article-title><source>Virology</source><year>2008</year><volume>374</volume><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">18222515</pub-id></citation></ref><ref id="B136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto-Tabata</surname><given-names>T</given-names></name><name><surname>McDonagh</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>HT</given-names></name><name><surname>Fisher</surname><given-names>S</given-names></name><name><surname>Pereira</surname><given-names>L</given-names></name></person-group><article-title>Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>2831</fpage><lpage>2840</lpage><pub-id pub-id-type="pmid">14990702</pub-id></citation></ref><ref id="B137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>C</given-names></name><name><surname>Abendroth</surname><given-names>A</given-names></name><name><surname>Slobedman</surname><given-names>B</given-names></name></person-group><article-title>A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>1440</fpage><lpage>1447</lpage><pub-id pub-id-type="pmid">14722299</pub-id></citation></ref><ref id="B138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>C</given-names></name><name><surname>Garcia</surname><given-names>W</given-names></name><name><surname>Abendroth</surname><given-names>A</given-names></name><name><surname>Slobedman</surname><given-names>B</given-names></name></person-group><article-title>Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection</article-title><source>Virology</source><year>2008</year><volume>370</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">17942134</pub-id></citation></ref><ref id="B139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>C</given-names></name><name><surname>Garcia</surname><given-names>W</given-names></name><name><surname>Godwin</surname><given-names>MJ</given-names></name><name><surname>Spencer</surname><given-names>JV</given-names></name><name><surname>Stern</surname><given-names>JL</given-names></name><name><surname>Abendroth</surname><given-names>A</given-names></name><name><surname>Slobedman</surname><given-names>B</given-names></name></person-group><article-title>Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>3736</fpage><lpage>3750</lpage><pub-id pub-id-type="pmid">18216121</pub-id></citation></ref><ref id="B140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lockridge</surname><given-names>KM</given-names></name><name><surname>Zhou</surname><given-names>SS</given-names></name><name><surname>Kravitz</surname><given-names>RH</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Sawai</surname><given-names>ET</given-names></name><name><surname>Blewett</surname><given-names>EL</given-names></name><name><surname>Barry</surname><given-names>PA</given-names></name></person-group><article-title>Primate cytomegaloviruses encode and express an IL-10-like protein</article-title><source>Virology</source><year>2000</year><volume>268</volume><fpage>272</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">10704336</pub-id></citation></ref><ref id="B141"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redpath</surname><given-names>S</given-names></name><name><surname>Angulo</surname><given-names>A</given-names></name><name><surname>Gascoigne</surname><given-names>NR</given-names></name><name><surname>Ghazal</surname><given-names>P</given-names></name></person-group><article-title>Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>6701</fpage><lpage>6707</lpage><pub-id pub-id-type="pmid">10352288</pub-id></citation></ref><ref id="B142"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cavanaugh</surname><given-names>VJ</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Birkenbach</surname><given-names>MP</given-names></name><name><surname>Slater</surname><given-names>JS</given-names></name><name><surname>Campbell</surname><given-names>AE</given-names></name></person-group><article-title>Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>1703</fpage><lpage>1717</lpage><pub-id pub-id-type="pmid">12525604</pub-id></citation></ref><ref id="B143"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benedict</surname><given-names>CA</given-names></name><name><surname>Butrovich</surname><given-names>KD</given-names></name><name><surname>Lurain</surname><given-names>NS</given-names></name><name><surname>Corbeil</surname><given-names>J</given-names></name><name><surname>Rooney</surname><given-names>I</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group><article-title>Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>6967</fpage><lpage>6970</lpage><pub-id pub-id-type="pmid">10358135</pub-id></citation></ref><ref id="B144"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lurain</surname><given-names>NS</given-names></name><name><surname>Kapell</surname><given-names>KS</given-names></name><name><surname>Huang</surname><given-names>DD</given-names></name><name><surname>Short</surname><given-names>JA</given-names></name><name><surname>Paintsil</surname><given-names>J</given-names></name><name><surname>Winkfield</surname><given-names>E</given-names></name><name><surname>Benedict</surname><given-names>CA</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name><name><surname>Bremer</surname><given-names>JW</given-names></name></person-group><article-title>Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>10040</fpage><lpage>10050</lpage><pub-id pub-id-type="pmid">10559318</pub-id></citation></ref><ref id="B145"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>E</given-names></name><name><surname>King</surname><given-names>CA</given-names></name><name><surname>Sinclair</surname><given-names>JH</given-names></name><name><surname>Alcami</surname><given-names>A</given-names></name></person-group><article-title>The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism</article-title><source>EMBO J</source><year>2006</year><volume>25</volume><fpage>4390</fpage><lpage>4399</lpage><pub-id pub-id-type="pmid">16932746</pub-id></citation></ref><ref id="B146"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>TC</given-names></name><name><surname>Humphreys</surname><given-names>IR</given-names></name><name><surname>Potter</surname><given-names>KG</given-names></name><name><surname>Norris</surname><given-names>PS</given-names></name><name><surname>Shumway</surname><given-names>HM</given-names></name><name><surname>Tran</surname><given-names>BR</given-names></name><name><surname>Patterson</surname><given-names>G</given-names></name><name><surname>Jean-Jacques</surname><given-names>R</given-names></name><name><surname>Yoon</surname><given-names>M</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name><name><surname>Murphy</surname><given-names>KM</given-names></name><name><surname>Lurain</surname><given-names>NS</given-names></name><name><surname>Benedict</surname><given-names>CA</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group><article-title>Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>13218</fpage><lpage>13223</lpage><pub-id pub-id-type="pmid">16131544</pub-id></citation></ref><ref id="B147"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedy</surname><given-names>JR</given-names></name><name><surname>Gavrieli</surname><given-names>M</given-names></name><name><surname>Potter</surname><given-names>KG</given-names></name><name><surname>Hurchla</surname><given-names>MA</given-names></name><name><surname>Lindsley</surname><given-names>RC</given-names></name><name><surname>Hildner</surname><given-names>K</given-names></name><name><surname>Scheu</surname><given-names>S</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name><name><surname>Murphy</surname><given-names>TL</given-names></name><name><surname>Murphy</surname><given-names>KM</given-names></name></person-group><article-title>B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><fpage>90</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">15568026</pub-id></citation></ref><ref id="B148"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>E</given-names></name><name><surname>Atkins</surname><given-names>E</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Yoshie</surname><given-names>O</given-names></name><name><surname>Groves</surname><given-names>I</given-names></name><name><surname>Alcami</surname><given-names>A</given-names></name><name><surname>Sinclair</surname><given-names>J</given-names></name></person-group><article-title>NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>4250</fpage><lpage>4256</lpage><pub-id pub-id-type="pmid">18287226</pub-id></citation></ref><ref id="B149"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arav-Boger</surname><given-names>R</given-names></name><name><surname>Battaglia</surname><given-names>CA</given-names></name><name><surname>Lazzarotto</surname><given-names>T</given-names></name><name><surname>Gabrielli</surname><given-names>L</given-names></name><name><surname>Zong</surname><given-names>JC</given-names></name><name><surname>Hayward</surname><given-names>GS</given-names></name><name><surname>Diener-West</surname><given-names>M</given-names></name><name><surname>Landini</surname><given-names>MP</given-names></name></person-group><article-title>Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection</article-title><source>J Infect Dis</source><year>2006</year><volume>194</volume><fpage>464</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">16845629</pub-id></citation></ref><ref id="B150"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arav-Boger</surname><given-names>R</given-names></name><name><surname>Willoughby</surname><given-names>RE</given-names></name><name><surname>Pass</surname><given-names>RF</given-names></name><name><surname>Zong</surname><given-names>JC</given-names></name><name><surname>Jang</surname><given-names>WJ</given-names></name><name><surname>Alcendor</surname><given-names>D</given-names></name><name><surname>Hayward</surname><given-names>GS</given-names></name></person-group><article-title>Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease</article-title><source>J Infect Dis</source><year>2002</year><volume>186</volume><fpage>1057</fpage><lpage>1064</lpage><pub-id pub-id-type="pmid">12355354</pub-id></citation></ref><ref id="B151"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bale</surname><given-names>JF</given-names><suffix>Jr</suffix></name><name><surname>Petheram</surname><given-names>SJ</given-names></name><name><surname>Robertson</surname><given-names>M</given-names></name><name><surname>Murph</surname><given-names>JR</given-names></name><name><surname>Demmler</surname><given-names>G</given-names></name></person-group><article-title>Human cytomegalovirus a sequence and UL144 variability in strains from infected children</article-title><source>J Med Virol</source><year>2001</year><volume>65</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">11505449</pub-id></citation></ref><ref id="B152"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>J</given-names></name><name><surname>Petheram</surname><given-names>S</given-names></name><name><surname>Demmler</surname><given-names>G</given-names></name><name><surname>Murph</surname><given-names>JR</given-names></name><name><surname>Adler</surname><given-names>SP</given-names></name><name><surname>Bale</surname><given-names>J</given-names></name><name><surname>Sparer</surname><given-names>TE</given-names></name></person-group><article-title>Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children</article-title><source>Virology</source><year>2008</year><pub-id pub-id-type="pmid">18556037</pub-id></citation></ref><ref id="B153"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>ZQ</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Ruan</surname><given-names>Q</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>YJ</given-names></name><name><surname>Ma</surname><given-names>YP</given-names></name><name><surname>Ji</surname><given-names>YH</given-names></name><name><surname>Sun</surname><given-names>ZR</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name></person-group><article-title>Genetic polymorphism of UL144 open reading frame of human cytomegalovirus DNA detected in colon samples from infants with Hirschsprung's disease</article-title><source>World J Gastroenterol</source><year>2007</year><volume>13</volume><fpage>4350</fpage><lpage>4354</lpage><pub-id pub-id-type="pmid">17708610</pub-id></citation></ref><ref id="B154"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Picone</surname><given-names>O</given-names></name><name><surname>Costa</surname><given-names>JM</given-names></name><name><surname>Chaix</surname><given-names>ML</given-names></name><name><surname>Ville</surname><given-names>Y</given-names></name><name><surname>Rouzioux</surname><given-names>C</given-names></name><name><surname>Leruez-Ville</surname><given-names>M</given-names></name></person-group><article-title>Human cytomegalovirus UL144 gene polymorphisms in congenital infections</article-title><source>J Clin Microbiol</source><year>2005</year><volume>43</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">15634946</pub-id></citation></ref><ref id="B155"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Koyano</surname><given-names>S</given-names></name><name><surname>Inami</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Suzutani</surname><given-names>T</given-names></name><name><surname>Mizuguchi</surname><given-names>M</given-names></name><name><surname>Ushijima</surname><given-names>H</given-names></name><name><surname>Kurane</surname><given-names>I</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name></person-group><article-title>Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children</article-title><source>Arch Virol</source><year>2008</year><volume>153</volume><fpage>667</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">18273679</pub-id></citation></ref><ref id="B156"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>MR</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name><name><surname>Virgin</surname><given-names>HWt</given-names></name></person-group><article-title>Late expression of a beta chemokine homolog by murine cytomegalovirus</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>1671</fpage><lpage>1678</lpage><pub-id pub-id-type="pmid">8995698</pub-id></citation></ref><ref id="B157"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>MR</given-names></name><name><surname>Burney</surname><given-names>MW</given-names></name><name><surname>Resnick</surname><given-names>SB</given-names></name><name><surname>Virgin</surname><given-names>HI</given-names></name></person-group><article-title>Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>3682</fpage><lpage>3691</lpage><pub-id pub-id-type="pmid">10196260</pub-id></citation></ref><ref id="B158"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>LM</given-names></name><name><surname>Shellam</surname><given-names>GR</given-names></name><name><surname>Redwood</surname><given-names>AJ</given-names></name></person-group><article-title>Genes of murine cytomegalovirus exist as a number of distinct genotypes</article-title><source>Virology</source><year>2006</year><volume>352</volume><fpage>450</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">16781754</pub-id></citation></ref><ref id="B159"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saederup</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Dairaghi</surname><given-names>DJ</given-names></name><name><surname>Schall</surname><given-names>TJ</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>10881</fpage><lpage>10886</lpage><pub-id pub-id-type="pmid">10485920</pub-id></citation></ref><ref id="B160"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saederup</surname><given-names>N</given-names></name><name><surname>Aguirre</surname><given-names>SA</given-names></name><name><surname>Sparer</surname><given-names>TE</given-names></name><name><surname>Bouley</surname><given-names>DM</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>9966</fpage><lpage>9976</lpage><pub-id pub-id-type="pmid">11559829</pub-id></citation></ref><ref id="B161"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>P</given-names></name><name><surname>Davis-Poynter</surname><given-names>N</given-names></name><name><surname>Degli-Esposti</surname><given-names>M</given-names></name><name><surname>Densley</surname><given-names>E</given-names></name><name><surname>Papadimitriou</surname><given-names>J</given-names></name><name><surname>Shellam</surname><given-names>G</given-names></name><name><surname>Farrell</surname><given-names>H</given-names></name></person-group><article-title>The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>6800</fpage><lpage>6809</lpage><pub-id pub-id-type="pmid">10400778</pub-id></citation></ref><ref id="B162"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noda</surname><given-names>S</given-names></name><name><surname>Aguirre</surname><given-names>SA</given-names></name><name><surname>Bitmansour</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>JM</given-names></name><name><surname>Sparer</surname><given-names>TE</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination</article-title><source>Blood</source><year>2006</year><volume>107</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">16046529</pub-id></citation></ref><ref id="B163"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vink</surname><given-names>C</given-names></name><name><surname>Beuken</surname><given-names>E</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name></person-group><article-title>Complete DNA sequence of the rat cytomegalovirus genome</article-title><source>J Virol</source><year>2000</year><volume>74</volume><fpage>7656</fpage><lpage>7665</lpage><pub-id pub-id-type="pmid">10906222</pub-id></citation></ref><ref id="B164"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaptein</surname><given-names>SJ</given-names></name><name><surname>van Cleef</surname><given-names>KW</given-names></name><name><surname>Gruijthuijsen</surname><given-names>YK</given-names></name><name><surname>Beuken</surname><given-names>EV</given-names></name><name><surname>van Buggenhout</surname><given-names>L</given-names></name><name><surname>Beisser</surname><given-names>PS</given-names></name><name><surname>Stassen</surname><given-names>FR</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name></person-group><article-title>The r131 gene of rat cytomegalovirus encodes a proinflammatory CC chemokine homolog which is essential for the production of infectious virus in the salivary glands</article-title><source>Virus Genes</source><year>2004</year><volume>29</volume><fpage>43</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">15215683</pub-id></citation></ref><ref id="B165"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Penfold</surname><given-names>M</given-names></name><name><surname>Miao</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Haggerty</surname><given-names>S</given-names></name><name><surname>Schleiss</surname><given-names>MR</given-names></name></person-group><article-title>A macrophage inflammatory protein homolog encoded by guinea pig cytomegalovirus signals via CC chemokine receptor 1</article-title><source>Virology</source><year>2003</year><volume>316</volume><fpage>202</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">14644603</pub-id></citation></ref><ref id="B166"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haggerty</surname><given-names>SM</given-names></name><name><surname>Schleiss</surname><given-names>MR</given-names></name></person-group><article-title>A novel CC-chemokine homolog encoded by guinea pig cytomegalovirus</article-title><source>Virus Genes</source><year>2002</year><volume>25</volume><fpage>271</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">12881638</pub-id></citation></ref><ref id="B167"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>TA</given-names></name><name><surname>Tom</surname><given-names>E</given-names></name><name><surname>Kemble</surname><given-names>GW</given-names></name><name><surname>Duke</surname><given-names>GM</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Spaete</surname><given-names>RR</given-names></name></person-group><article-title>Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains</article-title><source>J Virol</source><year>1996</year><volume>70</volume><fpage>78</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">8523595</pub-id></citation></ref><ref id="B168"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Penfold</surname><given-names>ME</given-names></name><name><surname>Dairaghi</surname><given-names>DJ</given-names></name><name><surname>Duke</surname><given-names>GM</given-names></name><name><surname>Saederup</surname><given-names>N</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Kemble</surname><given-names>GW</given-names></name><name><surname>Schall</surname><given-names>TJ</given-names></name></person-group><article-title>Cytomegalovirus encodes a potent alpha chemokine</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>9839</fpage><lpage>9844</lpage><pub-id pub-id-type="pmid">10449781</pub-id></citation></ref><ref id="B169"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>G</given-names></name><name><surname>Revello</surname><given-names>MG</given-names></name><name><surname>Patrone</surname><given-names>M</given-names></name><name><surname>Percivalle</surname><given-names>E</given-names></name><name><surname>Campanini</surname><given-names>G</given-names></name><name><surname>Sarasini</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Gallina</surname><given-names>A</given-names></name><name><surname>Milanesi</surname><given-names>G</given-names></name><name><surname>Koszinowski</surname><given-names>U</given-names></name><name><surname>Baldanti</surname><given-names>F</given-names></name><name><surname>Gerna</surname><given-names>G</given-names></name></person-group><article-title>Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>10023</fpage><lpage>10033</lpage><pub-id pub-id-type="pmid">15331735</pub-id></citation></ref><ref id="B170"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller-Kittrell</surname><given-names>M</given-names></name><name><surname>Sai</surname><given-names>J</given-names></name><name><surname>Penfold</surname><given-names>M</given-names></name><name><surname>Richmond</surname><given-names>A</given-names></name><name><surname>Sparer</surname><given-names>TE</given-names></name></person-group><article-title>Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV)</article-title><source>Virology</source><year>2007</year><volume>364</volume><fpage>454</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">17433398</pub-id></citation></ref><ref id="B171"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arav-Boger</surname><given-names>R</given-names></name><name><surname>Zong</surname><given-names>JC</given-names></name><name><surname>Foster</surname><given-names>CB</given-names></name></person-group><article-title>Loss of linkage disequilibrium and accelerated protein divergence in duplicated cytomegalovirus chemokine genes</article-title><source>Virus Genes</source><year>2005</year><volume>31</volume><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15965610</pub-id></citation></ref><ref id="B172"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassan-Walker</surname><given-names>AF</given-names></name><name><surname>Okwuadi</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Griffiths</surname><given-names>PD</given-names></name><name><surname>Emery</surname><given-names>VC</given-names></name></person-group><article-title>Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus</article-title><source>J Med Virol</source><year>2004</year><volume>74</volume><fpage>573</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">15484281</pub-id></citation></ref><ref id="B173"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>AJ</given-names></name><name><surname>Kovacs</surname><given-names>IJ</given-names></name><name><surname>Gatherer</surname><given-names>D</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>Alkharsah</surname><given-names>KR</given-names></name><name><surname>Chan</surname><given-names>PK</given-names></name><name><surname>Carman</surname><given-names>WF</given-names></name><name><surname>Dedicoat</surname><given-names>M</given-names></name><name><surname>Emery</surname><given-names>VC</given-names></name><name><surname>Geddes</surname><given-names>CC</given-names></name><name><surname>Gerna</surname><given-names>G</given-names></name><name><surname>Ben-Ismaeil</surname><given-names>B</given-names></name><name><surname>Kaye</surname><given-names>S</given-names></name><name><surname>McGregor</surname><given-names>A</given-names></name><name><surname>Moss</surname><given-names>PA</given-names></name><name><surname>Pusztai</surname><given-names>R</given-names></name><name><surname>Rawlinson</surname><given-names>WD</given-names></name><name><surname>Scott</surname><given-names>GM</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Schulz</surname><given-names>TF</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name></person-group><article-title>Genotypic analysis of two hypervariable human cytomegalovirus genes</article-title><source>J Med Virol</source><year>2008</year><volume>80</volume><fpage>1615</fpage><lpage>1623</lpage><pub-id pub-id-type="pmid">18649324</pub-id></citation></ref><ref id="B174"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akter</surname><given-names>P</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Dolan</surname><given-names>A</given-names></name><name><surname>Addison</surname><given-names>C</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>Hassan-Walker</surname><given-names>AF</given-names></name><name><surname>Emery</surname><given-names>VC</given-names></name><name><surname>Griffiths</surname><given-names>PD</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name></person-group><article-title>Two novel spliced genes in human cytomegalovirus</article-title><source>J Gen Virol</source><year>2003</year><volume>84</volume><fpage>1117</fpage><lpage>1122</lpage><pub-id pub-id-type="pmid">12692276</pub-id></citation></ref><ref id="B175"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>18153</fpage><lpage>18158</lpage><pub-id pub-id-type="pmid">16319222</pub-id></citation></ref><ref id="B176"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>10330</fpage><lpage>10338</lpage><pub-id pub-id-type="pmid">16051825</pub-id></citation></ref><ref id="B177"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chee</surname><given-names>MS</given-names></name><name><surname>Satchwell</surname><given-names>SC</given-names></name><name><surname>Preddie</surname><given-names>E</given-names></name><name><surname>Weston</surname><given-names>KM</given-names></name><name><surname>Barrell</surname><given-names>BG</given-names></name></person-group><article-title>Human cytomegalovirus encodes three G protein-coupled receptor homologues</article-title><source>Nature</source><year>1990</year><volume>344</volume><fpage>774</fpage><lpage>777</lpage><pub-id pub-id-type="pmid">2158627</pub-id></citation></ref><ref id="B178"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beisser</surname><given-names>PS</given-names></name><name><surname>Lavreysen</surname><given-names>H</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name></person-group><article-title>Chemokines and chemokine receptors encoded by cytomegaloviruses</article-title><source>Curr Top Microbiol Immunol</source><year>2008</year><volume>325</volume><fpage>221</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">18637509</pub-id></citation></ref><ref id="B179"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>PM</given-names></name></person-group><article-title>The molecular biology of leukocyte chemoattractant receptors</article-title><source>Annu Rev Immunol</source><year>1994</year><volume>12</volume><fpage>593</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">8011292</pub-id></citation></ref><ref id="B180"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Cleef</surname><given-names>KW</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name></person-group><article-title>Cytomegalovirus-encoded homologs of G protein-coupled receptors and chemokines</article-title><source>J Clin Virol</source><year>2006</year><volume>35</volume><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">16406796</pub-id></citation></ref><ref id="B181"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>JL</given-names></name><name><surname>Murphy</surname><given-names>PM</given-names></name></person-group><article-title>Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>28539</fpage><lpage>28542</lpage><pub-id pub-id-type="pmid">7961796</pub-id></citation></ref><ref id="B182"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>DE</given-names></name><name><surname>Beall</surname><given-names>CJ</given-names></name><name><surname>Kolattukudy</surname><given-names>PE</given-names></name></person-group><article-title>The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity</article-title><source>Biochem Biophys Res Commun</source><year>1995</year><volume>211</volume><fpage>325</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">7540006</pub-id></citation></ref><ref id="B183"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kledal</surname><given-names>TN</given-names></name><name><surname>Rosenkilde</surname><given-names>MM</given-names></name><name><surname>Schwartz</surname><given-names>TW</given-names></name></person-group><article-title>Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28</article-title><source>FEBS Lett</source><year>1998</year><volume>441</volume><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">9883886</pub-id></citation></ref><ref id="B184"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michelson</surname><given-names>S</given-names></name><name><surname>Dal Monte</surname><given-names>P</given-names></name><name><surname>Zipeto</surname><given-names>D</given-names></name><name><surname>Bodaghi</surname><given-names>B</given-names></name><name><surname>Laurent</surname><given-names>L</given-names></name><name><surname>Oberlin</surname><given-names>E</given-names></name><name><surname>Arenzana-Seisdedos</surname><given-names>F</given-names></name><name><surname>Virelizier</surname><given-names>JL</given-names></name><name><surname>Landini</surname><given-names>MP</given-names></name></person-group><article-title>Modulation of RANTES production by human cytomegalovirus infection of fibroblasts</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>6495</fpage><lpage>6500</lpage><pub-id pub-id-type="pmid">9261368</pub-id></citation></ref><ref id="B185"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodaghi</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Zipeto</surname><given-names>D</given-names></name><name><surname>Vita</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Laurent</surname><given-names>L</given-names></name><name><surname>Arenzana-Seisdedos</surname><given-names>F</given-names></name><name><surname>Virelizier</surname><given-names>JL</given-names></name><name><surname>Michelson</surname><given-names>S</given-names></name></person-group><article-title>Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>855</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">9730887</pub-id></citation></ref><ref id="B186"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>J</given-names></name><name><surname>Schall</surname><given-names>TJ</given-names></name><name><surname>Corey</surname><given-names>L</given-names></name><name><surname>Geballe</surname><given-names>AP</given-names></name></person-group><article-title>Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>8158</fpage><lpage>8165</lpage><pub-id pub-id-type="pmid">9733857</pub-id></citation></ref><ref id="B187"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Randolph-Habecker</surname><given-names>JR</given-names></name><name><surname>Rahill</surname><given-names>B</given-names></name><name><surname>Torok-Storb</surname><given-names>B</given-names></name><name><surname>Vieira</surname><given-names>J</given-names></name><name><surname>Kolattukudy</surname><given-names>PE</given-names></name><name><surname>Rovin</surname><given-names>BH</given-names></name><name><surname>Sedmak</surname><given-names>DD</given-names></name></person-group><article-title>The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production</article-title><source>Cytokine</source><year>2002</year><volume>19</volume><fpage>37</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">12200112</pub-id></citation></ref><ref id="B188"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraile-Ramos</surname><given-names>A</given-names></name><name><surname>Kledal</surname><given-names>TN</given-names></name><name><surname>Pelchen-Matthews</surname><given-names>A</given-names></name><name><surname>Bowers</surname><given-names>K</given-names></name><name><surname>Schwartz</surname><given-names>TW</given-names></name><name><surname>Marsh</surname><given-names>M</given-names></name></person-group><article-title>The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling</article-title><source>Mol Biol Cell</source><year>2001</year><volume>12</volume><fpage>1737</fpage><lpage>1749</lpage><pub-id pub-id-type="pmid">11408581</pub-id></citation></ref><ref id="B189"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Margulies</surname><given-names>BJ</given-names></name><name><surname>Gibson</surname><given-names>W</given-names></name></person-group><article-title>The chemokine receptor homologue encoded by US27 of human cytomegalovirus is heavily glycosylated and is present in infected human foreskin fibroblasts and enveloped virus particles</article-title><source>Virus Res</source><year>2007</year><volume>123</volume><fpage>57</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">16963142</pub-id></citation></ref><ref id="B190"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Billstrom</surname><given-names>MA</given-names></name><name><surname>Johnson</surname><given-names>GL</given-names></name><name><surname>Avdi</surname><given-names>NJ</given-names></name><name><surname>Worthen</surname><given-names>GS</given-names></name></person-group><article-title>Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>5535</fpage><lpage>5544</lpage><pub-id pub-id-type="pmid">9621010</pub-id></citation></ref><ref id="B191"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casarosa</surname><given-names>P</given-names></name><name><surname>Bakker</surname><given-names>RA</given-names></name><name><surname>Verzijl</surname><given-names>D</given-names></name><name><surname>Navis</surname><given-names>M</given-names></name><name><surname>Timmerman</surname><given-names>H</given-names></name><name><surname>Leurs</surname><given-names>R</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name></person-group><article-title>Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>1133</fpage><lpage>1137</lpage><pub-id pub-id-type="pmid">11050102</pub-id></citation></ref><ref id="B192"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilkie</surname><given-names>TM</given-names></name><name><surname>Scherle</surname><given-names>PA</given-names></name><name><surname>Strathmann</surname><given-names>MP</given-names></name><name><surname>Slepak</surname><given-names>VZ</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name></person-group><article-title>Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines</article-title><source>Proc Natl Acad Sci USA</source><year>1991</year><volume>88</volume><fpage>10049</fpage><lpage>10053</lpage><pub-id pub-id-type="pmid">1946421</pub-id></citation></ref><ref id="B193"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Streblow</surname><given-names>DN</given-names></name><name><surname>Soderberg-Naucler</surname><given-names>C</given-names></name><name><surname>Vieira</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><name><surname>Wakabayashi</surname><given-names>E</given-names></name><name><surname>Ruchti</surname><given-names>F</given-names></name><name><surname>Mattison</surname><given-names>K</given-names></name><name><surname>Altschuler</surname><given-names>Y</given-names></name><name><surname>Nelson</surname><given-names>JA</given-names></name></person-group><article-title>The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration</article-title><source>Cell</source><year>1999</year><volume>99</volume><fpage>511</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">10589679</pub-id></citation></ref><ref id="B194"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Streblow</surname><given-names>DN</given-names></name><name><surname>Orloff</surname><given-names>SL</given-names></name><name><surname>Nelson</surname><given-names>JA</given-names></name></person-group><article-title>The HCMV chemokine receptor US28 is a potential target in vascular disease</article-title><source>Curr Drug Targets Infect Disord</source><year>2001</year><volume>1</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">12455411</pub-id></citation></ref><ref id="B195"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>KA</given-names></name><name><surname>Holst</surname><given-names>PJ</given-names></name><name><surname>Martini</surname><given-names>L</given-names></name><name><surname>Schwartz</surname><given-names>TW</given-names></name><name><surname>Rosenkilde</surname><given-names>MM</given-names></name></person-group><article-title>Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74</article-title><source>Virology</source><year>2004</year><volume>325</volume><fpage>241</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">15246264</pub-id></citation></ref><ref id="B196"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waldhoer</surname><given-names>M</given-names></name><name><surname>Kledal</surname><given-names>TN</given-names></name><name><surname>Farrell</surname><given-names>H</given-names></name><name><surname>Schwartz</surname><given-names>TW</given-names></name></person-group><article-title>Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>8161</fpage><lpage>8168</lpage><pub-id pub-id-type="pmid">12134021</pub-id></citation></ref><ref id="B197"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stropes</surname><given-names>MP</given-names></name><name><surname>Miller</surname><given-names>WE</given-names></name></person-group><article-title>Functional analysis of human cytomegalovirus pUS28 mutants in infected cells</article-title><source>J Gen Virol</source><year>2008</year><volume>89</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">18089733</pub-id></citation></ref><ref id="B198"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>WE</given-names></name><name><surname>Houtz</surname><given-names>DA</given-names></name><name><surname>Nelson</surname><given-names>CD</given-names></name><name><surname>Kolattukudy</surname><given-names>PE</given-names></name><name><surname>Lefkowitz</surname><given-names>RJ</given-names></name></person-group><article-title>G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>21663</fpage><lpage>21671</lpage><pub-id pub-id-type="pmid">12668664</pub-id></citation></ref><ref id="B199"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maussang</surname><given-names>D</given-names></name><name><surname>Verzijl</surname><given-names>D</given-names></name><name><surname>van Walsum</surname><given-names>M</given-names></name><name><surname>Leurs</surname><given-names>R</given-names></name><name><surname>Holl</surname><given-names>J</given-names></name><name><surname>Pleskoff</surname><given-names>O</given-names></name><name><surname>Michel</surname><given-names>D</given-names></name><name><surname>van Dongen</surname><given-names>GA</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name></person-group><article-title>Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>13068</fpage><lpage>13073</lpage><pub-id pub-id-type="pmid">16924106</pub-id></citation></ref><ref id="B200"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>YF</given-names></name><name><surname>Leon</surname><given-names>MB</given-names></name><name><surname>Waclawiw</surname><given-names>MA</given-names></name><name><surname>Popma</surname><given-names>JJ</given-names></name><name><surname>Yu</surname><given-names>ZX</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name><name><surname>Epstein</surname><given-names>SE</given-names></name></person-group><article-title>Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy</article-title><source>N Engl J Med</source><year>1996</year><volume>335</volume><fpage>624</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">8687516</pub-id></citation></ref><ref id="B201"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melnick</surname><given-names>JL</given-names></name><name><surname>Adam</surname><given-names>E</given-names></name><name><surname>Debakey</surname><given-names>ME</given-names></name></person-group><article-title>Cytomegalovirus and atherosclerosis</article-title><source>Eur Heart J</source><year>1993</year><volume>14</volume><fpage>30</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">8131785</pub-id></citation></ref><ref id="B202"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harkins</surname><given-names>L</given-names></name><name><surname>Volk</surname><given-names>AL</given-names></name><name><surname>Samanta</surname><given-names>M</given-names></name><name><surname>Mikolaenko</surname><given-names>I</given-names></name><name><surname>Britt</surname><given-names>WJ</given-names></name><name><surname>Bland</surname><given-names>KI</given-names></name><name><surname>Cobbs</surname><given-names>CS</given-names></name></person-group><article-title>Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer</article-title><source>Lancet</source><year>2002</year><volume>360</volume><fpage>1557</fpage><lpage>1563</lpage><pub-id pub-id-type="pmid">12443594</pub-id></citation></ref><ref id="B203"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cobbs</surname><given-names>CS</given-names></name><name><surname>Harkins</surname><given-names>L</given-names></name><name><surname>Samanta</surname><given-names>M</given-names></name><name><surname>Gillespie</surname><given-names>GY</given-names></name><name><surname>Bharara</surname><given-names>S</given-names></name><name><surname>King</surname><given-names>PH</given-names></name><name><surname>Nabors</surname><given-names>LB</given-names></name><name><surname>Cobbs</surname><given-names>CG</given-names></name><name><surname>Britt</surname><given-names>WJ</given-names></name></person-group><article-title>Human cytomegalovirus infection and expression in human malignant glioma</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><fpage>3347</fpage><lpage>3350</lpage><pub-id pub-id-type="pmid">12067971</pub-id></citation></ref><ref id="B204"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melnychuk</surname><given-names>RM</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><name><surname>Kreklywich</surname><given-names>CN</given-names></name><name><surname>Ruchti</surname><given-names>F</given-names></name><name><surname>Vomaske</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>L</given-names></name><name><surname>Loh</surname><given-names>L</given-names></name><name><surname>Nelson</surname><given-names>JA</given-names></name><name><surname>Orloff</surname><given-names>SL</given-names></name><name><surname>Streblow</surname><given-names>DN</given-names></name></person-group><article-title>Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>10788</fpage><lpage>10795</lpage><pub-id pub-id-type="pmid">16051870</pub-id></citation></ref><ref id="B205"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gruijthuijsen</surname><given-names>YK</given-names></name><name><surname>Casarosa</surname><given-names>P</given-names></name><name><surname>Kaptein</surname><given-names>SJ</given-names></name><name><surname>Broers</surname><given-names>JL</given-names></name><name><surname>Leurs</surname><given-names>R</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name></person-group><article-title>The rat cytomegalovirus R33-encoded G protein-coupled receptor signals in a constitutive fashion</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>1328</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">11773407</pub-id></citation></ref><ref id="B206"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casarosa</surname><given-names>P</given-names></name><name><surname>Gruijthuijsen</surname><given-names>YK</given-names></name><name><surname>Michel</surname><given-names>D</given-names></name><name><surname>Beisser</surname><given-names>PS</given-names></name><name><surname>Holl</surname><given-names>J</given-names></name><name><surname>Fitzsimons</surname><given-names>CP</given-names></name><name><surname>Verzijl</surname><given-names>D</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Mertens</surname><given-names>T</given-names></name><name><surname>Leurs</surname><given-names>R</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name></person-group><article-title>Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>50010</fpage><lpage>50023</lpage><pub-id pub-id-type="pmid">14522997</pub-id></citation></ref><ref id="B207"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sherrill</surname><given-names>JD</given-names></name><name><surname>Miller</surname><given-names>WE</given-names></name></person-group><article-title>G protein-coupled receptor (GPCR) kinase 2 regulates agonist-independent Gq/11 signaling from the mouse cytomegalovirus GPCR M33</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>39796</fpage><lpage>39805</lpage><pub-id pub-id-type="pmid">17088245</pub-id></citation></ref><ref id="B208"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Margulies</surname><given-names>BJ</given-names></name><name><surname>Browne</surname><given-names>H</given-names></name><name><surname>Gibson</surname><given-names>W</given-names></name></person-group><article-title>Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles</article-title><source>Virology</source><year>1996</year><volume>225</volume><fpage>111</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">8918538</pub-id></citation></ref><ref id="B209"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davis-Poynter</surname><given-names>NJ</given-names></name><name><surname>Lynch</surname><given-names>DM</given-names></name><name><surname>Vally</surname><given-names>H</given-names></name><name><surname>Shellam</surname><given-names>GR</given-names></name><name><surname>Rawlinson</surname><given-names>WD</given-names></name><name><surname>Barrell</surname><given-names>BG</given-names></name><name><surname>Farrell</surname><given-names>HE</given-names></name></person-group><article-title>Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>1521</fpage><lpage>1529</lpage><pub-id pub-id-type="pmid">8995678</pub-id></citation></ref><ref id="B210"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beisser</surname><given-names>PS</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name><name><surname>Van Dam</surname><given-names>JG</given-names></name><name><surname>Grauls</surname><given-names>G</given-names></name><name><surname>Vanherle</surname><given-names>SJ</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name></person-group><article-title>The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection</article-title><source>J Virol</source><year>1998</year><volume>72</volume><fpage>2352</fpage><lpage>2363</lpage><pub-id pub-id-type="pmid">9499096</pub-id></citation></ref><ref id="B211"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Case</surname><given-names>R</given-names></name><name><surname>Sharp</surname><given-names>E</given-names></name><name><surname>Benned-Jensen</surname><given-names>T</given-names></name><name><surname>Rosenkilde</surname><given-names>MM</given-names></name><name><surname>Davis-Poynter</surname><given-names>N</given-names></name><name><surname>Farrell</surname><given-names>HE</given-names></name></person-group><article-title>Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>1884</fpage><lpage>1898</lpage><pub-id pub-id-type="pmid">18057236</pub-id></citation></ref><ref id="B212"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Streblow</surname><given-names>DN</given-names></name><name><surname>Kreklywich</surname><given-names>CN</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><name><surname>Soule</surname><given-names>JL</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Yin</surname><given-names>M</given-names></name><name><surname>Beisser</surname><given-names>P</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name><name><surname>Nelson</surname><given-names>JA</given-names></name><name><surname>Orloff</surname><given-names>SL</given-names></name></person-group><article-title>Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33</article-title><source>Am J Transplant</source><year>2005</year><volume>5</volume><fpage>436</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">15707397</pub-id></citation></ref><ref id="B213"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>SA</given-names></name><name><surname>Shenk</surname><given-names>TE</given-names></name></person-group><article-title>Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>3237</fpage><lpage>3242</lpage><pub-id pub-id-type="pmid">11248062</pub-id></citation></ref><ref id="B214"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beisser</surname><given-names>PS</given-names></name><name><surname>Grauls</surname><given-names>G</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name></person-group><article-title>Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>7218</fpage><lpage>7230</lpage><pub-id pub-id-type="pmid">10438809</pub-id></citation></ref><ref id="B215"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaptein</surname><given-names>SJ</given-names></name><name><surname>Beisser</surname><given-names>PS</given-names></name><name><surname>Gruijthuijsen</surname><given-names>YK</given-names></name><name><surname>Savelkouls</surname><given-names>KG</given-names></name><name><surname>van Cleef</surname><given-names>KW</given-names></name><name><surname>Beuken</surname><given-names>E</given-names></name><name><surname>Grauls</surname><given-names>GE</given-names></name><name><surname>Bruggeman</surname><given-names>CA</given-names></name><name><surname>Vink</surname><given-names>C</given-names></name></person-group><article-title>The rat cytomegalovirus R78 G protein-coupled receptor gene is required for production of infectious virus in the spleen</article-title><source>J Gen Virol</source><year>2003</year><volume>84</volume><fpage>2517</fpage><lpage>2530</lpage><pub-id pub-id-type="pmid">12917474</pub-id></citation></ref><ref id="B216"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>D</given-names></name><name><surname>Milotic</surname><given-names>I</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Vaida</surname><given-names>B</given-names></name><name><surname>Holl</surname><given-names>J</given-names></name><name><surname>Ansorge</surname><given-names>R</given-names></name><name><surname>Mertens</surname><given-names>T</given-names></name></person-group><article-title>The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system</article-title><source>J Gen Virol</source><year>2005</year><volume>86</volume><fpage>297</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">15659748</pub-id></citation></ref><ref id="B217"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seet</surname><given-names>BT</given-names></name><name><surname>McFadden</surname><given-names>G</given-names></name></person-group><article-title>Viral chemokine-binding proteins</article-title><source>J Leukoc Biol</source><year>2002</year><volume>72</volume><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12101259</pub-id></citation></ref><ref id="B218"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lalani</surname><given-names>AS</given-names></name><name><surname>McFadden</surname><given-names>G</given-names></name></person-group><article-title>Secreted poxvirus chemokine binding proteins</article-title><source>J Leukoc Biol</source><year>1997</year><volume>62</volume><fpage>570</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">9365110</pub-id></citation></ref><ref id="B219"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Bresnahan</surname><given-names>W</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Human cytomegalovirus encodes a highly specific RANTES decoy receptor</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>16642</fpage><lpage>16647</lpage><pub-id pub-id-type="pmid">15536129</pub-id></citation></ref><ref id="B220"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>V</given-names></name></person-group><article-title>Viruses and apoptosis</article-title><source>J Gen Virol</source><year>1998</year><volume>79</volume><fpage>1833</fpage><lpage>1845</lpage><pub-id pub-id-type="pmid">9714231</pub-id></citation></ref><ref id="B221"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaux</surname><given-names>DL</given-names></name><name><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Cell death in development</article-title><source>Cell</source><year>1999</year><volume>96</volume><fpage>245</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">9988219</pub-id></citation></ref><ref id="B222"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mocarski</surname><given-names>ES</given-names><suffix>Jr</suffix></name></person-group><article-title>Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion</article-title><source>Trends Microbiol</source><year>2002</year><volume>10</volume><fpage>332</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">12110212</pub-id></citation></ref><ref id="B223"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>AL</given-names></name></person-group><article-title>Control of apoptosis by human cytomegalovirus</article-title><source>Curr Top Microbiol Immunol</source><year>2008</year><volume>325</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">18637512</pub-id></citation></ref><ref id="B224"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldmacher</surname><given-names>VS</given-names></name></person-group><article-title>Cell death suppression by cytomegaloviruses</article-title><source>Apoptosis</source><year>2005</year><volume>10</volume><fpage>251</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">15843887</pub-id></citation></ref><ref id="B225"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldmacher</surname><given-names>VS</given-names></name></person-group><article-title>vMIA, a viral inhibitor of apoptosis targeting mitochondria</article-title><source>Biochimie</source><year>2002</year><volume>84</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">12022948</pub-id></citation></ref><ref id="B226"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>AL</given-names></name><name><surname>Meiering</surname><given-names>CD</given-names></name><name><surname>Smith</surname><given-names>GB</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>12205</fpage><lpage>12217</lpage><pub-id pub-id-type="pmid">16160147</pub-id></citation></ref><ref id="B227"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldmacher</surname><given-names>VS</given-names></name><name><surname>Bartle</surname><given-names>LM</given-names></name><name><surname>Skaletskaya</surname><given-names>A</given-names></name><name><surname>Dionne</surname><given-names>CA</given-names></name><name><surname>Kedersha</surname><given-names>NL</given-names></name><name><surname>Vater</surname><given-names>CA</given-names></name><name><surname>Han</surname><given-names>JW</given-names></name><name><surname>Lutz</surname><given-names>RJ</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Cahir McFarland</surname><given-names>ED</given-names></name><name><surname>Kieff</surname><given-names>ED</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Chittenden</surname><given-names>T</given-names></name></person-group><article-title>A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>12536</fpage><lpage>12541</lpage><pub-id pub-id-type="pmid">10535957</pub-id></citation></ref><ref id="B228"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skaletskaya</surname><given-names>A</given-names></name><name><surname>Bartle</surname><given-names>LM</given-names></name><name><surname>Chittenden</surname><given-names>T</given-names></name><name><surname>McCormick</surname><given-names>AL</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Goldmacher</surname><given-names>VS</given-names></name></person-group><article-title>A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>7829</fpage><lpage>7834</lpage><pub-id pub-id-type="pmid">11427719</pub-id></citation></ref><ref id="B229"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reboredo</surname><given-names>M</given-names></name><name><surname>Greaves</surname><given-names>RF</given-names></name><name><surname>Hahn</surname><given-names>G</given-names></name></person-group><article-title>Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication</article-title><source>J Gen Virol</source><year>2004</year><volume>85</volume><fpage>3555</fpage><lpage>3567</lpage><pub-id pub-id-type="pmid">15557228</pub-id></citation></ref><ref id="B230"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mavinakere</surname><given-names>MS</given-names></name><name><surname>Williamson</surname><given-names>CD</given-names></name><name><surname>Goldmacher</surname><given-names>VS</given-names></name><name><surname>Colberg-Poley</surname><given-names>AM</given-names></name></person-group><article-title>Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>6771</fpage><lpage>6783</lpage><pub-id pub-id-type="pmid">16809283</pub-id></citation></ref><ref id="B231"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mavinakere</surname><given-names>MS</given-names></name><name><surname>Colberg-Poley</surname><given-names>AM</given-names></name></person-group><article-title>Dual targeting of the human cytomegalovirus UL37 exon 1 protein during permissive infection</article-title><source>J Gen Virol</source><year>2004</year><volume>85</volume><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">14769889</pub-id></citation></ref><ref id="B232"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bozidis</surname><given-names>P</given-names></name><name><surname>Williamson</surname><given-names>CD</given-names></name><name><surname>Colberg-Poley</surname><given-names>AM</given-names></name></person-group><article-title>Mitochondrial and secretory human cytomegalovirus UL37 proteins traffic into mitochondrion-associated membranes of human cells</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>2715</fpage><lpage>2726</lpage><pub-id pub-id-type="pmid">18199645</pub-id></citation></ref><ref id="B233"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayajneh</surname><given-names>WA</given-names></name><name><surname>Colberg-Poley</surname><given-names>AM</given-names></name><name><surname>Skaletskaya</surname><given-names>A</given-names></name><name><surname>Bartle</surname><given-names>LM</given-names></name><name><surname>Lesperance</surname><given-names>MM</given-names></name><name><surname>Contopoulos-Ioannidis</surname><given-names>DG</given-names></name><name><surname>Kedersha</surname><given-names>NL</given-names></name><name><surname>Goldmacher</surname><given-names>VS</given-names></name></person-group><article-title>The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains</article-title><source>Virology</source><year>2001</year><volume>279</volume><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">11145905</pub-id></citation></ref><ref id="B234"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharon-Friling</surname><given-names>R</given-names></name><name><surname>Goodhouse</surname><given-names>J</given-names></name><name><surname>Colberg-Poley</surname><given-names>AM</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>19117</fpage><lpage>19122</lpage><pub-id pub-id-type="pmid">17135350</pub-id></citation></ref><ref id="B235"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnoult</surname><given-names>D</given-names></name><name><surname>Bartle</surname><given-names>LM</given-names></name><name><surname>Skaletskaya</surname><given-names>A</given-names></name><name><surname>Poncet</surname><given-names>D</given-names></name><name><surname>Zamzami</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>PU</given-names></name><name><surname>Sharpe</surname><given-names>J</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name><name><surname>Goldmacher</surname><given-names>VS</given-names></name></person-group><article-title>Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>7988</fpage><lpage>7993</lpage><pub-id pub-id-type="pmid">15148411</pub-id></citation></ref><ref id="B236"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poncet</surname><given-names>D</given-names></name><name><surname>Larochette</surname><given-names>N</given-names></name><name><surname>Pauleau</surname><given-names>AL</given-names></name><name><surname>Boya</surname><given-names>P</given-names></name><name><surname>Jalil</surname><given-names>AA</given-names></name><name><surname>Cartron</surname><given-names>PF</given-names></name><name><surname>Vallette</surname><given-names>F</given-names></name><name><surname>Schnebelen</surname><given-names>C</given-names></name><name><surname>Bartle</surname><given-names>LM</given-names></name><name><surname>Skaletskaya</surname><given-names>A</given-names></name><name><surname>Boutolleau</surname><given-names>D</given-names></name><name><surname>Martinou</surname><given-names>JC</given-names></name><name><surname>Goldmacher</surname><given-names>VS</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name><name><surname>Zamzami</surname><given-names>N</given-names></name></person-group><article-title>An anti-apoptotic viral protein that recruits Bax to mitochondria</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>22605</fpage><lpage>22614</lpage><pub-id pub-id-type="pmid">15004026</pub-id></citation></ref><ref id="B237"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pauleau</surname><given-names>AL</given-names></name><name><surname>Larochette</surname><given-names>N</given-names></name><name><surname>Giordanetto</surname><given-names>F</given-names></name><name><surname>Scholz</surname><given-names>SR</given-names></name><name><surname>Poncet</surname><given-names>D</given-names></name><name><surname>Zamzami</surname><given-names>N</given-names></name><name><surname>Goldmacher</surname><given-names>VS</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><article-title>Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA</article-title><source>Oncogene</source><year>2007</year><volume>26</volume><fpage>7067</fpage><lpage>7080</lpage><pub-id pub-id-type="pmid">17496930</pub-id></citation></ref><ref id="B238"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>GB</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>14923</fpage><lpage>14932</lpage><pub-id pub-id-type="pmid">16282491</pub-id></citation></ref><ref id="B239"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>AL</given-names></name><name><surname>Roback</surname><given-names>L</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA)</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000063</fpage><pub-id pub-id-type="pmid">18769594</pub-id></citation></ref><ref id="B240"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>AL</given-names></name><name><surname>Skaletskaya</surname><given-names>A</given-names></name><name><surname>Barry</surname><given-names>PA</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name><name><surname>Goldmacher</surname><given-names>VS</given-names></name></person-group><article-title>Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses</article-title><source>Virology</source><year>2003</year><volume>316</volume><fpage>221</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">14644605</pub-id></citation></ref><ref id="B241"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>KL</given-names></name><name><surname>Youle</surname><given-names>RJ</given-names></name></person-group><article-title>Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>6232</fpage><lpage>6243</lpage><pub-id pub-id-type="pmid">18417572</pub-id></citation></ref><ref id="B242"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnoult</surname><given-names>D</given-names></name></person-group><article-title>Apoptosis-associated mitochondrial outer membrane permeabilization assays</article-title><source>Methods</source><year>2008</year><volume>44</volume><fpage>229</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">18314053</pub-id></citation></ref><ref id="B243"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>CE</given-names></name><name><surname>Shenk</surname><given-names>T</given-names></name></person-group><article-title>Human cytomegalovirus UL36 protein is dispensable for viral replication in cultured cells</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>7126</fpage><lpage>7131</lpage><pub-id pub-id-type="pmid">10438798</pub-id></citation></ref><ref id="B244"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andoniou</surname><given-names>CE</given-names></name><name><surname>Degli-Esposti</surname><given-names>MA</given-names></name></person-group><article-title>Insights into the mechanisms of CMV-mediated interference with cellular apoptosis</article-title><source>Immunol Cell Biol</source><year>2006</year><volume>84</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">16405657</pub-id></citation></ref><ref id="B245"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thome</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name><name><surname>Hofmann</surname><given-names>K</given-names></name><name><surname>Fickenscher</surname><given-names>H</given-names></name><name><surname>Meinl</surname><given-names>E</given-names></name><name><surname>Neipel</surname><given-names>F</given-names></name><name><surname>Mattmann</surname><given-names>C</given-names></name><name><surname>Burns</surname><given-names>K</given-names></name><name><surname>Bodmer</surname><given-names>JL</given-names></name><name><surname>Schroter</surname><given-names>M</given-names></name><name><surname>Scaffidi</surname><given-names>C</given-names></name><name><surname>Krammer</surname><given-names>PH</given-names></name><name><surname>Peter</surname><given-names>ME</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><article-title>Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors</article-title><source>Nature</source><year>1997</year><volume>386</volume><fpage>517</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">9087414</pub-id></citation></ref><ref id="B246"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JA</given-names></name><name><surname>Pari</surname><given-names>GS</given-names></name></person-group><article-title>Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>1925</fpage><lpage>1931</lpage><pub-id pub-id-type="pmid">7853536</pub-id></citation></ref><ref id="B247"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Biegalke</surname><given-names>BJ</given-names></name></person-group><article-title>Characterization of a cluster of late genes of guinea pig cytomegalovirus</article-title><source>Virus Genes</source><year>2001</year><volume>23</volume><fpage>247</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">11778692</pub-id></citation></ref><ref id="B248"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menard</surname><given-names>C</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Ruzsics</surname><given-names>Z</given-names></name><name><surname>Holak</surname><given-names>K</given-names></name><name><surname>Brune</surname><given-names>W</given-names></name><name><surname>Campbell</surname><given-names>AE</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Role of murine cytomegalovirus US22 gene family members in replication in macrophages</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>5557</fpage><lpage>5570</lpage><pub-id pub-id-type="pmid">12719548</pub-id></citation></ref><ref id="B249"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cicin-Sain</surname><given-names>L</given-names></name><name><surname>Ruzsics</surname><given-names>Z</given-names></name><name><surname>Podlech</surname><given-names>J</given-names></name><name><surname>Bubic</surname><given-names>I</given-names></name><name><surname>Menard</surname><given-names>C</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Reddehase</surname><given-names>MJ</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>2056</fpage><lpage>2064</lpage><pub-id pub-id-type="pmid">18094168</pub-id></citation></ref><ref id="B250"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lembo</surname><given-names>D</given-names></name><name><surname>Gribaudo</surname><given-names>G</given-names></name><name><surname>Hofer</surname><given-names>A</given-names></name><name><surname>Riera</surname><given-names>L</given-names></name><name><surname>Cornaglia</surname><given-names>M</given-names></name><name><surname>Mondo</surname><given-names>A</given-names></name><name><surname>Angeretti</surname><given-names>A</given-names></name><name><surname>Gariglio</surname><given-names>M</given-names></name><name><surname>Thelander</surname><given-names>L</given-names></name><name><surname>Landolfo</surname><given-names>S</given-names></name></person-group><article-title>Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts</article-title><source>J Virol</source><year>2000</year><volume>74</volume><fpage>11557</fpage><lpage>11565</lpage><pub-id pub-id-type="pmid">11090153</pub-id></citation></ref><ref id="B251"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lembo</surname><given-names>D</given-names></name><name><surname>Donalisio</surname><given-names>M</given-names></name><name><surname>Hofer</surname><given-names>A</given-names></name><name><surname>Cornaglia</surname><given-names>M</given-names></name><name><surname>Brune</surname><given-names>W</given-names></name><name><surname>Koszinowski</surname><given-names>U</given-names></name><name><surname>Thelander</surname><given-names>L</given-names></name><name><surname>Landolfo</surname><given-names>S</given-names></name></person-group><article-title>The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>4278</fpage><lpage>4288</lpage><pub-id pub-id-type="pmid">15047841</pub-id></citation></ref><ref id="B252"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brune</surname><given-names>W</given-names></name><name><surname>Menard</surname><given-names>C</given-names></name><name><surname>Heesemann</surname><given-names>J</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism</article-title><source>Science</source><year>2001</year><volume>291</volume><fpage>303</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">11209080</pub-id></citation></ref><ref id="B253"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Upton</surname><given-names>JW</given-names></name><name><surname>Kaiser</surname><given-names>WJ</given-names></name><name><surname>Mocarski</surname><given-names>ES</given-names></name></person-group><article-title>Cytomegalovirus M45 cell death suppression requires RHIM-dependent interaction with receptor-interacting protein 1 (RIP1)</article-title><source>J Biol Chem</source><year>2008</year><pub-id pub-id-type="pmid">18442983</pub-id></citation></ref><ref id="B254"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>C</given-names></name><name><surname>Sickmann</surname><given-names>A</given-names></name><name><surname>Lembo</surname><given-names>D</given-names></name><name><surname>Brune</surname><given-names>W</given-names></name></person-group><article-title>Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>3094</fpage><lpage>3099</lpage><pub-id pub-id-type="pmid">18287053</pub-id></citation></ref><ref id="B255"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holler</surname><given-names>N</given-names></name><name><surname>Zaru</surname><given-names>R</given-names></name><name><surname>Micheau</surname><given-names>O</given-names></name><name><surname>Thome</surname><given-names>M</given-names></name><name><surname>Attinger</surname><given-names>A</given-names></name><name><surname>Valitutti</surname><given-names>S</given-names></name><name><surname>Bodmer</surname><given-names>JL</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name><name><surname>Seed</surname><given-names>B</given-names></name><name><surname>Tschopp</surname><given-names>J</given-names></name></person-group><article-title>Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule</article-title><source>Nat Immunol</source><year>2000</year><volume>1</volume><fpage>489</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">11101870</pub-id></citation></ref><ref id="B256"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiertz</surname><given-names>EJ</given-names></name><name><surname>Devlin</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>HL</given-names></name><name><surname>Ressing</surname><given-names>ME</given-names></name></person-group><article-title>Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>4389</fpage><lpage>4396</lpage><pub-id pub-id-type="pmid">17079308</pub-id></citation></ref><ref id="B257"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alcami</surname><given-names>A</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Viral mechanisms of immune evasion</article-title><source>Trends Microbiol</source><year>2000</year><volume>8</volume><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">10989308</pub-id></citation></ref><ref id="B258"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Reusch</surname><given-names>U</given-names></name><name><surname>Gutermann</surname><given-names>A</given-names></name><name><surname>Ziegler</surname><given-names>H</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Lucin</surname><given-names>P</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Cytomegaloviral control of MHC class I function in the mouse</article-title><source>Immunol Rev</source><year>1999</year><volume>168</volume><fpage>167</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">10399073</pub-id></citation></ref><ref id="B259"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Hislop</surname><given-names>A</given-names></name><name><surname>Gudgeon</surname><given-names>N</given-names></name><name><surname>Cobbold</surname><given-names>M</given-names></name><name><surname>Khanna</surname><given-names>R</given-names></name><name><surname>Nayak</surname><given-names>L</given-names></name><name><surname>Rickinson</surname><given-names>AB</given-names></name><name><surname>Moss</surname><given-names>PA</given-names></name></person-group><article-title>Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection</article-title><source>J Immunol</source><year>2004</year><volume>173</volume><fpage>7481</fpage><lpage>7489</lpage><pub-id pub-id-type="pmid">15585874</pub-id></citation></ref><ref id="B260"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trzonkowski</surname><given-names>P</given-names></name><name><surname>Mysliwska</surname><given-names>J</given-names></name><name><surname>Szmit</surname><given-names>E</given-names></name><name><surname>Wieckiewicz</surname><given-names>J</given-names></name><name><surname>Lukaszuk</surname><given-names>K</given-names></name><name><surname>Brydak</surname><given-names>LB</given-names></name><name><surname>Machala</surname><given-names>M</given-names></name><name><surname>Mysliwski</surname><given-names>A</given-names></name></person-group><article-title>Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination &#x02013; an impact of immunosenescence</article-title><source>Vaccine</source><year>2003</year><volume>21</volume><fpage>3826</fpage><lpage>3836</lpage><pub-id pub-id-type="pmid">12922116</pub-id></citation></ref><ref id="B261"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Hanson</surname><given-names>LK</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Slater</surname><given-names>JS</given-names></name><name><surname>Stenberg</surname><given-names>RM</given-names></name><name><surname>Campbell</surname><given-names>AE</given-names></name></person-group><article-title>Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>4830</fpage><lpage>4841</lpage><pub-id pub-id-type="pmid">7609050</pub-id></citation></ref><ref id="B262"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>del Val</surname><given-names>M</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Hacker</surname><given-names>H</given-names></name><name><surname>Hartlaub</surname><given-names>U</given-names></name><name><surname>Ruppert</surname><given-names>T</given-names></name><name><surname>Lucin</surname><given-names>P</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment</article-title><source>J Exp Med</source><year>1992</year><volume>176</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">1324970</pub-id></citation></ref><ref id="B263"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thrower</surname><given-names>AR</given-names></name><name><surname>Bullock</surname><given-names>GC</given-names></name><name><surname>Bissell</surname><given-names>JE</given-names></name><name><surname>Stinski</surname><given-names>MF</given-names></name></person-group><article-title>Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination</article-title><source>J Virol</source><year>1996</year><volume>70</volume><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">8523597</pub-id></citation></ref><ref id="B264"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greijer</surname><given-names>AE</given-names></name><name><surname>Verschuuren</surname><given-names>EA</given-names></name><name><surname>Dekkers</surname><given-names>CA</given-names></name><name><surname>Adriaanse</surname><given-names>HM</given-names></name><name><surname>Bij</surname><given-names>W van der</given-names></name><name><surname>The</surname><given-names>TH</given-names></name><name><surname>Middeldorp</surname><given-names>JM</given-names></name></person-group><article-title>Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients</article-title><source>J Infect Dis</source><year>2001</year><volume>184</volume><fpage>247</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">11443549</pub-id></citation></ref><ref id="B265"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Wiertz</surname><given-names>EJ</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Fish</surname><given-names>KN</given-names></name><name><surname>Nelson</surname><given-names>JA</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>11327</fpage><lpage>11333</lpage><pub-id pub-id-type="pmid">8876135</pub-id></citation></ref><ref id="B266"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>K</given-names></name><name><surname>Angulo</surname><given-names>A</given-names></name><name><surname>Ghazal</surname><given-names>P</given-names></name><name><surname>Peterson</surname><given-names>PA</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>Human cytomegalovirus inhibits antigen presentation by a sequential multistep process</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>10990</fpage><lpage>10995</lpage><pub-id pub-id-type="pmid">8855296</pub-id></citation></ref><ref id="B267"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jun</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Sung</surname><given-names>HC</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Geraghty</surname><given-names>DE</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>805</fpage><lpage>811</lpage><pub-id pub-id-type="pmid">10623826</pub-id></citation></ref><ref id="B268"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gruhler</surname><given-names>A</given-names></name><name><surname>Peterson</surname><given-names>PA</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association</article-title><source>Traffic</source><year>2000</year><volume>1</volume><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">11208117</pub-id></citation></ref><ref id="B269"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hegde</surname><given-names>NR</given-names></name><name><surname>Tomazin</surname><given-names>RA</given-names></name><name><surname>Wisner</surname><given-names>TW</given-names></name><name><surname>Dunn</surname><given-names>C</given-names></name><name><surname>Boname</surname><given-names>JM</given-names></name><name><surname>Lewinsohn</surname><given-names>DM</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name></person-group><article-title>Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>10929</fpage><lpage>10941</lpage><pub-id pub-id-type="pmid">12368336</pub-id></citation></ref><ref id="B270"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Jun</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Sung</surname><given-names>HC</given-names></name><name><surname>Kim</surname><given-names>IH</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>EJ</given-names></name><name><surname>Ahn</surname><given-names>BY</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules</article-title><source>J Virol</source><year>2000</year><volume>74</volume><fpage>11262</fpage><lpage>11269</lpage><pub-id pub-id-type="pmid">11070025</pub-id></citation></ref><ref id="B271"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Biegalke</surname><given-names>BJ</given-names></name></person-group><article-title>Functional analysis of the human cytomegalovirus immune evasion protein, pUS3(22kDa)</article-title><source>Virology</source><year>2003</year><volume>315</volume><fpage>353</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">14585338</pub-id></citation></ref><ref id="B272"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>2147</fpage><lpage>2156</lpage><pub-id pub-id-type="pmid">12525649</pub-id></citation></ref><ref id="B273"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misaghi</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>ZY</given-names></name><name><surname>Stern</surname><given-names>P</given-names></name><name><surname>Gaudet</surname><given-names>R</given-names></name><name><surname>Wagner</surname><given-names>G</given-names></name><name><surname>Ploegh</surname><given-names>H</given-names></name></person-group><article-title>Structural and functional analysis of human cytomegalovirus US3 protein</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>413</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">14671122</pub-id></citation></ref><ref id="B274"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion</article-title><source>Immunity</source><year>2004</year><volume>20</volume><fpage>71</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">14738766</pub-id></citation></ref><ref id="B275"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Biegalke</surname><given-names>BJ</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>5397</fpage><lpage>5404</lpage><pub-id pub-id-type="pmid">16699020</pub-id></citation></ref><ref id="B276"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiertz</surname><given-names>EJ</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name><name><surname>Bogyo</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Mothes</surname><given-names>W</given-names></name><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Rapoport</surname><given-names>TA</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction</article-title><source>Nature</source><year>1996</year><volume>384</volume><fpage>432</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">8945469</pub-id></citation></ref><ref id="B277"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiertz</surname><given-names>EJ</given-names></name><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Bogyo</surname><given-names>M</given-names></name><name><surname>Geuze</surname><given-names>HJ</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol</article-title><source>Cell</source><year>1996</year><volume>84</volume><fpage>769</fpage><lpage>779</lpage><pub-id pub-id-type="pmid">8625414</pub-id></citation></ref><ref id="B278"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><article-title>Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>2970</fpage><lpage>2979</lpage><pub-id pub-id-type="pmid">9060656</pub-id></citation></ref><ref id="B279"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehm</surname><given-names>A</given-names></name><name><surname>Engelsberg</surname><given-names>A</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name><name><surname>Korner</surname><given-names>IJ</given-names></name><name><surname>Lehmann</surname><given-names>I</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Hopken</surname><given-names>UE</given-names></name></person-group><article-title>Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>5043</fpage><lpage>5050</lpage><pub-id pub-id-type="pmid">11967320</pub-id></citation></ref><ref id="B280"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kikkert</surname><given-names>M</given-names></name><name><surname>Hassink</surname><given-names>G</given-names></name><name><surname>Barel</surname><given-names>M</given-names></name><name><surname>Hirsch</surname><given-names>C</given-names></name><name><surname>Wal</surname><given-names>FJ van der</given-names></name><name><surname>Wiertz</surname><given-names>E</given-names></name></person-group><article-title>Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol</article-title><source>Biochem J</source><year>2001</year><volume>358</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">11513735</pub-id></citation></ref><ref id="B281"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassink</surname><given-names>GC</given-names></name><name><surname>Barel</surname><given-names>MT</given-names></name><name><surname>Van Voorden</surname><given-names>SB</given-names></name><name><surname>Kikkert</surname><given-names>M</given-names></name><name><surname>Wiertz</surname><given-names>EJ</given-names></name></person-group><article-title>Ubiquitination of MHC class I heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>30063</fpage><lpage>30071</lpage><pub-id pub-id-type="pmid">16877758</pub-id></citation></ref><ref id="B282"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shamu</surname><given-names>CE</given-names></name><name><surname>Story</surname><given-names>CM</given-names></name><name><surname>Rapoport</surname><given-names>TA</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate</article-title><source>J Cell Biol</source><year>1999</year><volume>147</volume><fpage>45</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">10508854</pub-id></citation></ref><ref id="B283"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flierman</surname><given-names>D</given-names></name><name><surname>Coleman</surname><given-names>CS</given-names></name><name><surname>Pickart</surname><given-names>CM</given-names></name><name><surname>Rapoport</surname><given-names>TA</given-names></name><name><surname>Chau</surname><given-names>V</given-names></name></person-group><article-title>E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>11589</fpage><lpage>11594</lpage><pub-id pub-id-type="pmid">16868077</pub-id></citation></ref><ref id="B284"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shamu</surname><given-names>CE</given-names></name><name><surname>Flierman</surname><given-names>D</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Rapoport</surname><given-names>TA</given-names></name><name><surname>Chau</surname><given-names>V</given-names></name></person-group><article-title>Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol</article-title><source>Mol Biol Cell</source><year>2001</year><volume>12</volume><fpage>2546</fpage><lpage>2555</lpage><pub-id pub-id-type="pmid">11514634</pub-id></citation></ref><ref id="B285"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tirosh</surname><given-names>B</given-names></name><name><surname>Iwakoshi</surname><given-names>NN</given-names></name><name><surname>Lilley</surname><given-names>BN</given-names></name><name><surname>Lee</surname><given-names>AH</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Human cytomegalovirus protein US11 provokes an unfolded protein response that may facilitate the degradation of class I major histocompatibility complex products</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>2768</fpage><lpage>2779</lpage><pub-id pub-id-type="pmid">15708995</pub-id></citation></ref><ref id="B286"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>MS</given-names></name><name><surname>Daniels</surname><given-names>GM</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name></person-group><article-title>Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>8265</fpage><lpage>8275</lpage><pub-id pub-id-type="pmid">12134032</pub-id></citation></ref><ref id="B287"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barel</surname><given-names>MT</given-names></name><name><surname>Hassink</surname><given-names>GC</given-names></name><name><surname>van Voorden</surname><given-names>S</given-names></name><name><surname>Wiertz</surname><given-names>EJ</given-names></name></person-group><article-title>Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation</article-title><source>Mol Immunol</source><year>2006</year><volume>43</volume><fpage>1258</fpage><lpage>1266</lpage><pub-id pub-id-type="pmid">16098592</pub-id></citation></ref><ref id="B288"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oresic</surname><given-names>K</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name></person-group><article-title>Endoplasmic reticulum chaperones participate in human cytomegalovirus US2-mediated degradation of class I major histocompatibility complex molecules</article-title><source>J Gen Virol</source><year>2008</year><volume>89</volume><fpage>1122</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">18420789</pub-id></citation></ref><ref id="B289"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lilley</surname><given-names>BN</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>A membrane protein required for dislocation of misfolded proteins from the ER</article-title><source>Nature</source><year>2004</year><volume>429</volume><fpage>834</fpage><lpage>840</lpage><pub-id pub-id-type="pmid">15215855</pub-id></citation></ref><ref id="B290"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barel</surname><given-names>MT</given-names></name><name><surname>Ressing</surname><given-names>M</given-names></name><name><surname>Pizzato</surname><given-names>N</given-names></name><name><surname>van Leeuwen</surname><given-names>D</given-names></name><name><surname>Le Bouteiller</surname><given-names>P</given-names></name><name><surname>Lenfant</surname><given-names>F</given-names></name><name><surname>Wiertz</surname><given-names>EJ</given-names></name></person-group><article-title>Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation</article-title><source>J Immunol</source><year>2003</year><volume>171</volume><fpage>6757</fpage><lpage>6765</lpage><pub-id pub-id-type="pmid">14662880</pub-id></citation></ref><ref id="B291"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schust</surname><given-names>DJ</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name><name><surname>Seebach</surname><given-names>J</given-names></name><name><surname>Phan</surname><given-names>C</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11</article-title><source>J Exp Med</source><year>1998</year><volume>188</volume><fpage>497</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">9687527</pub-id></citation></ref><ref id="B292"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Machold</surname><given-names>RP</given-names></name><name><surname>Wiertz</surname><given-names>EJ</given-names></name><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains</article-title><source>J Exp Med</source><year>1997</year><volume>185</volume><fpage>363</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">9016885</pub-id></citation></ref><ref id="B293"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>MH</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name></person-group><article-title>Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>3258</fpage><lpage>3267</lpage><pub-id pub-id-type="pmid">11717308</pub-id></citation></ref><ref id="B294"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gewurz</surname><given-names>BE</given-names></name><name><surname>Gaudet</surname><given-names>R</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>EW</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Wiley</surname><given-names>DC</given-names></name></person-group><article-title>Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>6794</fpage><lpage>6799</lpage><pub-id pub-id-type="pmid">11391001</pub-id></citation></ref><ref id="B295"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gewurz</surname><given-names>BE</given-names></name><name><surname>Wang</surname><given-names>EW</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name><name><surname>Schust</surname><given-names>DJ</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>5197</fpage><lpage>5204</lpage><pub-id pub-id-type="pmid">11333901</pub-id></citation></ref><ref id="B296"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Story</surname><given-names>CM</given-names></name><name><surname>Furman</surname><given-names>MH</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>8516</fpage><lpage>8521</lpage><pub-id pub-id-type="pmid">10411907</pub-id></citation></ref><ref id="B297"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thilo</surname><given-names>C</given-names></name><name><surname>Berglund</surname><given-names>P</given-names></name><name><surname>Applequist</surname><given-names>SE</given-names></name><name><surname>Yewdell</surname><given-names>JW</given-names></name><name><surname>Ljunggren</surname><given-names>HG</given-names></name><name><surname>Achour</surname><given-names>A</given-names></name></person-group><article-title>Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>8950</fpage><lpage>8957</lpage><pub-id pub-id-type="pmid">16452487</pub-id></citation></ref><ref id="B298"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barel</surname><given-names>MT</given-names></name><name><surname>Pizzato</surname><given-names>N</given-names></name><name><surname>van Leeuwen</surname><given-names>D</given-names></name><name><surname>Bouteiller</surname><given-names>PL</given-names></name><name><surname>Wiertz</surname><given-names>EJ</given-names></name><name><surname>Lenfant</surname><given-names>F</given-names></name></person-group><article-title>Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation</article-title><source>Eur J Immunol</source><year>2003</year><volume>33</volume><fpage>1707</fpage><lpage>1716</lpage><pub-id pub-id-type="pmid">12778489</pub-id></citation></ref><ref id="B299"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SO</given-names></name><name><surname>Hwang</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Jin</surname><given-names>BS</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name></person-group><article-title>Functional dissection of HCMV US11 in mediating the degradation of MHC class I molecules</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>330</volume><fpage>1262</fpage><lpage>1267</lpage><pub-id pub-id-type="pmid">15823579</pub-id></citation></ref><ref id="B300"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Koopmann</surname><given-names>JO</given-names></name><name><surname>Flohr</surname><given-names>T</given-names></name><name><surname>Muranyi</surname><given-names>W</given-names></name><name><surname>Goulmy</surname><given-names>E</given-names></name><name><surname>Hammerling</surname><given-names>GJ</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Momburg</surname><given-names>F</given-names></name></person-group><article-title>A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter</article-title><source>Immunity</source><year>1997</year><volume>6</volume><fpage>623</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">9175840</pub-id></citation></ref><ref id="B301"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>K</given-names></name><name><surname>Gruhler</surname><given-names>A</given-names></name><name><surname>Galocha</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Wiertz</surname><given-names>EJ</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Peterson</surname><given-names>PA</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP</article-title><source>Immunity</source><year>1997</year><volume>6</volume><fpage>613</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">9175839</pub-id></citation></ref><ref id="B302"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>JH</given-names></name><name><surname>Hayward</surname><given-names>GS</given-names></name></person-group><article-title>The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>4599</fpage><lpage>4613</lpage><pub-id pub-id-type="pmid">9151854</pub-id></citation></ref><ref id="B303"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halenius</surname><given-names>A</given-names></name><name><surname>Momburg</surname><given-names>F</given-names></name><name><surname>Reinhard</surname><given-names>H</given-names></name><name><surname>Bauer</surname><given-names>D</given-names></name><name><surname>Lobigs</surname><given-names>M</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name></person-group><article-title>Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>5383</fpage><lpage>5390</lpage><pub-id pub-id-type="pmid">16356928</pub-id></citation></ref><ref id="B304"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kyritsis</surname><given-names>C</given-names></name><name><surname>Gorbulev</surname><given-names>S</given-names></name><name><surname>Hutschenreiter</surname><given-names>S</given-names></name><name><surname>Pawlitschko</surname><given-names>K</given-names></name><name><surname>Abele</surname><given-names>R</given-names></name><name><surname>Tampe</surname><given-names>R</given-names></name></person-group><article-title>Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>48031</fpage><lpage>48039</lpage><pub-id pub-id-type="pmid">11606590</pub-id></citation></ref><ref id="B305"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dugan</surname><given-names>GE</given-names></name><name><surname>Hewitt</surname><given-names>EW</given-names></name></person-group><article-title>Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>3271</fpage><lpage>3282</lpage><pub-id pub-id-type="pmid">18199642</pub-id></citation></ref><ref id="B306"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>EW</given-names></name><name><surname>Gupta</surname><given-names>SS</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name></person-group><article-title>The human cytomegalovirus gene product US6 inhibits ATP binding by TAP</article-title><source>EMBO J</source><year>2001</year><volume>20</volume><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">11157746</pub-id></citation></ref><ref id="B307"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Flohr</surname><given-names>T</given-names></name><name><surname>Hammerling</surname><given-names>GJ</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Momburg</surname><given-names>F</given-names></name></person-group><article-title>Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly</article-title><source>J Gen Virol</source><year>1996</year><volume>77</volume><fpage>2287</fpage><lpage>2296</lpage><pub-id pub-id-type="pmid">8811029</pub-id></citation></ref><ref id="B308"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Llano</surname><given-names>M</given-names></name><name><surname>Guma</surname><given-names>M</given-names></name><name><surname>Ortega</surname><given-names>M</given-names></name><name><surname>Angulo</surname><given-names>A</given-names></name><name><surname>Lopez-Botet</surname><given-names>M</given-names></name></person-group><article-title>Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets</article-title><source>Eur J Immunol</source><year>2003</year><volume>33</volume><fpage>2744</fpage><lpage>2754</lpage><pub-id pub-id-type="pmid">14515258</pub-id></citation></ref><ref id="B309"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tirabassi</surname><given-names>RS</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>The human cytomegalovirus US8 glycoprotein binds to major histocompatibility complex class I products</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>6832</fpage><lpage>6835</lpage><pub-id pub-id-type="pmid">12050396</pub-id></citation></ref><ref id="B310"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>MH</given-names></name><name><surname>Dey</surname><given-names>N</given-names></name><name><surname>Tortorella</surname><given-names>D</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>11753</fpage><lpage>11756</lpage><pub-id pub-id-type="pmid">12388737</pub-id></citation></ref><ref id="B311"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>SG</given-names></name><name><surname>Strelow</surname><given-names>LI</given-names></name><name><surname>Franchi</surname><given-names>DC</given-names></name><name><surname>Anders</surname><given-names>DG</given-names></name><name><surname>Wong</surname><given-names>SW</given-names></name></person-group><article-title>Complete sequence and genomic analysis of rhesus cytomegalovirus</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>6620</fpage><lpage>6636</lpage><pub-id pub-id-type="pmid">12767982</pub-id></citation></ref><ref id="B312"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pande</surname><given-names>NT</given-names></name><name><surname>Powers</surname><given-names>C</given-names></name><name><surname>Ahn</surname><given-names>K</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>5786</fpage><lpage>5798</lpage><pub-id pub-id-type="pmid">15827193</pub-id></citation></ref><ref id="B313"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Powers</surname><given-names>CJ</given-names></name><name><surname>Fruh</surname><given-names>K</given-names></name></person-group><article-title>Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000150</fpage><pub-id pub-id-type="pmid">18833297</pub-id></citation></ref><ref id="B314"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>H</given-names></name><name><surname>Thale</surname><given-names>R</given-names></name><name><surname>Lucin</surname><given-names>P</given-names></name><name><surname>Muranyi</surname><given-names>W</given-names></name><name><surname>Flohr</surname><given-names>T</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Farrell</surname><given-names>H</given-names></name><name><surname>Rawlinson</surname><given-names>W</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments</article-title><source>Immunity</source><year>1997</year><volume>6</volume><fpage>57</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">9052837</pub-id></citation></ref><ref id="B315"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reusch</surname><given-names>U</given-names></name><name><surname>Muranyi</surname><given-names>W</given-names></name><name><surname>Lucin</surname><given-names>P</given-names></name><name><surname>Burgert</surname><given-names>HG</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation</article-title><source>EMBO J</source><year>1999</year><volume>18</volume><fpage>1081</fpage><lpage>1091</lpage><pub-id pub-id-type="pmid">10022849</pub-id></citation></ref><ref id="B316"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krmpotic</surname><given-names>A</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Crnkovic-Mertens</surname><given-names>I</given-names></name><name><surname>Polic</surname><given-names>B</given-names></name><name><surname>Jonjic</surname><given-names>S</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo</article-title><source>J Exp Med</source><year>1999</year><volume>190</volume><fpage>1285</fpage><lpage>1296</lpage><pub-id pub-id-type="pmid">10544200</pub-id></citation></ref><ref id="B317"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtappels</surname><given-names>R</given-names></name><name><surname>Gillert-Marien</surname><given-names>D</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Podlech</surname><given-names>J</given-names></name><name><surname>Deegen</surname><given-names>P</given-names></name><name><surname>Herter</surname><given-names>S</given-names></name><name><surname>Oehrlein-Karpi</surname><given-names>SA</given-names></name><name><surname>Strand</surname><given-names>D</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Reddehase</surname><given-names>MJ</given-names></name></person-group><article-title>Cytomegalovirus encodes a positive regulator of antigen presentation</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>7613</fpage><lpage>7624</lpage><pub-id pub-id-type="pmid">16840340</pub-id></citation></ref><ref id="B318"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kavanagh</surname><given-names>DG</given-names></name><name><surname>Gold</surname><given-names>MC</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name></person-group><article-title>The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion</article-title><source>J Exp Med</source><year>2001</year><volume>194</volume><fpage>967</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">11581318</pub-id></citation></ref><ref id="B319"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Gutermann</surname><given-names>A</given-names></name><name><surname>Podlech</surname><given-names>J</given-names></name><name><surname>Reddehase</surname><given-names>MJ</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus</article-title><source>J Exp Med</source><year>2002</year><volume>196</volume><fpage>805</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">12235213</pub-id></citation></ref><ref id="B320"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LoPiccolo</surname><given-names>DM</given-names></name><name><surname>Gold</surname><given-names>MC</given-names></name><name><surname>Kavanagh</surname><given-names>DG</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name></person-group><article-title>Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">12477835</pub-id></citation></ref><ref id="B321"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Reusch</surname><given-names>U</given-names></name><name><surname>Geginat</surname><given-names>G</given-names></name><name><surname>Holtappels</surname><given-names>R</given-names></name><name><surname>Ruppert</surname><given-names>T</given-names></name><name><surname>Hellebrand</surname><given-names>E</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name></person-group><article-title>Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus</article-title><source>J Virol</source><year>2000</year><volume>74</volume><fpage>7861</fpage><lpage>7868</lpage><pub-id pub-id-type="pmid">10933693</pub-id></citation></ref><ref id="B322"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MC</given-names></name><name><surname>Munks</surname><given-names>MW</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name><name><surname>Fling</surname><given-names>SP</given-names></name></person-group><article-title>The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>359</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">12077265</pub-id></citation></ref><ref id="B323"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>AK</given-names></name><name><surname>Munks</surname><given-names>MW</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name></person-group><article-title>Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><fpage>3225</fpage><lpage>3234</lpage><pub-id pub-id-type="pmid">16920962</pub-id></citation></ref><ref id="B324"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munks</surname><given-names>MW</given-names></name><name><surname>Pinto</surname><given-names>AK</given-names></name><name><surname>Doom</surname><given-names>CM</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name></person-group><article-title>Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>7235</fpage><lpage>7241</lpage><pub-id pub-id-type="pmid">17513772</pub-id></citation></ref><ref id="B325"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bohm</surname><given-names>V</given-names></name><name><surname>Podlech</surname><given-names>J</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Deegen</surname><given-names>P</given-names></name><name><surname>Pahl-Seibert</surname><given-names>MF</given-names></name><name><surname>Lemmermann</surname><given-names>NA</given-names></name><name><surname>Grzimek</surname><given-names>NK</given-names></name><name><surname>Oehrlein-Karpi</surname><given-names>SA</given-names></name><name><surname>Reddehase</surname><given-names>MJ</given-names></name><name><surname>Holtappels</surname><given-names>R</given-names></name></person-group><article-title>Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy</article-title><source>Med Microbiol Immunol</source><year>2008</year><volume>197</volume><fpage>135</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">18340461</pub-id></citation></ref><ref id="B326"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kleijnen</surname><given-names>MF</given-names></name><name><surname>Huppa</surname><given-names>JB</given-names></name><name><surname>Lucin</surname><given-names>P</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Farrell</surname><given-names>H</given-names></name><name><surname>Campbell</surname><given-names>AE</given-names></name><name><surname>Koszinowski</surname><given-names>UH</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name></person-group><article-title>A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface</article-title><source>EMBO J</source><year>1997</year><volume>16</volume><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">9049298</pub-id></citation></ref><ref id="B327"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Kavanagh</surname><given-names>DG</given-names></name><name><surname>Hill</surname><given-names>AB</given-names></name></person-group><article-title>Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/gp34 with major histocompatibility complex class I molecules</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>6048</fpage><lpage>6055</lpage><pub-id pub-id-type="pmid">16731943</pub-id></citation></ref><ref id="B328"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odeberg</surname><given-names>J</given-names></name><name><surname>Soderberg-Naucler</surname><given-names>C</given-names></name></person-group><article-title>Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>5174</fpage><lpage>5181</lpage><pub-id pub-id-type="pmid">11333898</pub-id></citation></ref><ref id="B329"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomazin</surname><given-names>R</given-names></name><name><surname>Boname</surname><given-names>J</given-names></name><name><surname>Hegde</surname><given-names>NR</given-names></name><name><surname>Lewinsohn</surname><given-names>DM</given-names></name><name><surname>Altschuler</surname><given-names>Y</given-names></name><name><surname>Jones</surname><given-names>TR</given-names></name><name><surname>Cresswell</surname><given-names>P</given-names></name><name><surname>Nelson</surname><given-names>JA</given-names></name><name><surname>Riddell</surname><given-names>SR</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name></person-group><article-title>Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells</article-title><source>Nat Med</source><year>1999</year><volume>5</volume><fpage>1039</fpage><lpage>1043</lpage><pub-id pub-id-type="pmid">10470081</pub-id></citation></ref><ref id="B330"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hegde</surname><given-names>NR</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name></person-group><article-title>Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>9287</fpage><lpage>9294</lpage><pub-id pub-id-type="pmid">12915544</pub-id></citation></ref><ref id="B331"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>MS</given-names></name><name><surname>Johnson</surname><given-names>DC</given-names></name></person-group><article-title>Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>4731</fpage><lpage>4738</lpage><pub-id pub-id-type="pmid">12663780</pub-id></citation></ref><ref id="B332"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odeberg</surname><given-names>J</given-names></name><name><surname>Plachter</surname><given-names>B</given-names></name><name><surname>Branden</surname><given-names>L</given-names></name><name><surname>Soderberg-Naucler</surname><given-names>C</given-names></name></person-group><article-title>Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain</article-title><source>Blood</source><year>2003</year><volume>101</volume><fpage>4870</fpage><lpage>4877</lpage><pub-id pub-id-type="pmid">12609847</pub-id></citation></ref><ref id="B333"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heise</surname><given-names>MT</given-names></name><name><surname>Connick</surname><given-names>M</given-names></name><name><surname>Virgin</surname><given-names>HWt</given-names></name></person-group><article-title>Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes</article-title><source>J Exp Med</source><year>1998</year><volume>187</volume><fpage>1037</fpage><lpage>1046</lpage><pub-id pub-id-type="pmid">9529320</pub-id></citation></ref></ref-list></back></article>